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“Education is the great engine of personal development. It is through education that the 
daughter of a peasant can become a doctor, that the son of a mineworker can become the 
head of the mine, that the child of a farmworker can become the president of a great nation. 
It is what we make out of what we have, not what we are given, that separates one person 
from another.”  
Nelson Mandela 
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Exeuctive Summary  
Traditional nutritional approaches for endurance training typically advise high 
carbohydrate (CHO) availability before, during and after each training session to suppor 
high training volume, intensity and recovery. However, during the last decade, 
accumulating data demonstrate that carefully scheduled periods of reduced CHO 
availability actually augment training-induced oxidative adaptations of skeletal muscle, the 
so-called train-low paradigm. In accordance with this movement there is also growing 
rationale ot consume protein before, during and/or after train-low sessions in an attempt to 
simultaneously promote mitochondrial biogenesis, muscle protein synthesis (MPS) and 
improve net muscle protein balance. The aim of this thesis was to assess the effects of 
reduced CHO but high protein availability on the regulation of molecular pathways 
associated with modulation of the aforementioned components of training adaptation. On 
the basis of characterising such molecular responses, a secondary aim was to formulate a 
nevel framework for which to practically apply train-low paradigms.  
Given the enhanced oxidative adaptatios observed when training in CHO restricted state is 
potentially regulated through free fatty acid (FFA)-mediated signalling, the aim of study 1 
(chapter 4) was to test the hypothesis that leucine-enriched protein feeding before and 
during exercise does not impair FFA availability or whole body lipid oxidation during 
exercise. Here I utulised a novel leucine enriched protein gel and compaired this agains a 
whey drink or placebo gel in a repeated masures design. This study showed that despite the 
insulemic effects of protein provision, there was no imparment in FFA availability or 
whole body lipid oxidation during exercise. Therefore, suggesting that protein feeding does 
not hinder a key objective of train-low sessions.  
Building on the results from study 1, I next saught to characterise the effects of reduced 
CHO but high leucine availability on exercise capacity and cell-signalling responses 
associated with exercise-induced regulation of mitochondrial biogenesis and MPS. While 
low CHO availability inhibited exercise capacity, comparible mitochondrial signalling 
responces were seen at the point of fatigue despite participants performing significantly 
more work in high CHO condition. This demonstrated that training with low CHO is work-
efficient in eliciting beneficial signals regulating mitochondrial biogenesis. Despite 
providing leucine rich protein before, during and after exercise, MPS related signalling 
could not be rescued during the CHO restriced post-exercise period in the low CHO 
condition. The data from this study suggest that although there are potential metabolic 
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benefits associated with reduced pre-exercise CHO availability, the post-exercise meal 
should contain sufficient CHO to restore muscle glycogen to sufficient levels and/or 
provide the nexessary energy to support post-exercise remodelling process.   
Having identified the potential detrimental effects of low CHO recovery, the aim of study 
3 (Chapter 6) was to examine the role of leucine availability in regulating post-exercise 
skeletal muscle remodelling processes in recovery from a train-low training session. Here I 
fed one of two protein types, a collagen (naturally low in leucine) or a whey (naturally high 
in leucine) protein during a low CHO training session, in a repeated measures design. 
When considered with study 2, the data from this study suggested that leucine is essential 
for reactivation of signalling mechanisms involved in protein translation, interestingly 
while low CHO training appeared to activate components of the system that selectively 
degrades malfunctional parts of the cell, leucine content had no effect on these processes.  
When taken together, the novel data presented in this thesis allude to a potential muscle 
glycogen threshold hypothesis surmising that reduced pre-exercise muscle glycogen may 
enhance the activation of those pathways regulating mitochondrial biogenesis but also 
suggest that keeping glycogen (and energy) at critically low levels may impair the 
regulation if post-exercise remodelling processes. From a practical perspective, data lend 
support for a potential “fuel for the work required” train-low paradigm in that athletes 
could strategically reduce CHO availability prior to completing pre-determined training 
workloads that can be redily performed with reduced CHO availability, thereby inducing a 
work efficient approach to training. Alternativly, when the goals of the training session are 
to complete the highest workload possible over more prolonged duration, then adequate 
CHO should be provided prior to and during the specific training session.   
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1.1 General Introduction 
It is well established that regular physical activity is beneficial for skeletal muscle, 
cardiovascular, pulmonary and cerebral health (Kodama et al. 2009).  Additionally, 
repeated bouts of exercise induce an adaptive effect of these systems thereby establishing 
new set points in homeostasis (Holloszy and Coyle, 1984).  In sport, the deliberate pursuit 
and attainment of such adaptations is known as the “training” effect, the result of which 
improves exercise performance (Bassett and Howley, 1999).  In the context of endurance 
exercise, the adaptive response to training on a whole body level is recognised functionally 
by increases in maximal oxygen uptake (V̇O2max) and the classic rightward shift of the 
lactate threshold curve (Morales-Alamo et al. 2015).  Such adaptations are underpinned by 
enhancement in oxygen delivery and utilisation by skeletal muscle, largely mediated via 
increased cardiac output (Mitchell et al. 1958), angiogenesis (Andersen and Henriksson, 
1977) and an increase in the size and number of mitochondria within skeletal muscle 
(Holloszy, 1967).  The latter process of mitochondrial biogenesis (an increased 
mitochondrial mass per gram of muscle tissue) is especially relevant for training-induced 
improvements in endurance performance (Coffey and Hawley, 2007). Indeed, increased 
mitochondrial mass and function permits less disturbance to homeostasis for a given 
workload (e.g. less ADP, AMP accumulation, glycogen utilisation, lactate production etc.), 
the result of which confers fatigue resistance.    
The traditional approach to enhancing endurance training adaptations is to manipulate 
training intensity, duration and recovery periods where the aim is to optimise the adaptive 
response to each consecutive training session (Bompa and Buzzichelli, 2015). However, 
with the increasing utilisation of molecular biology techniques in the sport and exercise 
science domain, accumulating data over the last two decades has also demonstrated a 
potent effect of nutrient availability on modulating many of the skeletal muscle cell 
signalling pathways that regulate components of training adaptation (Philp et al. 2012; 
Bartlett et al. 2015). Such nutritional modulation of endurance training adaptation is 
perhaps most widely recognised for carbohydrate (CHO) availability, where it is now 
generally accepted that carefully chosen periods of training with reduced CHO availability 
actually augments oxidative adaptations of human skeletal muscle (Bartlett et al. 2015).  
This approach, is of course, in stark contrast to the long held belief that training should 
always be completed with high CHO availability before, during and after exercise in order 
to promote training intensity, training volume and recovery (Bergstrom et al. 1967; Burke, 
17 
 
2010; Cermak and Van Loon, 2013).  Given the well-documented effects of high CHO 
availability on “competition” performance (Hawley et al. 1997), the strategy that has 
emerged therefore, is the concept of ‘train-low, compete high’.  This approach surmises 
that athletes deliberately complete specific sections of their training with restricted or ‘low’ 
CHO availability in order to enhance the adaptive response of skeletal muscle but yet, 
competition is always competed with ‘high’ CHO availability so as to maximise 
performance (Burke, 2010). 
When reviewing the relevant train-low literature to date, numerous independent 
laboratories have consistently observed that reducing endogenous and/or exogenous CHO 
availability during short-term (e.g. 3-10 week) endurance training increases mitochondrial 
enzyme activity and protein content (Morton et al. 2009; Yeo et al. 2008; Van Proeyen et 
al. 2011), increases both whole body (Yeo et al. 2008) and intramuscular lipid oxidation 
(Hulston et al. 2010) and in some instances, improves exercise capacity and performance 
(Hansen et al. 2005; Cochran et al. 2015; Marquet et al. 2016).  The augmented training 
response observed when “training low” is likely mediated via the complex regulation of 
cell signalling pathways that co-ordinate increased expression of both nuclear and 
mitochondrial encoded genes.  In the context of nutrient-gene interactions, it is therefore 
apparent that the acute molecular regulation of cell signalling processes provides a 
theoretical basis for understanding the molecular mechanisms underpinning chronic 
training adaptations.  
The research designs that have been used to study both acute and chronic train-low 
adaptations thus far, have largely adopted twice per day training protocols (Hansen et al. 
2005; Yeo et al. 2008; Hulston et al. 2010), fasted training (Van Proyen et al. 2011) and 
CHO restriction during (Morton et al. 2009) and/or post-exercise (Pilegaard et al. 2005). 
More recently, a “sleep-low, train-low” model has also been developed in which athletes 
perform an evening training session but sleep with reduced post-exercise CHO intake, 
followed by completion of a fasted training session on the subsequent morning (Bartlett et 
al. 2013; Marquet et al. 2016).  Despite the emergence of the aforementioned train-low 
paradigms, the optimal approach for which to practically apply with athletic populations is 
not currently known.  Such limitations are most well recognised for the potential 
reductions in absolute training intensity associated with reduced CHO availability (Widrick 
et al. 1993; Yeo et al. 2008; Hulston et al. 2010), perturbations to immune function and 
associated increases in muscle protein degradation (Lemon and Mullin, 1980; Howarth et 
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al. 2010), all of which could be detrimental to long term training and athletic performance. 
To compensate for the latter limitation, one potential strategy may be to consume intact 
protein or essential amino acids, before, during and/or after exercise. For example, the 
provision of nutrients in the form of protein (as opposed to CHO) may still allow for the 
enhanced cell signalling pathways associated with training with reduced carbohydrate 
availability but also provide an important substrate to promote skeletal muscle remodelling 
and potentially, minimise any progressive loss of lean mass during training. In this regard, 
accumulating data suggest that protein provision before (Coffey et al. 2011), during 
(Hulston et al. 2011) and after (Breen et al. 2011; Howarth et al. 2010) endurance or 
repeated sprint type protocols, enhances post-exercise skeletal muscle protein synthesis 
(MPS) as well as activation of some of the signalling molecules regulating translation 
initiation and elongation. Furthermore, increased protein availability reduces lean mass 
loss during heavy training periods when energy and CHO availability are restricted 
(Morton et al. 2010; Mettler et al. 2010; Pasiakos et al. 2013). Taken together, the above 
data suggest that protein ingestion before, during and after train-low sessions may 
therefore prove beneficial as it is likely to still allow for the enhanced cell signalling 
responses associated with reduced CHO availability whilst also improving net protein 
balance.  Nonetheless, it is also important to characterise the effects of protein feeding (and 
associated insulin response) during train-low sessions on circulating free fatty acid (FFA) 
concentrations, given that some of the training adaptations arising from “train-low” may 
actually be mediated by increased FFA availability, secondary to the effects of CHO 
restriction per se (Philp et al. 2013). 
In real world training environments of elite endurance athletes, it is also likely that athletes 
practice an “amalgamation” of the aforementioned train-low paradigms (either through 
default of their current training structure or via coach and sport scientist-led practices), as 
opposed to undertaking one potential strategy in isolation.  The complexity of practical 
train-low models is also further exacerbated by the observations that many endurance 
athletes (especially cyclists) also practice day-to-day or longer term periods of energy 
periodisation (as opposed to CHO per se) in an attempt to reduce both body mass and fat 
mass in preparation for key competitive events (Stellingwerff, 2012; Vogt et al. 2005). 
When taken together, such data highlight the requirement to study train-low paradigms that 
may be more reflective of real world athletic practice (i.e. both CHO and energy 
19 
 
restriction) and that are representative of an amalgamation of the train-low protocols 
previously studied in the research setting. 
The cellular recycling process of autophagy has emerged as an integral component of 
exercise induced remodelling processes. Indeed studies performed both in rodant and 
human muscle show that autophagy is activated in response to exercise in order to 
eliminate damaged or aberrantly folded proteins, contribute to remodelling of muscle as 
part of the adaptive response to exercise and mobilise proteins as alternative energy 
substrates for neoglucogenesis by the liver in cases of energetic stress (Schwalm et al. 
2015). Nonetheless, the understanding of how exercise affects autophagic flux is currently 
limited due to between species (rodent versus humans), nutritional status (fed versus 
fasted) and differences in exercise protocols (e.g. modality, intensity and duration) between 
studies (Vainshten and Hood, 2016).  Furthermore, to the best of my knowledge, no 
investigators have yet examined the effects of endurance exercise on autophagy markers 
whilst also quantifying muscle glycogen availability.  Given the well-documented effect of 
reduced muscle glycogen availability on exercise-induced protein degradation (Lemon and 
Mullin, 1980; Howarth et al. 2010), there is also a need to better understand the effects of 
exercise on markers of autophagy when completed under the conditions of reduced CHO 
(and energy) but high protein availability.  
 
1.2 Aims and Objectives  
The primary aim of the present thesis is to examine the effects of reduced CHO but high 
protein availability on the regulation of molecular pathways associated with modulating 
mitochondrial biogenesis, MPS and autophagy. On the basis of characterising such 
molecular responses, a secondary aim is to formulate a novel framework for which to 
practically apply train-low paradigms. 
This aim will be achieved by completion of the following objectives: 
 a) To test the hypothesis that leucine-enriched protein feeding does not impair circulating 
FFA availability or whole body lipid oxidation during exercise (Study 1, Chapter 4). 
b) To characterise the effects of reduced carbohydrate (CHO) but high leucine availability 
on exercise capacity and skeletal muscle cell-signalling responses associated with exercise-
induced regulation of mitochondrial biogenesis and MPS (Study 2, Chapter 5). 
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c) To examine the role of protein composition in regulating skeletal muscle cell-signalling 
responses associated with exercise-induced regulation of mitochondrial biogenesis, MPS 
and autophagy when in recovery from a train-low endurance training session (Study 3, 
Chapter 6).  
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Literature review  
2.1 Introduction 
Endurance exercise training induces many adaptations in skeletal muscle that function to 
improve exercise capacity and performance.  The most important of these adaptations is 
widely recognised as the increase in mitochondrial mass (i.e. mitochondrial biogenesis) 
which ultimately, permits athletes to exercise at higher intensities for a longer duration 
(Holloszy, 1967; Holloszy and Coyle, 1984).  The mechanism by which an increase in 
muscle mitochondria induces an improvement in exercise capacity and performance is by 
reducing the disturbance to metabolic homeostasis for a given exercise intensity (Coffey 
and Hawley, 2007; Coyle, 2000; Holloszy and Coyle, 1984).  In the trained state, acute 
customary exercise is therefore associated with smaller decreases in ATP, phosphocreatine 
and muscle glycogen utilisation and smaller increases in ADP, AMP, inorganic phosphate 
and muscle lactate accumulation. Such adaptations are recognised physiologically by the 
classic rightward shift of the lactate threshold curve and an increased reliance upon lipid 
sources to fuel muscle contraction (Camera et al. 2016). An increased understanding of the 
mechanisms by which regular exercise promotes mitochondrial biogenesis is therefore of 
paramount importance for those individuals with the common goal of improving endurance 
performance. 
With the introduction of molecular biology techniques to the sport and exercise sciences, a 
large body of research over the last decade has focused on elucidating the cellular and 
molecular mechanisms underpinning exercise-induced mitochondrial biogenesis (Holloszy, 
1967). The potential exercise-induced molecular ‘signals’ and signal transduction 
pathways are, of course, undoubtedly multi-factorial and highly complex. These signals 
(acting alone or likely in combination with each other) can activate a multitude of signal 
transduction pathways which initiate gene transcription and translation to create new 
proteins (Coffey and Hawley, 2007).  The cumulative effect of each acute exercise bout 
therefore leads to a change in the steady-state level of specific proteins (Holloszy and 
Booth, 1976).  Depending on the nature of the exercise stimulus (i.e. endurance versus 
resistance), the proteins up-regulated are typically mitochondrial or myofibrillar based, 
respectively.  It is these repeated and transient changes in gene expression and protein 
translation which are thought to form the molecular basis for training adaptation.  
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In addition to training stimulus, the capacity for nutritional modulation to augment 
adaptation is receiving increased recognition. The concept of training with low 
carbohydrate (CHO) availability has especially been identified as a potential component of 
nutrition-training interactions designed to improve performance (Bartlett et al. 2015). 
However, further research is required to elucidate the molecular mechanisms underpinning 
the enhanced adaptation associated with CHO restriction. Furthermore, the optimal 
strategy for which to practically apply a train low strategy with athletic populations is not 
currently known. 
The present chapter presents an overview of some of the key signalling pathways currently 
thought to mediate mitochondrial biogenesis, skeletal muscle protein turnover and 
autophagy. A brief review of how specific nutritional strategies affect these pathways is 
also included. This chapter is intended to provide the reader with an extended introduction 
and rationale as to the nature of the studies undertaken in this thesis. Where possible, data 
are reviewed from human studies though use of murine and cell culture models has been 
included to substantiate discussion points.       
 2.2 Carbohydrate and Performance 
2.2.1 Overview of CHO storage 
Glycogen is a branched polymer of glucose that serves as an energy reserve for ATP 
production and is found principally within muscle and liver cells. In skeletal muscle, the 
key importance of glycogen as an energy reserve lies in its rapid mobilization in response 
to elevated energy requirements, its capacity to serve as an energy source in the absence of 
oxygen, and the fact that the glycogen granule and glycolytic enzymes are widely 
distributed within the cell.  Glycogen molecules are exquisite examples of highly efficient 
cellular energy storage systems. The branched structure allows the dense 
compartmentalization of free glucose, providing muscle, or liver, with a readily accessible 
form of energy (Melendez-Hevia et al. 1993). Incorporation of glucose into a branched 
polymer allows glycogen granules to store large amounts of glucose without significantly 
affecting cellular osmolality. A single glycogen molecule can contain ~ 55,000 glucose 
residues in an area of 8,000 nm3. The branched structure of the glycogen granule enhances 
surface area, an essential component for phophorlyase-based degradation. In accordance, 
the regulation of the branch length, number and density appear to be highly regulated by 
conserved processes.  
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Beyond the structure and amount of glycogen particles, its location within the muscle also 
appears to be important. Evidence for compartmentalized glycogen metabolism arise from 
studies showing simultaneous synthesis and utilization of glycogen (Shulman and 
Rothman, 2001), lactate production during fully aerobic contractions, and a preferential 
requirement for glycolytic ATP by Na+-K+ pumps in several cell types including skeletal 
muscle (James et al. 1999). In accordance with these observations, glycogen particles are 
found in distinct locations within skeletal muscle. Three distinct sub-regions of glycogen 
storage appear in skeletal muscle, 1. Intermyofibrillar which is located between the 
myofibrils in close proximity to the sarcoplasmic reticulum and mitochondria; 2. 
Intramyofibrillar which is located in the myofibrils interspersed within the contractile 
filaments, and most often in the I-band of the sarcomere; and 3. Subsarcolemmal which is 
distributed just beneath the surface membrane in close association with the mitochondria, 
lipids, golgi apparatus and nuclei (Nielsen and Ortenblad. 2011). Several studies have 
demonstrated that the distribution of glycogen is related to distinct processes in skeletal 
muscle (Nielsen et al. 2009; Ortenblad et al. 2011). In relative terms, intermyofibrillar 
glycogen is the major site of glycogen deposition, constituting approximately 75% of the 
cell’s total store, whereas intramyofibrillar and subsarcolemmal account for 5 to 15% of 
the total respectively (Figure 2.1).  
 
 
 
 
 
 
 
 
Figure 2.1 – Electron micrograph of human vastus lateralis displaying compartmental 
glycogen distribution. 1. Intermyofibrillar, 2. Intramyofibrillar and 3. Subsarcolemmal. 
Image taken at LJMU microscopy laboratory by S. Impey.   
 
2 
1 
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Glycogen is stored in liver (~100g) and skeletal muscle (350 – 700g depending on training 
status and diet). These endogenous carbohydrate stores are relatively small (~5% of total 
energy storage) although it is well recognised that muscle glycogen represents a significant 
fuel source for sustained moderate- to high-intensity exercise contributing to more than 
50% of total energy requirements (Tsintzas and Williams. 1998). Carbohydrate oxidation 
yields greater ATP re-synthesis per unit of oxygen delivered to the mitochondria, when 
compared with fat, thereby making it a logical choice for skeletal muscle to use given the 
effect of improved gross efficiency (Krough and Lindhard, 1923).  Furthermore, given the 
ability for carbohydrate to support energy production in both anaerobic and aerobic 
exercise, even when working at very high exercise intensities carbohydrate is still able to 
derive energy through oxidative phosphorylation (van Loon et al. 2001).   
2.2.2 CHO availability and exercise performance 
Pre-exercise meals 
The consensus from the wealth of studies undertaken in the last 40 years is that CHO 
loading can improve performance and capacity especially when the exercise is greater than 
90 minutes in duration (Hawley et al.  1997). Initial evidence for the beneficial effect of 
pre-exercise CHO provision was provided by classic studies from Christensen and Hansen 
(1939a, 1939b) showing that greater ingestion of CHO extended the duration work at a 
fixed power output could be sustained. Subsequently two seminal studies of Burgstrom et 
al.  (1967) and Karlsson and Saltin (1971) characterised the supercompensation of muscle 
glycogen following depletion and the beneficial effects this had on exercise capacity. 
These studies categorically demonstrated that commencing exercise with higher muscle 
glycogen levels through several days of feeding improved exercise capacity and 
performance, in an almost linear fashion. A less extreme form of CHO loading was 
developed in the 1980s where Sherman et al. (1991) observed that a simple exercise taper 
in conjunction with several days of increased dietary CHO intake was also sufficient to 
increase glycogen storage, It is now generally accepted that trained athletes can increase 
glycogen storage in both type I and II fibres within 24 – 48 hours of increased CHO intake 
(Bussau et al. 2002).  
 
The enhanced performance effect is likely initially mediated by a delay in the time-point at 
which energy availability becomes limiting to the maintenance of the desired workload, 
26 
 
which in the case of race pace is dependent on sustained and high rates of CHO oxidation 
(O’Brien et al.  1993; Leckey et al.  2016).  Indeed, in reviewing the literature Hawley et 
al.  (1997) cited that CHO loading can improve exercise capacity by approximately 20% 
and time-trial performance can increase by 2-3%.  In addition to providing substrate 
availability for ATP production, it is now recognized that glycogen availability (especially 
the intramyofibrillar storage pool) can directly modulate contractile function.  Indeed, a 
series of studies from Ørtenblad and colleagues (Geji et al.  2014; Ørtenblad et al.  2011, 
2013) have collectively shown a preferential utilization of this storage pool during exercise 
in a manner that also correlates with impaired Ca2+ release from the sarcoplasmic 
reticulum.  Such impaired excitation-contraction coupling is likely to be of particular 
importance during those situations where higher power outputs and sprint finishes are 
required in the very late and finishing stages of races.  
Even without several days of high CHO feeding, performance can still be improved by 
feeding in the 1 (Sherman et al. 1991) to 4 hours (Neufer et al. 1987; Sherman et al. 1989; 
Wright et al. 1991) prior to exercise. While a window of 1 – 4 h remains comparatively 
vague, is interesting to note that when CHO provision was given < 1h prior to exercise 
evidence has presented negative (Foster et al. 1978; Hargreaves et al. 1987) and neutral 
(Devlin et al. 1986) performance outcomes. The magnitude of glycogen increase resulting 
from pre-exercise CHO provision was characterised by Chryssanthopoulous et al. (2004) 
who observed that an increase of 10% was achievable in 3h by the provision of 2.5 g·kg-1 
CHO meal following an overnight fast.  
In relation to practical application pre-exercise CHO should come from foods low in fat 
and fibre with high glycaemic index carbohydrates (Burk et al.  1993), often with low-
moderate protein content to minimise propensity to gastrointestinal problems and promote 
gastric emptying (Rehrer et al. 1992). In relation to athlete prescription it is essential to suit 
the timing, amount and food/supplement choice to the athlete ensuring sufficient 
nutritional training has been undertaken prior to a competitive event to ensure no 
gastrointestinal distress from a unique or novel digestive challenge. In relation to training, 
pre-exercise feeding should be planned to facilitate the intensity and duration of training, 
considering feeding during exercise and recovery strategy (discussed below) to maximise 
the adaptive response.    
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Carbohydrate during exercise  
Numerous studies have demonstrated the ergogenic effects of CHO feeding during 
prolonged moderate- to high-intensity exercise (Burgstrom and Hultman, 1967; Febbraio et 
al. 2000; Widrick et al. 1993; Sherman et al. 1991). Meta-analysis of 88 randomized 
crossover studies investigating the effect of CHO intake during exercise concluded a range 
of substantial 6% improvement to moderate 2% improvements (range -2 to 6.5%) in 
performance metrics. The authors concluded the largest effect (6.5%) occurred when the 
supplement consisted of 3 – 10% CHO plus protein drink providing ~0.7 g·kg-1.h-1 glucose 
polymers, ~0.2 g·kg-1.h-1 fructose and 0.2 g·kg-1.h-1 protein (Vanderbogaerde and Hopkins, 
2011). It is important to consider 83% of the included studies utilised cycling exercise and 
measured ether exercise capacity by time-to-exhaustion (mean duration 106 min) or 
exercise performance using time-trials (mean duration 47 min), thus interpretation of the 
overall results should be considered in an exercise and duration specific manor. 
Nonetheless, the bulk of studies to date demonstrate CHO appears to confer improvements 
in exercise capacity (time to exhaustion) and exercise performance during prolonged 
exercise (>2h) at low intensity as well as shorter exercise of high intensity (~1h at >75% 
V̇O2max) (Jeukendrup et al.  1997).  
It is well established that CHO intake before and during exercise improves performance, 
however initial studies presented controversy regarding the nature of the mechanism 
underpinning this response. Glycogen sparing resulting from provision and oxidation of 
exogenous CHO was suggested, however few studies observed decreased glycogen 
utilization during continuous cycling exercise with CHO intake (Bergstrom and Hultman, 
1967; Erickson et al. 1987), with several experiments observing equivocal net glycogen 
breakdown pre- to post-exercise between nutritional conditions (Coyle et al. 1997; De 
Bock et al. 2005; Hargreaves and Briggs, 1988). The lack of observed change in the latter 
studies may be due to methodological factors. The analysis of muscle glycogen content 
from whole muscle homogenates does not allow the differentiation of glycogen use 
between fibre types. Given that glycogen synthase and phosphorylase enzymes are 
differentially expressed within muscle fibres, with type I exhibiting lower phosphorylase 
and greater synthase activity compared with type II fibres (Dauggard and Richter, 2004), a 
distinct patter of glycogen use during exercise is logical. Indeed, De Bock et al. (2007) 
were the first to demonstrate muscle glycogen sparing during exercise in type IIa fibres 
with provision of CHO in line with appropriate nutritional recommendations compared to 
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fasted exercise; these authors suggested this as the mechanism by which sprint 
performance is augmented at the end of an endurance exercise bout when CHO is 
provided. The intensity of exercise plays an important role in the contribution of fibre 
types to power production in that lower intensities require more type I with increased type 
II contribution with increasing intensity (Gollnick et al. 1974), thus the glycogen use 
within specific components of skeletal muscle is highly dependent on exercise intensity 
and this should be taken into consideration when applying research outcomes to 
prescription of nutrition within specific sporting situations.  
The rate of exogenous CHO oxidation during exercise was initially thought maximal at 
~1g/min (Leijssen et al. 1995), likely mediated by saturation of the sodium-dependent 
glucose transporter (SGLT1) in the intestine. Thus, addition of fructose was speculated to 
be able to increase total delivery of CHO into the circulation via its absorption through a 
different transporter (GLUT-5) (Ferraris and Diamond. 1997). Subsequently many studies 
have demonstrated rates of oxidation greater than 1 g/min up to 1.75 g/min when multiple 
transportable CHO’s are provided during exercise (Jeukendrup. 2010). Improved 
performance has been observed with multiple transportable CHO’s, the consensus of 
research indicates that these are best used during endurance events lasting greater than 3h 
when CHO is ingested at high rates (Jeukendrup. 2010). 
Collectively the significant bulk of experimental data produced to date demonstrates a 
beneficial effect for provision of CHO during endurance exercise. The mechanisms by 
which CHO conveys performance improvements has yet to be fully characterised. Given 
the well documented observations that fatigue coincides with muscle glycogen depletion 
(Burgstrom et al, 1967), exogenous carbohydrate consumption during prolonged exercise 
has consistantly been shown to attenuate the rate of glycogenolysis thereby sparing muscle 
glycogen and ultimately delaying the onset of fatigue (Bjorkman et al. 1984; Tsintzas et al. 
1998). Of note the sparing of muscle glycogen appears to be fibre type dependent. The 
duration and intensity of exercise appear to regulate the fibres in which glycogen is spared, 
in that shorter duration (≤ 1 h) higher intensity (≥ 70% V̇O2max) exercise preferentially 
spares glycogen in type I fibres (Hulston et al. 2009), whereas longer duration (~ 3 h) at 
lower intensity (≤ 60% V̇O2max) appears to spare type II muscle fibres only (Tsintzas et al. 
1995). Thus, the mechanism for glycogen sparing may be exercise specific and localised to 
specific fibre pools. One immediate benefit from supply of exogenous CHO is maintained 
euglycemic during exercise. Maintenance of blood glucose concentrations is purported to 
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convey beneficial effects on performance via provision of exogenous substrate to 
contracting muscle but also likely delays fatigue induced by central mechanisms (Nybo, 
2003), which also appear to be activated by mouth rinsing CHO when in a glycogen 
depleted state (Kasper et al. 2015).  These data point to a combination of different systems 
interacting under the provision of exogenous CHO to increase performance (Cermac and 
van Loon, 2013).  
Carbohydrate post exercise  
Muscle glycogen synthesis following exercise follows a biphasic pattern. Initially a period 
of rapid synthesis occurs independent of insulin, lasting 30 – 60 minutes. This rapid phase 
of glycogen synthesis is characterised by exercise-induced translocation of GLUT-4 to the 
cell membrane facilitating glucose uptake from the circulation. Following the initial rapid 
phase, muscle glycogen synthesis occurs at a much slower rate and this phase can last for 
several hours (Jentjens and Jeukendrup, 2003).   
The rapid phase of glycogen synthesis proceeds without the requirement of insulin and is 
thus often referred to as the insulin-independent phase (Piehl, 1974). This rapid phase has 
been suggested to occur only when post-exercise muscle glycogen concentrations are 
lower than ~120 – 150 mmol/kg dw (Price et al. 1994) and CHO is provided immediately 
after exercise (Ivy et al. 1998). Several mechanisms underpin the insulin-independent 
nature of this rapid phase. GLUT-4 mediated transport of CHO into skeletal muscle to 
facilitate rapid resynthesis is stimulated by mechanical stress activating p38 MAPK 
induced by sustained muscle contraction (Geiger et al. 2005), in addition AMPK activity 
further stimulates GLUT-4 membrane translocation, this process is partly regulated by 
muscle glycogen concentrations per se given the glycogen binding domain found in the β 
subunit of AMPK (McBride et al. 2009).  
Parallel with augmented glucose uptake the enzyme activity of glycogen synthase is 
significantly increased with low glycogen levels. The increased glycogen synthase activity 
is regulated by the binding of glycogen synthase, glycogen synthase phosphatase and 
glycogen phosphorylase to glycogen (Ivy and Kuo, 1998). When glycogen concentrations 
decrease both glycogen synthase phosphatase and glycogen synthases are released, the 
active phosphatase then catalyses dephosphorylation of glycogen synthase converting it to 
its active form increasing the rate of glycogen synthesis (Ivy and Kuo, 1998). The slow 
phase, or insulin dependent phase is characterised by skeletal muscle displaying an 
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increased sensitivity to insulin that can last for several hours depending on level of 
glycogen depletion and provision of CHO (Cartee et al. 1989). The precise mechanism 
underpinning the increased insulin sensitivity is currently unknown, but is likely a 
cumulative interaction between muscle glycogen concentration, serum factor(s), AMPK 
and insulin signalling molecules (Jensen and Richter, 2012) 
Regarding the amount of CHO required to facilitate maximal rates of glycogen synthesis, 
early work suggested that provision of 0.7 g/kg/h given immediately after exercise as a 
single bolus eliciting ~20 mmol/kg dw/h rate of resynthesis was the maximal rate 
attainable over 4h (Ivy et al. 1987). However, later work using smaller but more numerous 
(30 min interval) provision of CHO feeds following exercise providing 1.2 g/kg/h elicited a 
much greater synthesis rate of 44.8 mmol/kg dw/h (van Loon et al. 2000). Several other 
studies have observed similar rates of synthesis when providing 1 g/kg/h or greater CHO at 
15 – 60 min intervals in the first 0 – 5 h post exercise reporting resynthesis rates of 40 – 50 
mmol/kg dw/h (Blom, 1989; Doyle et al. 1993; Hickner et al. 1997; Jentjens et al. 2001; 
Piehl, 1974; Tarnopolsky et al. 1997; van Hall et al. 2000). The highest rate of glycogen 
resynthesis recorded following infusion of CHO while being in a glycogen depleted state 
was 85 mmol/kg dw/h (Burgstrom and Hultman, 1967). Given the insulemic effects of 
protein, early studies speculated that the addition of protein may further augment glycogen 
synthesis. Several well-designed methodologies tested multiple amino acid and protein 
(whey, wheat, isolate, hydrolysate etc.) combinations with CHO between 0.8 – 1.5 g/kg/h 
and showed no further benefit to provision of 1.2 g/kg/h CHO alone (Jentjens et al. 2001; 
van Hall et al. 2000; van Loon et al. 2001; Zawadzki et al. 1992). Given CHO alone was 
most effective at resynthesizing glycogen, the type of CHO ingested and method of 
delivery are also important factors to consider. CHO of high glycaemic index (GI) has 
been shown to produce 61% greater rate of resynthesis of glycogen than provision of CHO 
with low-GI (Burke, 1993). The effect of GI likely mediates its effect via increased gastric 
emptying and thus concentration in the blood available for absorption by skeletal muscle. 
Provision of high-GI CHO in liquid versus solid form appears to be equivocal in relation to 
muscle glycogen synthesis (Reed et al. 1989). Liquid provision of CHO using low or high 
molecular weight monomers and oligomers (concentration of 85 and 350 mosmol.l-1 has 
been shown to be most effective to facilitate glycogen synthesis (Piehl, 1974). Recent work 
utilising the concept of multiple transportable CHO’s suggest this may be a method to 
further augment glycogen synthesis. Wallis et al. (2008) found no benefit of addition of 
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fructose to glucose for glycogen resynthesis following exercise, however glucose in the 
glucose-fructose trial was provided at 0.8 g/kg/h, well below the 1.2 g/kg/h recommended. 
Further work by Trommelen et al.  (2016) examined glucose, glucose-fructose and 
glucose-sucrose combinations feeding at 1.5 g/kg/h at 30 min intervals for 5h, this group 
also noted no additive effect of fructose or sucrose over glucose alone at facilitating 
glycogen synthesis.  
Practically, provision of a mix of fluid and solid CHO is recommended to facilitate 
rehydration and repletion of glycogen following exercise. The CHO provided should be 
high-GI and easily palatable providing 1.2 g/kg/h CHO at 30 min intervals for up to 5h if 
necessary, depending on the duration and intensity of exercise in addition to consideration 
of the goals of the next training session or proximity of competition.     
2.3 Training adaptations to endurance exercise 
2.3.1 Overview of adaptations  
Physiologists have long held an appreciation for the trainability of skeletal muscle. For 
example, Astrand (1956) reviewed the physiological limits of human performance, noting 
that the outstanding feats that could be achieved by athletes were the result of both natural 
endowment as well as specific exercise training. It was, however, another decade before 
Holloszy (1967) published seminal work demonstrating that respiratory enzymes in rat 
skeletal muscle as well as whole-body oxygen consumption could be increased with 
stringent endurance exercise training. In addition, a plethora of adaptive responses have 
been observed following endurance exercise training including fibre type shifts towards an 
oxidative phenotype (Andersen and Heriksson, 1977), angiogenesis and increased capillary 
to fibre ratio (Andersen and Henriksson, 1977) as well as increased vascular bedding 
around alveoli. In addition to the increased surface area for gaseous exchange, enhanced 
cardiac output via increased left ventricular ejection fraction (Ekblom et al. 1968) 
circulates the oxygenated blood at greater rate. Skeletal muscle displays increased capacity 
for glycogen storage in (Saltin and Rowell, 1980) in addition to increased intramuscular 
lipid content and oxidation during exercise, as well as reductions in blood lactate 
accumulation during incremental exercise intensities (Gollinck and Saltin, 1982). Thus, the 
picture emerges is that increases in exercise capacity or performance are a combination of 
several tissues and a cumulative result of systemic as well as local adaptations.  
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Mitochondrial biogenesis underpins skeletal muscle oxidative capacity and is therefore 
considered the hallmark of intracellular adaptation to endurance exercise (Camera et al. 
2016). The metabolic adaptations that accompany mitochondrial biogenesis are increased 
abundance of proteins involved in mitochondrial ATP production, the TCA cycle, 
mobilization, transport and oxidation of free fatty acids, glycolytic metabolism, antioxidant 
capacity, glucose transport, glycogen synthesis, and oxygen delivery to and utilisation by 
skeletal muscle. These training induced increases in metabolic enzyme activity and 
mitochondrial density result in enhanced respiratory control sensitivity such that a lower 
[ADP] is required to achieve the same level of oxygen consumption per gram of muscle. 
This adaptation allows the same cellular rate of oxidative metabolism with less agitation of 
adenine nucleotides and a lower rate of oxidative phosphorylation per mitochondrion 
(Holloszy and Coyle, 1984). The effect of this enhanced efficiency of energy production in 
the mitochondria in addition to the constituents of the skeletal cell results in smaller 
increases in free [ADP] and greater preservation of [ATP] and [PCr] at the same absolute 
power output prior to training. These adaptations attenuate the formation of allosteric 
regulators for glycogenolysis, glycolysis and lactate production after training (Gollinck and 
Saltin, 1982). Accordingly, the overall capacity for lipid oxidation is markedly increased 
(Talanian, et al. 2010), resulting in an increase in the fraction of ATP provision from 
oxidative metabolism (resulting from mitochondrial biogenesis) analogous with superior 
respiratory control sensitivity coupled to decreased flux through glycolytic pathways 
resulting in reduction of carbohydrate utilization after training. Consequently, decreased 
carbohydrate utilization during exercise in the trained state is compensated for by a 
proportional increase in lipid oxidation rates at the same absolute and intensities (Holloszy 
and Coyle, 1984). Hence, increased endurance performance resulting from training is 
attributable to enhanced fatigue resistance by virtue of reduced muscle glycogen depletion, 
enhanced coupling of ATP supply and demand, enhanced transport and β-oxidation of fatty 
acid sources, thereby producing smaller disturbances to homeostasis (Egan and Zierath, 
2013).  
2.3.2 Molecular mechanisms regulating training adaptation 
Skeletal muscle adaptation to exercise training is a consequence of repeated contraction-
induced increases in gene expression that lead to the accumulation of proteins that function 
to blunt the homeostatic perturbations generated by contraction-induced increases in 
energy demand and substrate turnover. The development of a specific “exercise 
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phonotype” is the result of a new, augmented steady-state mRNA and protein levels that 
stem from the training stimulus (Perry et al. 2010), which can be modified by the 
prevailing energy availability. This section will focus on the molecular regulators of 
mitochondrial adaptation, while acknowledging the contribution of multiple systems in 
contributing to enhanced endurance performance.  
In accordance with the ~100-fold increase in ATP turnover elicited by endurance exercise, 
significant perturbations in the intracellular constituents of skeletal muscle bioenergetics 
and redox reactions are induced triggering respiratory bursts of free radicals in 
collaboration with calcium oscillations for sustained actin-myosin cross bridge cycling 
(Egam and Zerath, 2013). The dynamic fluctuation in ratio and subcellular location of 
these exercise associated energetic by-products activates key enzymes such as AMP-
dependent protein kinase (AMPK), p38 mitogen-activate protein kinase (p38 MAPK) and 
Ca2+/calmodulin-dependent protein kinase II (CaMKII). Once activated these kinases 
converge on nuclear and mitochondrial transcription factors (e.g. p53) and transcriptional 
co-activators (e.g. PGC-1α), responsible for synthesis of mitochondrial proteins, lipid and 
DNA constructs required for mitochondrial biogenesis (Egan and Zierath, 2013).  
Briefly, increased ADP and AMP resulting from exercise bind to the APMKγ subunit 
resulting in a conformational change that exposes the amino-terminal kinase domain in the 
catalytic α subunit. The α subunit can be phosphorylated at Thr172 by activating kinases 
such as CaMK kinase and liver kinase B-1, resulting in AMPK activation. In addition, the 
discovery of a glycogen binding domain in the β subunit further supports the exercise 
induced activation of AMPK (McBride et al. 2009). CaMKII autophosphorylates and 
activates through shifts in intracellular Ca2+ concentrations resulting from muscle 
concentrations. p38MAPK has been shown to be activated by various types of exercise, 
however the precise mechanism of exercise-induced activation and isoform specificity 
remain to be fully elucidated. The elevation of cytosolic Ca2+ during muscle contraction 
has been demonstrated to activate p38MAPK likely through a CaMKII mediated 
mechanism (Drake et al. 2015). Following the initial activation of regulatory enzymes 
following metabolic perturbations, these signalling mechanisms converge on peroxisome 
proliferator-activate receptor γ coactivator 1α (PGC-1α) (Puigserver and Spiegelamn, 
2003) a purported ‘master regulator’ of mitochondrial biogenesis and p53, a well-known 
stress sensing gene known for involvement with tumour suppression, genomic stability and 
recently regulation of mitochondrial respiration (Matoba, et al. 2006).  
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2.3.2.1 PGC-1α  
PGC-1α has been termed the ‘master regulator’ of mitochondrial biogenesis and is 
implicated as a co-activator for a significant number of nuclear and mitochondrial 
transcription factors, hence there has been considerable interest in this protein in relation to 
exercise as discussed here. PGC-1α is a second class co-activator with a basic protein 
structure consisting of an activation domain with the LXXLL sequence in the N-terminal, a 
central region associated with repression, and a RNA-binding motif and serine-arginine-
rich region in the C-terminal (Puigserver and Spiegelamn, 2003). PGC-1α was discovered 
via its functional interaction with the transcription factor PPARγ in brown adipose tissue 
(Puigserver, et al. 1998). The gene encoding PGC-1α is located on chromosome 4 in 
humans, consisting of 798 amino acids it has a predicted molecular weight of 92 kDa 
(Uguccioni, et al. 2010).  
PGC-1α is activated by proteins containing histone acetlytransferase binding to its N-
terminal when the coactivator is bound to a transcription factor. This binding remodels 
histones and chromatin and allows for greater access of the transcriptional machinery to 
DNA for gene transcription (Ugucioni, et al. 2010). Additionally, the RNA-binding motif 
and serine-arginine rich region domains in the C-terminus are characteristics of proteins 
with mRNA splicing and export activity, thus indicating that PGC-1α acts as a platform to 
integrate many proteins and processes involved in the production of mature mRNA 
transcripts (Pugiserver et al. 1998).  In relation to mitochondrial biogenesis, PGC-1α exerts 
these effects through direct interaction with, and coactivation of PPARs, ERRs and NRF-
1/NRF-2 among other transcription factors (Scarpulla et al. 2012). NRF-1/NRF-2 binding 
sites are located in the promoter regions or multiple nuclear genes encoding mitochondrial 
proteins including, cytocrome c, components of the electron transport chain complexes, 
heme biosynthesis proteins, mitochondrial import-proteins, and mitochondrial transcription 
factor A (Tfam) which subsequently binds mitochondrial DNA (mtDNA) (Hood, 2009). In 
this way, PGC-1α can effectively coordinate both nuclear and mitochondrial genomes in 
the regulation of mitochondrial biogenesis. 
Early work in human exercise trials demonstrated transcription of PGC-1 variants (α, β and 
PRC) following a single bout of knee extensor exercise, and that this transcriptional 
response to acute exercise was sustained following training (Mortensen, et al. 2007). 
Seminal work by Burgomaster et al.  (2008) demonstrated the ability of sprint interval 
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(SIT) and traditional endurance training to elicit similar increases in PGC-1α protein 
content despite significantly less time and energy expenditure in SIT. The observed 
increase correlated with increased mitochondrial enzyme content and augmented lipid 
oxidation during submaximal exercise (Burgomaster et al. 2008). Subsequently, exercise 
intensity has been shown to be a key factor in determining PGC-1α transcriptional 
response to exercise.  Indeed, when exercise was work matched in a repeated measures 
design, participants expressed significantly more PGC-1α following work completed at 
80% than 40% V̇O2max (Egan et al. 2010), however no further beneficial effect has been 
observed when exercise is undertaken above 100% V̇O2max (Edgett et al. 2013).  
The accumulation of PGC-1α protein has been shown to result from cumulative repeated 
transient mRNA bursts, with measurable increases in protein content 24 h following 
exercise (Perry et al. 2010). However, transcription of mRNA from known PGC-1α targets 
have been observed in parallel with PGC-1α transcription prompting the notion that 
cellular location in addition to protein content is an essential component of the exercise-
PGC-1α interaction. HIT exercise was initially shown to induce nuclear shuttling of PGC-
1α in human skeletal muscle (Little et al. 2011), subsequent work in rats has shown 
translocation to both nuclear and mitochondria following exercise (Safdar et al. 2011). 
AMPK activity was subsequently identified as an essential component in this translocation 
process using both human and murine total knock out models (Smith et al. 2013). Of 
interest, when a muscle specific PGC-1α knock out model was used similar adaptations to 
endurance exercise training were observed in both exercise capacity and mitochondrial 
morphology and function (Row et al. 2012), demonstrating PGC-1α is not a “sole” master 
regulator and further eliciting the multifactorial nature of signals integrating to cause 
mitochondrial biogenesis. Further effects of the regulation of PGC-1α are being explored 
and recently, a single nucleotide polymorphism (SNP) of the PGC-1α was identified to 
contribute to slow twitch fibre type accumulation following endurance exercise 
(Steinbacher et al. 2015). Significant evidence exists describing the nutritional regulation 
of PGC-1α, as discussed in later sections.   
2.3.2.2 p53  
P53 was first reported and cloned in the mid 1980’s, with the protein consisting of 393 
amino acids (Matlashewski et al. 1984). The role of p53 as a tumor suppressor protein and 
the effects it has on cell cycle arrest, apoptosis, pro- and antioxidant activity, angiogenesis, 
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DNA repair, differentiation, fertilisation, aging and senescence is well documented. Whilst 
these were recognised as primary functions, emerging evidence suggests p53 is also 
involved in regulating pathways of energy metabolism and mitochondrial biogenesis. 
Initial evidence for p53 holding a mitochondrial regulatory role is derived from cells 
lacking p53 reverting to high glucose in aerobic metabolism and having perturbed 
mitochondrial respiration (Feng et al. 2010). Additionally, p53 regulates synthesis of 
cytochrome c oxidase 2 (SCO2), which is required for the assembly of mtDNA-encoded 
COXII subunit in the COVIV complex (Matoba et al. 2006). The importance of p53 in an 
exercise capacity was first documented following a significant reduction in exercise 
capacity of p53 null mice (Saleem et al. 2009; Park et al. 2009).  
Exercise per se has been shown to facilitate translocation of p53 to both subsarcolemal and 
intermyofibrillar mitochondria, reducing the nuclear content of p53. This translocation was 
associated with increased D-loop binding to mtDNA and Tfam association (Saleem et al, 
2013a). Knocking out p53 was shown to diminish nuclear PGC-1α translocation as well as 
reducing kinase activity of putative exercise signalling cascades and transcripts mRNA 
related to mitochondrial biogenesis (Saleem et al. 2013b). The knockout of p53 precluded 
a morphological change in mitochondria in addition to reduction in mitochondrial import 
protein content, assembly of COXIV complex in intramyofibrillar mitochondria and the 
expression of proteins regulating mitochondria fusion and fission (Saleem et al. 2015). 
Subsequent to the seminal studies mentioned above, Bartlett et al.  (2012) were the first to 
demonstrate the capacity of p53 to become phosphorylated following exercise in human 
skeletal muscle, an effect augmented by commencing exercise with low muscle glycogen 
(Bartlett et al. 2013). Recently, nuclear translocation of p53 was also demonstrated in 
human skeletal muscle following exercise (Tachtsis et al. 2016).  
In the context of exercise, activation and regulation of p53 would appear to be mediated by 
exercise-nutrition interventions designed to elicit considerable stress on the body. In 
addition to the work of Bartlett et al.  (2013) demonstrating the apparent regulatory 
component of glycogen, exercise intensity has been show essential to elicit increases in 
mitochondrial respiration rate associated with increase in p53 protein content (Granata et 
al. 2015). Indeed, sprint intervals performed for 30s at 200% peak power elicited greater 
increases in protein content and mitochondrial respiration than sub-lactate threshold 
continuous and high intensity intermittent (4min at 90% peak power) work matched 
training. These authors noted dissociation between changes in respiration and 
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mitochondrial content of electron transport system components, however, changes in 
protein content of p53 in addition to PGC-1α and PHF20 correlated with the observed 
respiration changes. The same group subsequently demonstrated a similar effect with 
increased total training volume (Granata et al. 2016), adding to the notion that increases in 
p53 activity and protein content require an augmented stress response, ether from nutrition, 
exercise or combination of both. This logic follows principles of training in that to induce 
an adaptation, homeostasis needs to be perturbed to force a response minimising the stress 
placed on the body if the exercise is undertaken again. While the body of literature 
surrounding exercise and p53 is relatively small, given the number of cellular interactions 
and regulatory capacity p53 holds, significantly more biomolecular and physiological data 
is likely to be produced from further examination of this protein in the context of exercise.  
2.4 Train smart compete high 
While the provision of high CHO before, during and after exercise to promote performance 
and recovery during competition is an essential part of a well-structured nutritional 
program (Stellingwerff et al. 2012), recent evidence suggests that training with reduced 
CHO availability augments cellular adaptations to exercise, increasing the potency of the 
training response leading to enhanced performance. This methodology was initially termed 
“train-low” and is composed of several nutrition-exercise interactions detailed below.  
2.4.1 Physiological and metabolic effects of exercise with low muscle glycogen 
Early experiments examining the effects of exercising with low muscle glycogen 
investigated the metabolic contribution of amino acids to energy production during 
exercise (Lemon and Mullin, 1980; Haralambie and Berg, 1976). However, these early 
studies while extremely informative contained an order effect limiting the interpretation of 
the role of glycogen content per se. Blomstrand and Saltin (1999) resolved this via the use 
of an elegant study design where one leg completed a glycogen depleting exercise in the 
evening before exercising both legs the next morning, thus providing the same arterial 
supply to both legs and same hormonal response during exercise. Glycogen breakdown 
during exercise was 60% lower, and the rate of glucose uptake during exercise was 30% 
higher in the leg with reduced pre-exercise glycogen content, additionally amino acid 
efflux from the low glycogen leg was significantly greater indicating differential 
contributions of substrate to energy production during exercise between high- and low-
glycogen legs, and that this shift was caused by low muscle glycogen per se.  
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In addition to differential amino acid metabolism, a significant contribution of lipid 
oxidation was observed with exercise undertaken with low muscle glycogen. Several 
studies reported significant increases in FFA concentrations in venous (Widrick et al. 
1993) and arterial (Pilegaard et al. 2002) samples in addition to increased FFA uptake 
across a – v difference during exercise across the leg (Wojtaszewski et al. 2003). While 
increased circulatory lipid concentrations are apparent while exercising with low muscle 
glycogen, the concentrations of intramyocellular lipids within skeletal muscle were less 
well described due to compounding factors of adipose and extracellular lipid 
contamination of biopsy samples. Utilising proton magnetic resonance spectroscopy (1H-
MRI) Johnson et al. (2003) demonstrated the capacity for low CHO diets and low muscle 
glycogen to increase intramyocellular lipid content in skeletal muscle in a relatively short 
period (48h), and increase the contributions of this sub-fraction to energy production 
during exercise compared to exercise undertaken following high CHO diet with high 
muscle glycogen.  
Subsequently, the effects on cellular mechanisms directing changes occurring while 
training with low glycogen were examined. Given the observations that increased glycogen 
synthase activity and insulin sensitivity following exercise are inversely related to muscle 
glycogen content (Wojtaszewski et al. 2000, 2001), it is clear a high metabolic priority is 
placed on glycogen resynthesis during recovery from exercise. Based on these 
observations, Pilegaard et al. (2002) observed augmented gene transcription in the early (0 
– 5 h) stages of recovery from low intensity (45% V̇O2max for 2h) cycling exercise where 
one leg commenced exercise with low muscle glycogen compared with a leg that 
commenced exercise with high muscle. Exercise undertaken with low muscle glycogen 
displayed elevated mRNA transcription of genes regulating CHO and fat metabolism 
compared to the leg which started exercise with high muscle glycogen. To understand the 
regulatory mechanisms underpinning the differential metabolic response of skeletal muscle 
to exercise with low glycogen, Wojtaszewski et al. (2003) observed significantly elevated 
AMPKα2 activity and ACCSer221 phosphorylation during moderate intensity cycling 
exercise (70% for 1h) when undertaken with low muscle glycogen. Previous research in 
rodents demonstrated allosteric regulators of AMPK activity, adenine nucleotide and 
creatine phosphate content to be similar between muscles with low and normal muscle 
glycogen (Derave et al. 2000; Wojtaszewski et al. 2002), implicating a role for glycogen 
content per se on AMPK activity. Indeed, the identification of a glycogen binding domain 
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on the beta subunit of AMPK provided further support for this regulatory role of glycogen 
in modulating skeletal muscle metabolism (McBride et al. 2009). Further stress signalling 
mechanisms activated by exercise and metabolic shift were demonstrated to be regulated 
by the availability of muscle glycogen. For example, the nuclear abundance of 
phosphorylated p38-MAPK and subsequent IL-6 mRNA transcription was shown to be 
enhanced following exercise undertaken with low muscle glycogen (Chan et al. 2004). The 
phosphorylation of p38-MAPK has subsequently been demonstrated to require increased 
circulatory FFAs (Zbinden-Foncea et al. 2013), these data and others above demonstrate 
the complexity and diversity of regulatory mechanisms that bring about the metabolic shift 
and transcriptional response induced by exercise undertaken with low muscle glycogen.    
2.4.2 Exercise in the fasted state 
While evidence indicates augmented signalling responses following exercise in a glycogen 
depleted versus loaded state, research has also shown beneficial metabolic adaptations with 
exercise in the fasted state. As the name suggests this method involves undertaking 
exercise, generally shortly after waking before breakfast. The general idea underpinning 
this modality is the potential for elevated fat oxidation resulting from an overnight fast. 
Indeed an increased transcription of genes regulating fat metabolism was observed with 
moderate intensity (75% V̇O2max for 1h) undertaken following an overnight fast (van 
Proeyen et al. 2011), in the counter balanced trial of this study the provision of 6% CHO 
drink before and at regular intervals throughout the trial dampened the transcriptional 
response of the same genes to exercise (Cluberton et al. 2005). In addition to data from 
acute interventions, van Proeyen et al. (2011) observed that training in a fasted state 
enhanced citrate synthase and β-HAD enzyme activity and a reduction in glycogen use 
during 2 h constant load cycling to a greater extent that when training was undertaken with 
provision of CHO before and during exercise. These observations were accompanied by 
increases in circulatory FFA availability and oxidation during exercise also seen when 
exercising with lowered muscle glycogen (Pilegaard et al. 2002; Widrick et al. 1993; 
Wojtaszewski et al. 2003). Thus, while exercising in a fasted state my not confer the same 
level of glycogen or energy deficit that intentionally lowering muscle glycogen prior to 
exercise will, exercising in the fasted state is still able to induce the physiological and 
metabolic conditions necessary to induce an augmented regulatory response. This response 
is likely mediated via augmented AMPK activity, which when glucose is provided is 
suppressed (Civitarese et al. 2005) (Table 2.1).  
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2.4.3 Twice per day model 
Modulation of muscle glycogen content via twice per day training has be used previously 
in acute interventions (Blomstrand and Saltin, 1999), however its application in a chronic 
training scenario to examine potential performance responses to training with low muscle 
glycogen was first employed by Hansen et al, (2005). This study used fixed intensity knee 
extensor exercise and elegantly matched total work between bilateral legs over a three-
week training period. In this design, one leg trained once per day in a glycogen loaded stat 
whereas the contralateral leg trained twice every second day where the second session was 
commenced with reduced muscle glycogen. Training with low glycogen increased time to 
exhaustion and capacity for glycogen storage compared with the leg that consistently 
trained with high muscle glycogen. During exercise the contribution of glycogen to energy 
production was reduced while an enhanced catecholamine concentration was observed, the 
enzymatic activity of CS was also increased in the leg trained with low glycogen only.  
 
 
 
 
Figure 2.2 – Schematic representation of training routine and leg kicking exercise used by 
Hansen et al.  (2005). Black dots represent training sessions. Thus participants in the low 
CHO group trained twice every other day versus once per day in the normal CHO group.  
To address low CHO training from a more practical perspective, Yeo et al. (2008) trained 
two groups of well-trained cyclists for 3 weeks employing a twice per day model using 
steady state cycling (100 min at 70% V̇O2peak) followed by high intensity intermittent 
exercise (HIT) (8 x 5min maximal work with 1 min recovery) without feeding between 
sessions. HIT was undertaken with reduced muscle glycogen, whereas the parallel group 
completed steady state and HIT sessions on different days so that both sessions were 
completed with high muscle glycogen. In line with previous studies, an increased 
contribution of fat during steady state exercise was observed in the ‘train-low group’ in 
addition to enhanced CS, β-HAD activity and cytochrome c oxidase subunit IV protein 
content. Despite intensity of HIT sessions being compromised by low muscle glycogen, 
both groups improved average power output during 60 min TT by ~10%.  In a parallel 
acute study, the same group sought to identify molecular mechanisms underpinning the 
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differential adaptive response and confirmed that enhanced AMPK mediated signalling is a 
suggested mechanism (Yeo et al. 2009). Despite consistent observations of elevated 
plasma FFA content and lipid oxidation during exercise following train-low, the specific 
source of lipids to energy production had not been identified. To answer this question, 
Hulston et al. (2010) assessed fuel utilisation via labelled glucose and palmate infusions, 
during 60 min steady state cycling exercise before and after 3 weeks of training utilising 
the same twice per day model of Yeo et al. (2008). Following training, the contribution of 
energy from muscle-derived triglyceride oxidation significantly increased in the group 
training with low muscle glycogen, this effect was observed in conjunction with increased 
protein expression of CD36 and β-HAD in skeletal biopsies from low trained participants 
only. The beneficial effects of low CHO training using the twice per day model are not 
unique to cycling as indeed, increased SDH activity was reported in both vastus lateralis 
and lateral head of the gastrocnemius following 6 weeks of running training undertaken 
with reduced endogenous and exogenous CHO availability (Morton et al. 2009) (Table 
2.1).   
2.4.4 Sleep low 
Previous studies had utilised sustained periods of intermittent exercise in the 12 – 18h 
before an experimental trial followed by fasting or low CHO diet to modulate muscle 
glycogen between legs within the same subject to study the subsequent shift in metabolism 
that followed (Blomstrand and Saltin, 1999; Pilegaard et al. 2002). This method of 
“sleeping” with low muscle glycogen and low CHO availability was first examined in the 
context of training during whole body exercise by Bartlett et al. (2013) who employed a 
low CHO diet and cycling exercise the evening before the main experimental trial thus 
inducing a period of sleep low. The phosphorylation of the stress response protein p53 was 
significantly elevated following exercise with low glycogen following a period of sleep-
low. In addition to this novel molecular finding, the mRNA content of genes regulating 
mitochondrial biogenesis (PGC-1α, Tfam) and oxidative phosphorylation (COXIV, PDK-
4) were significantly augmented during HIT undertaken following a period of sleep-low 
(Bartlett et al. 2013). Due to the nature of the intervention there was significant energy 
deficit between high and low CHO conditions hence it is difficult to separate the adaptive 
responses resulting from systemic and local modulation in energy availability opposed to 
glycogen content per se.  To isolate the effect of reduced glycogen Lane et al. (2015) 
employed a sleep low strategy where by participants received 8 g/kg CHO throughout the 
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day and completed HIT in the evening and then received no further nutrition until 
completion of a steady state ride the following. In the counter balanced trial participants 
received 4 g/kg then completed HIT and ingested a further 4 g/kg thus trials were matched 
for CHO intake but different in temporal spread of nutrition, in this way the trials were 
energy matched unlike the study of Bartlett et al. (2013). This nutrition-exercise interaction 
of sleeping low brought about augmented phosphorylation of signalling proteins (ACC, 
AMPK, p38MAPK) known to regulate oxidative adaptations to endurance exercise in the 
morning following a period of sleeping low. Following the second exercise session an 
increase in transcription and shift in DNA methylation of selected genes with putative roles 
in lipid oxidation and transport were observed with sleep low; of interest this nutritional 
strategy also allowed maintenance of intensity during HIT sessions in the sleep low group. 
However, no difference in genes regulating mitochondrial biogenesis were observed 
between groups, the authors stipulate that despite the exercise interventions used the 
participants still reserved a large amount of muscle glycogen, likely a result of the training 
status of the participants, thus some of the beneficial effects of training with low glycogen 
may not have been elicited, this view also points to the potential of a critical glycogen 
threshold that is necessary to go below before enhanced training response is seen.  
Given the capacity for the sleep low strategy employed by Lane et al. (2015) to sustain 
training intensity during HIT sessions, in addition to eliciting augmented lipid transport 
and oxidation its application in training warranted investigation. Marquet et al. (2016) 
employed this strategy with elite triathletes during a 3-week training block with two groups 
under the same nutrition conditions employed by Lane et al. (2015). Training with the 
inclusion of sleep low augmented 10 km running performance by -2.9 (± 2.15%) and time 
to exhaustion during supramaximal cycling by +12.5 (± 19%) both of which were 
significant improvements over the control condition, in addition the delta efficiency of 
cycling significantly increased with sleep low over control likely as an artefact of ~1kg 
decrease in body weight that occurred during the training in sleep low group only (Table 
2.1).  
  2.4.5 Amalgamation of nutritional strategies  
All the studies in the sections mentioned above indicate specific signalling, transcriptional, 
metabolic or performance benefits from their respective nutrition-exercise interactions. 
However, an optimal strategy has not been developed within this relatively young field of 
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investigation. Burke et al. (2017) recently utilised CHO periodisation during three-week 
training camp with elite race walkers, where some training sessions were completed with 
high muscle glycogen and some with low muscle glycogen. While CHO periodisation 
conferred no additional beneficial effect to race performance versus traditional nutritional 
recommendations, reductions in body mass and O2 cost of exercise were noted with 
periodised CHO intake. These data pave the way for refinement of nutrition-exercise 
interactions potentially leading to interventions that can bring about performance 
enhancement.  
While considerable research has focused on the adaptive networks regulated by CHO and 
glycogen availability, very little work around CHO or nutritional periodisation has 
examined the effect of protein ingestion in these training sessions. Several papers have 
demonstrated a direct increase in net protein breakdown when exercise was undertaken 
with low muscle glycogen (Blomstrand and Saltin, 1999; Haworth et al. 2010; Lemon and 
Mullin, 1980), yet how ingestion of amino acids or protein and its effects on signalling or 
adaptation are not well characterised in a low CHO or endurance exercise context. The 
next sections will present a brief overview of protein synthesis and review the research to 
date in provision of protein and CHO during endurance exercise (Table 2.1).  
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Reference Participants Duration Exercise Protocol Molecular Outcomes Performance Outcomes 
Twice per day model 
Hansen et al 
(2005) 
7 untrained men 10 weeks 
5 days x 
week 
Knee extensor exercise. One leg trained 50% 
of sessions with low glycogen (LOW) whist 
the other trained all sessions with high 
glycogen (HIGH) 
Greater increase in CS activity in 
LOW condition 
Increased β-HAD activity only in 
LOW condition 
Improved time to 
exhaustion knee extensor 
exercise 
Yeo et al 
(2008) 
14 trained 
cyclists/triathletes 
3 weeks 
4 x week 
100-min steady state (63% PPO) followed by 
8 x 5-min intervals at maximal pace either 2h 
(LOW) or 24h (HIGH) later 
Increased CS & β-HAD activity in 
LOW condition 
Increased COXIV protein content in 
LOW condition 
 
Similar improvements 
(~10%) in 60-min TT for 
both groups 
Morton et al 
(2009) 
30 active men 6 weeks 
4 x week 
6 x 3-min running at 90% V̇O2max 
NORM trained once per day whilst 
LOW+PLA & LOW+GLU trained twice per 
day (every other day). LOW+GLU ingested 
CHO before and during every second training 
session 
 
Greater increase in SDH activity in 
LOW+PLA compared with 
LOW+GLU & NORM  
Similar improvements in 
V̇O2max & YoYoIR2 for all 
groups 
Yeo et al 
(2010) 
12 trained 
cyclists/triathletes 
Acute 
exercise 
100-min steady state cycling (63% PPO) 
followed by 8 x 5-min intervals at maximal 
pace either 2h (LOW) or 24h (HIGH) later 
Greater phosphorylation of AMPK 
in LOW 
N/A 
Hulston et al 
(2010) 
14 trained cyclists 3 weeks 
6 x week 
90-min cycling at 70% V̇O2max followed by 
(2h apart) HIT (8 x 5-min) in LOW group. 
HIGH group performed alternate days of 
either SS or HIT cycling. 
β-HAD increased in LOW only 
Increased fat utilisation in LOW 
Similar improvements in 
60-min TT for both groups 
Table 2.1 – Overview current low CHO literature  
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Cochran 
(2010) 
10 active men Acute 
exercise 
HIT training (5 x 4-min cycling at 90-95% 
heart rate reserve) twice per day (separated by 
3h). One group consumed CHO (2.3 g·kg) 
between sessions (HIGH) whereas the other 
restricted CHO intake (LOW) 
Greater phosphorylation of 
p38MAPK in LOW following PM 
exercise 
 
N/A 
Cochran et al 
(2014) 
18 active men 2 weeks 
3 x week 
HIT training (5 x 4-min at 90-95% heart rate 
reserve) twice per day (separated by 3h). One 
group consumed CHO (2.3 g·kg) between 
sessions (HIGH) whereas the other restricted 
CHO intake (LOW) 
Similar improvements in CS activity 
& protein content of both CS and 
COXIV  
Improved 250-kJ TT 
performance in LOW 
group only 
Fasted training model 
Akerstrom et 
al (2006) 
9 active men Acute 
exercise 
2h one-legged knee extensor exercise in either 
a fasted (FAST) or fed (exogenous CHO 
during) (FED) state. 
Reduced AMPKa2 activation in 
FED 
N/A 
De Bock et al 
(2008) 
20 active men 6 weeks 
3 x week 
1 – 2h cycling (75% V̇O2max).  One group 
trained in the fasted state (FAST) with the 
other consuming CHO before and during 
exercise (FED) 
 
FABPm increased in FAST 
condition only 
N/A 
Van Proeyen 
et al (2010) 
20 active men 6 weeks 
4 x week 
1 – 1.5h cycling (70% V̇O2max). One group 
trained in the fasted state (FAST) with the 
other consuming CHO before and during 
exercise (FED) 
 
CS &  β-HAD activity increased in 
FAST condition only 
Similar improvements in 1-
h TT performance in both 
groups 
Sleep low model 
46 
 
Marquet et al 
(2015) 
21 triathletes 3 weeks 
6 x week 
HIT (8 x 5-min cycling at 85% MAP or 6 x 5-
min running at individual 10-km intensity) in 
the evening and LIT (60-min cycling at 65% 
MAP) the subsequent morning. One group 
consumed CHO between training sessions 
(HIGH) whereas the other restricted CHO 
intake (LOW) 
N/A Improved 10-km TT 
performance and improved 
time to exhaustion (150% 
peak aerobic power) in 
LOW group only 
Marquet et al 
(2016) 
11 trained cyclists 1 week 
6 x week 
HIT (8 x 5-min cycling at 85% MAP) in the 
evening and LIT (60 min cycling at 65% 
MAP) the subsequent morning. One group 
consumed CHO between training sessions 
(HIGH) whereas the other restricted CHO 
intake (LOW) 
N/A Improved 20-km TT 
performance in LOW 
group only 
Pilegaard et 
al (2002)  
Study a) 6 active 
men 
Study b) 6 active 
men 
Acute 
exercise 
1-legged glycogen depleting exercise 
followed by 2-legged cycling (2-h at 45% 
V̇O2max) the subsequent day (study a) 
3-h of 2-legged knee extensor exercise with 
either normal (NORM) or LOW glycogen 
(study b) 
N/A Study A: Elevated PDK4, 
LPL & HKII at rest in 
LOW only  
Study A&B: Elevated DK4 
& UCP3 post-exercise in 
LOW only  
Wojtaszewski 
et al (2003) 
8 trained men Acute 
exercise 
60-min cycling at 70% V̇O2peak with either 
LOW or HIGH muscle glycogen (from 
exercise/diet manipulation the previous day) 
AMPKα2 activated in LOW only 
Greater phosphorylation of ACC in 
LOW  
N/A 
Steinberg et 
al (2006) 
7 active men Acute 
exercise 
60 min cycling at 70% V̇O2max with either 
reduced (LOW) or normal (NORM) muscle 
glycogen 
Greater phosphorylation of ACC & 
AMPKα2 in LOW 
Increased translocation of AMPKα2 
to the nucleus 
N/A 
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Bartlett et al  
(2012) 
8 active men Acute 
exercise 
High-intensity running (6 x 3-min at 90% 
V̇O2max). LOW performed glycogen-depleting 
cycling the night before and restricted CHO 
overnight. HIGH consumed high CHO 
breakfast & CHO during exercise. 
 
Enhanced phosphorylation of ACC 
& p53 
Enhanced transcriptional activity of 
PGC-1a in LOW only 
N/A 
Lane et al 
(2015) 
7 trained cyclists Acute 
exercise 
Evening bout of high-intensity cycling (8 x 5-
min at 80% PPO) followed by 120-min steady 
state cycling (50% PPO) the subsequent 
morning. LOW group restricted CHO 
overnight whereas HIGH group consumed 
high CHO diet (4 g·kg BM) 
Enhanced phosphorylation of ACC 
post AM exercise 
Enhanced transcriptional activity of 
CD36 & FABP3 in LOW group 
N/A 
Recover low model 
Pilegaard et 
al (2005) 
9 active men Acute 
exercise 
75-min cycling (75% V̇O2max) followed by 
24-h recovery with either HIGH or LOW 
CHO diet 
UCP3, LPL & CPT1 remained 
elevated in LOW for 24h 
N/A 
Periodised model 
Burke et al 
(2017) 
22 international 
race walkers  
3 weeks 
7 x week 
3 weeks of intensified training (race walking, 
resistance training, cross training). Athletes 
consumed 3 different diets across the training 
period: a) high CHO b) LCHF c) periodised 
CHO intake with periods of low CHO training 
N/A Similar improvements in 
V̇O2peak between all groups 
Improved 10km race times 
in high CHO and 
periodised CHO groups (no 
change in LCHF) 
LCHF increased O2 cost of 
race walking  
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2.5 Protein Synthesis 
Skeletal muscle comprises 40 – 50% of the body’s mass, and displays a high level of 
plasticity in being able to adapt to increased locomotion and metabolic demands of the 
environment as well as playing a crucial role in the regulation of whole body homeostasis 
and health (Atherton and Smith, 2012). Skeletal muscle therefore is highly adaptable 
dependent on the stimulus imposed and the genetic predisposition of the individual to 
adaptation (Timmons, 2011). Skeletal muscle mass has the ability to change quite rapidly. 
Healthy, recreationally active individuals display protein turnover rates of ~1.2% day-1 
which exists as a dynamic equilibrium: muscle protein break down (MPB) exceeds muscle 
protein synthesis (MPS) in the fasted state, and MPS exceeds MPB in the fed state (Kumar 
et al. 2009). The changes in equilibrium are evoked by a variety of stimuli including 
mechanical loads, nutrients, neural activity, cytokines, growth factors and hormones 
(Sandri, 2008), thus the complexity of the system regulating skeletal muscle protein 
turnover becomes apparent.  
2.5.1 Skeletal muscle protein synthesis  
In skeletal muscle, protein synthesis can be induced by insulin like growth factor (IGF1), 
which in turn activates phosphatidylinositol 3-kinase (PI3K) and protein kinase B 
(PKB/Akt). Activated PKB/Akt inhibits the protein complex tuberous sclerosis complex 1 
– 2 (TSC1 – TSC2), which inactivates the small GTPase protein ras homolog enriched in 
brain (Rheb). Rheb activates mammalian target of rapmycin complex 1 (mTORC1), which 
causes an increase in protein translation by phosphorylating the well-known targets 
p70S6K and 4E-BP1 (Bentzinger et al. 2013).  
  2.5.2 Molecular regulation of protein synthesis 
mTOR has emerged as a key regulator of several anabolic processes including protein 
synthesis, ribosome biogenesis, and mitochondrial biogenesis, as well as catabolic 
processes such as autophagy (Zoncu et al. 2011). It is the centre of a regulatory network 
that is capable of sensing the energy status, nutritional situation and genotoxic stress levels 
of the cell, as well as receiving information from membrane-bound receptors for growth 
factors such as insulin (Weigl, 2012). mTOR exists as two distinct complexes: mTORC1 
and mTORC2; mTORC1 is composed of the scaffold protein RAPTOR and is selectively 
inhibited by the growth regulatory agent rapamycin (Goodman et al. 2011), mTORC2 
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comprises the scaffold protein RICTOR and as a result is unaffected by rapamycin (Weigl, 
2012).  
mTOR regulates the translational process predominately via two downstream substrates, 
4E-BP1 and p70S6K1 (Barr and Esser, 1999). The process of translation is assumed to be 
regulated at the stages of initiation, elongation, or release from the protein synthesis 
machinery. Initiation of translation appears to be the most effective site of control because 
it is the rate limiting step in protein synthesis. Briefly, eukaryotic initiation factor 4E 
(eIF4E) binds to the 7-methylguanosine cap structure of the 5’end of the mRNA, 
subsequently the small 40S ribosomal subunit is recurred to the cap structure, where it 
begins to scan for a start codon. Initiation starts once the eIF4F scaffold structure 
(composed of eIF4G/A/B) has attached via eIF4E binding eIF4G, combined with the 
ternary complex (eIF3/Met-tRNA-GTP) (TC) forming the 48S pre-initiation complex 
(PIC) (Goodman et al. 2011; Merrick, 2010 (Figure 2.3). 4E-BP1 binds to eIF4E thus 
preventing its association with eIF4G, suppressing cap-dependent translation initiation, this 
inhibition is removed by the phosphorylation of 4E-BP1 by mTORC1 causing 4E-BP1 to 
dissociate from eIF4E dramatically increasing the rate of protein synthesis.  In addition, the 
activation of mTOR also leads to the phosphorylation, and activation of p70S6K1 which is 
dissociated from the eIF3 complex. Full activation of p70S6K1 is achieved by its 
subsequent phosphorylation within its activation loop by PDK1. Once fully active, 
p70S6K1 can phosphorylate eIF4B and the 40S ribosomal subunit protein S6, stimulating 
their participation in the 48S-PIC (Holz et al. 2005).  
 
 
 
 
 
 
Figure 2.3 – Schematic representation of 48S-PIC. Formation of the 48S-PIC is the first 
step in translation initiation, the rate limiting step of protein synthesis.  
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Once initiation has taken place, the mRNA is translated into a peptide chain (Weigl, 2012). 
The elongation process requires eukaryotic elongation factor 2 (eEF2), which is a GTP-
binding protein that mediates the translocation of the ribosome relative to the mRNA after 
the addition of each amino acid to the peptide chain (Browne and Proud, 2004), and is 
under inhibitory control of eEF2-kinase (eEF2K). Elongation is the most energy-
consuming reaction during protein synthesis and logically not a priority for energy 
distribution during sustained exercise. Rose et al.  (2005) identified a Ca2+-calmodulin 
(CaM)-dependent phosphorylation of eEF2K resulting in a 5- to 7-fold increase in eEF2 
inhibition by phosphorylation in working muscles. The Ca2+/CaM binding to eEF2K can 
be negatively modulated by an mTOR dependent mechanism that, when nutrients are 
available, could alleviate the Ca2+/Cam dependent inhibition of elongation (Browne and 
Proud, 2004).  
  2.5.3 Skeletal muscle protein synthesis during endurance exercise 
Several comprehensive studies show a depression in MPS in rodents (Dohm et al. 1982; 
Williamson et al. 2006). The suppression of MPS was dependent on modality of exercise, 
as well as intensity and duration; 1h of swimming produced the smallest decrease in MPS 
(18%), then 1h of treadmill running (30%) and running to exhaustion producing the largest 
effect (71%) (Dohm et al. 1982).  In human participants, early reports suggested a fall in 
whole body protein synthesis during walking uphill at 50% of maximum O2 uptake 
(V̇O2peak) (Rennie, et al. 1980). More accurate direct measurements of tracer incorporation 
were made by Bowtell et al (1998) who measured a 31% fall in whole body protein 
synthesis during 2h of treadmill exercise at 60% V̇O2peak following 7 days’ diet 
manipulation to standardise protein intake. However, conflicting evidence also exists in 
human studies. Carraro et al (1990) did not measure a detectable change in MPS during 
treadmill walking at 40% V̇O2peak, the basal values reported may have been 
uncharacteristically low compared with those on the non-exercise day, indicating a false 
negative result. Consistent with these observations of reduced MPS, van Hall et al. (1999) 
observed that one-leg knee-extensor exercise in the post-absorptive state leads to an 
increase in net protein degradation compared to rest, and that this exercise induced increase 
in net protein degradation is augmented in muscles commencing exercise with low muscle 
glycogen. This work has recently been supported by Howarth et al.  (2010) who observed a 
decrease in net leg protein balance during exercise when undertaken following a 2-day diet 
with low CHO, compared with rest and high CHO trial. This group attributed the negative 
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shift in balance in the low CHO condition primarily to an increase in protein degradation, 
but also to a reduction in synthesis towards the later stages of the exercise.   
2.5.4 Protein provision during endurance exercise 
Sustained endurance exercise has been shown to alter the balance between MPS and MPB 
in favour of the later, and this effect is compounded by reduced carbohydrate availability. 
Given the negative effects of MPB for athletes’ performance, several groups have 
examined MPS responses with different nutrition-exercise interactions. Very few studies 
have examined the effects of feeding protein alone during endurance exercise.  One of the 
first studies to examine this was conducted by MacLean et al. (1994), who administered 
77mg/kg of branched-chain amino acids (BCAA) prior to one leg knee extensor exercise at 
70% max work capacity for 60 min. This study demonstrated that BCAA supplementation 
significantly decreased efflux of protein into the intramuscular space and circulation 
indicating a reduction of net muscle protein degradation, this was accompanied by 
reductions in 3-methylhistaidine release, a marker of contractile protein degradation. When 
exercise was undertaken with altered glycogen levels between legs, the provision of 
BCAA’s had the effect of enhancing protein synthesis during the recovery period 
irrespective of prior glycogen content (Blomstrand and Saltin, 2001). The anabolic 
response observed during the recovery period, surprisingly, did not seem to be mediated by 
insulin as arterial insulin concentrations between the two conditions (BCAA and placebo) 
were similar (Blomstrand and Saltin, 2001). 
In an effort to explore the effects of leucine content Pasiakos et al. (2011) supplemented 
10g of essential amino acids (EAA) in two conditions of, leucine-enriched drinks (3.5 g 
leucine in 10g EAA) or isonitrogenous EAA drinks (1.87 g leucine in 10g EAA). 
Participants consumed beverages at the onset of 60 min, 60% V̇O2max cycle ergometry, and 
every 20 min thereafter until completion of the protocol; the leucine-enriched drink 
produced a 33% increase in MPS compared to EAA condition, producing a small but 
positive protein balance after exercise. Whole-body proteolysis was lower with 
consumption of the leucine-enriched supplement, suggesting that the protein-sparing effect 
attributed to EAA ingestion during endurance exercise is enhanced by increasing leucine 
availability. The study does not detail if the participants began exercise following an 
overnight fast, this data would be useful given the effect of CHO availability on MPS and 
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MPB during endurance exercise (Howorth, et al. 2010). These data point to the potential 
for provision of leucine rich amino acids to rescue protein balance during exercise.  
2.5.5 Carbohydrate and protein feeding during endurance exercise 
Carbohydrate ingestion has unequivocally been demonstrated to enhance endurance 
exercise lasting >1h (Pfeiffer et al. 2012), but has little positive effect on anabolic 
responses or protein kinetics in skeletal muscle (Koopman et al. 2007). In contrast, protein 
intake pre-, during and post-resistive or endurance type exercise has been shown to 
enhance translation initiation signalling and promote muscle protein synthesis during post-
exercise recovery (Moore et al. 2009). Indeed, Coffey et al.  (2011) demonstrated a similar 
response in that post exercise myofibrillar protein synthesis was enhanced, with equivocal 
(as percentage of content of muscle) mitochondrial protein synthesis by feeding a protein 
carbohydrate mix versus carbohydrate alone, before repeated sprint cycle exercise. This 
work was followed by Hulston et al.  (2011) who examined ingestion of a carbohydrate, or 
carbohydrate plus protein solution during 3h cycling at 60% V̇O2max, on the rates of leg 
protein synthesis and breakdown. This group reported consuming protein during endurance 
exercise increased leg protein synthesis and decreased net leg protein breakdown; however, 
the fractional synthesis rate of the vastus lateralis was unaffected by protein feeding. The 
authors reported a positive post-exercise protein balance across the leg with carbohydrate 
plus protein feeding that was negative with carbohydrate alone. This group concluded that 
even with protein feeding, a positive protein balance cannot be established in highly active 
muscles during endurance exercise. In a similar study, Beelen et al.  (2011) concluded that 
carbohydrate, or carbohydrate plus protein ingestion during 2h cycle exercise at 55% Wmax 
improves whole body protein synthesis and net protein balance but does not further 
augment mixed muscle protein synthesis rates during exercise. The studies of Hulston et 
al.  (2010) and Beelen et al.  (2011) observed the largest insulin response with 
carbohydrate plus protein ingestion and a slight positive protein balance during this trial. 
This observation is likely due to a combination of the stimulatory effects of insulin on the 
protein synthetic pathway itself, as a combination of increased perfusion of circulating 
amino acids to the working muscles and insulin stimulating protein synthesis or an artefact 
of increased energy intake. Collectively these data point to the ability of CHO to further 
contribute the balancing of fractional synthesis and breakdown during endurance type 
exercise and may contribute to enhanced synthetic rate during recovery.  
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2.5.6 Post exercise nutrition 
As with the above data demonstrating positive effects of protein intake pre- and during 
endurance exercise, there are also several studies examining protein intake post-endurance 
exercise. The addition of protein to carbohydrate given post-endurance exercise has been 
shown to enhance whole-body and leg protein accretion (Levenhagen et al. 2002). Breen et 
al (2011) also measured an increase in myofibrillar MPS with the addition of protein to 
carbohydrate verses carbohydrate alone, ingested following 90 min cycling at 77% 
V̇O2max. This group, unlike Coffey et al (2010), did not observe an increase in 
mitochondrial MPS rates with carbohydrate + protein verses carbohydrate alone. Given the 
differences in training status of the two cohorts, the more elite training status in Breen et al 
(2011) may not have undergone stress sufficient to stimulate a synthetic response, or the 
time frame examined may have been too short for a mitochondrial synthetic response to 
have been detected. In addition to the indication that protein ingestion pre-, during-, and 
post-exercise has positive effects on skeletal muscle protein balance during endurance 
exercise, there is data indicating the addition of protein to carbohydrate verses 
carbohydrate alone supplemented over a 4.5-week training block, enhances adaptation to 
aerobic training, with favourable improvements in whole body composition of increased 
lean and reduced fat mass (Ferguson-Stegall et al. 2011).  
Several studies have examined the precursor molecular signalling responses to skeletal 
muscle protein synthesis following nutrient provision.  Fujit et al.  (2007) examined the 
signalling response of skeletal muscle to carbohydrate + protein provision versus 
carbohydrate alone at rest. Unsurprisingly, the phosphorylation of mTOR measured at 1h 
following ingestion was significantly enhanced with protein provision in accordance with 
enhanced whole-body protein synthetic rate, this was matched by a significant reduction in 
eEF2 phosphorylation allowing greater elongation and translation rate. Wilkinson et al. 
(2008) also used contralateral resistance and endurance training, to examine the differential 
signalling effects of acute and chronic exercise in the fed state. This study was the first to 
show a differential response of exercise modality, in that the resistance trained leg 
displayed preference towards myofibrillar protein synthesis with greater mTOR 
phosphorylation immediately after exercise, compared to the endurance trained leg in 
which mitochondrial protein synthesis was enhanced, with minimal myofibrillar synthesis.  
Coffey et al (2010) reported a significant elevation of mTOR phosphorylation 15 min after 
exercise versus placebo conditions, returning towards basal at 240 min. Similar data was 
54 
 
subsequently reported by Breen et al, (2011) who observed a group x time effect of mTOR 
phosphorylation following exercise (4 h post) when protein was added to carbohydrate, as 
reported previously (Fujit et al. 2007). The effect of feeding protein alone during exercise 
has been shown not to produce a discernible change in mTORC1 phosphorylation 
(Pasiakos et al. 2011) despite the addition of extra leucine producing elevated MPS. 
Although enhanced intracellular signalling does not necessarily correlate with the observed 
rate of MPS when measured directly (Greenhaff et al. 2008), activation of the putative 
signalling kinases responcible for MPS are still essential for MPS to occure. The 
differences in signalling observed between studies is likely an artefact of different feeding 
strategies (during- opposed to post-exercise), the time points at which muscle biopsies 
were taken, modality of exercise and training status of the participants may also be a 
deciding factor.  
Measuring the effects of physical activity on MPS during energy deficient states is 
methodologically challenging. As such replication of real world scenarios are difficult to 
produce due to constraints of traditional tracer methodologies, in being confined to 
laboratories to sustain constant infusions (Wilkinson et al. 2014). Recently one study 
examined a relatively large cohort (39 adults) over a 21d energy deficit (ED) with the 
prescription of recommended daily allowance (RDA), 2 x RDA and 3 x RDA protein 
(Pasiakos, et al. 2013). This group demonstrated that consuming protein at RDA caused a 
greater loss of fat free mass and blunted the anabolic synthetic response to protein 
containing meal following ED. These findings were concurrent with blunted signalling 
through p70S6K (Ser424/Thr421), additionally transcription of the mTORC1 inhibitors 
REDD1 and 2 were enhanced during ED (Pasiakos, et al. 2013). The use of healthy active 
(military personnel) in the above mentioned study, combined with assessment of MPS in 
the post-absorptive and post-prandial state before and after ED provides one of the most 
accurate assessments of the effect of energy deficit with high protein availability that has 
applicable translation to athletes. The data presented above generally points towards the 
ability of protein to rescue MPS during endurance type exercise when above RDA levels of 
protein with high leucine content are ingested. No study has however looked at feeding 
protein before, during and after endurance exercise. In addition, the effect of glycogen 
availability on protein turnover rates during endurance exercise needs to be examined 
further.  
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2.6 Autophagy 
A basal level of autophagy is ongoing in all eukaryotic cells and is vital for cellular 
turnover. Autophagy is the recycling mechanism responsible for the disposal of toxic 
protein aggregates as well as nansecent organelles. Three different types of autophagy have 
been described to date and they differ mainly in their mode of substrate delivery to the 
lysosome. Microautophagy refers to the degradation of substrates in the immediate vicinity 
of the lysosome through lysosomal membrane invaginations. Chaperone mediated 
autophagy is a targeted degradation mechanism through which dedicated chaperones 
recognise selected substrates and directly deliver them to lysosomes for degradation. 
Macroautophagy (here after termed autophagy) the best characterised of the three, here 
substrates along with any cytosolic materials surrounding them are engulfed with double 
membrane vesicles known as autophagosomes which are subsequently delivered to the 
lysosome for degradation (Vaishten and Hood, 2016)   
Increases in autophagy resulting from exercise were first noticed in the 1980’s, where 
increased number and size of autophagic vacuoles was observed in the liver and skeletal 
muscle of exercised animals (Salminen & Vihko, 1984). However, the functional 
importance of this system to cellular and skeletal muscle health did not become apparent 
until more recently. Systemic and internal signalling resulting from endurance exercise 
naturally precludes the activation of autophagy when you consider muscle contraction 
constitutes a form of energetic stress. Alterations in molecular messengers such as calcium, 
AMP, NAD+, and redox networks activate downstream signalling cascades that converge 
on acute regulators of autophagic activity via post-translational modifications and longer 
term nuclear transcriptional remodelling processes. Autophagy induction following 
exercise has subsequently been documented in various tissues including liver, heart, 
pancreas, adipose and brain (He et al. 2012). Autophagy appears to consist of several key 
steps, induction, nucleation and expansion, cargo selection, fusion and finally degradation 
(Ding and Yin, 2012). Each stage is mediated by distinct molecular markers that are 
regulated by numerous upstream effectors such as energy status of the cell and nutrient 
availability as well as specific disease pathologies (Dodson et al. 2013). Here, autophagy 
in the context of response to exercise and as contributor to adaptation resulting from 
endurance exercise will be discussed with specific focus on the targeted degradation of 
mitochondria by autophagy.   
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2.6.1 Acute molecular regulators of autophagic process 
The induction of the autophagy process is mediated by Atg proteins, several of which are 
transcriptionally regulated by FOXO3 (Zaho et al. 2008). For autophagosome biogenesis 
and maturation, the Unc-51-like kinase (ULK1)/Atg13/FIP200/Atg101 and Beclin-
1/Vps34 complexes integrate regulatory responses from several stress signals induced by 
exercise such as AMPK, mTOR and FOXO’s (Vainshten and Hood, 2016).  Beclin-1 is 
phosphorylated by ULK1 at Ser14 and is necessary for Vps34 activation and full 
autophagic induction (Petherick et al. 2015). Nucleation and expansion of the membrane 
appears to be mediated via a Beclin-1 complex which can be antagonised by Bcl-2.  
Indeed, seminal work by He et al (2012) revealed exercise-induced autophagy engages 
Bcl-2-Beclin complex via phosphorylation of Beclin-1 allowing its emancipation and 
subsequent full autophagosome nucleation (He et al. 2012).  
Currently it is unclear where material involved in membrane formation is procured from 
within the cell; mitochondria, endoplasmic reticulum, plasma membrane, and even the 
nuclear envelope have all been suggested in membrane donation (Juhasz and Neufeld. 
2006).   It is likely the selection of membrane material is the outcome of inductive signals 
specific to the identified target for degradation, although this requires considerable further 
investigation (Vainshten & Hood, 2016).  Expansion and sealing of the phagophore 
(autophagosome precursor) is mediated by two ubiquitin-like conjugation systems and are 
involved in the ultimate conjugation of microtube-associated protein light chain 3 (LC3), 
and its close relatives GABARAP and GATE16 to phosphatidylethanolamine (PE) 
(Dodson et al. 2013).  LC3 exists in its inactive form free in the cytosol and must first be 
cleaved by the protease Atg4, giving rise to LC3-I prior to conjugation to PE.  Lipid 
conjugation converts LC3-I to the LC3-II form that is attached to either side of the growing 
phagophore membrane (Sandri. 2010). Cargo selection occurs in parallel with the 
expansion of the autophagosome and, contrary to original ideas is not random, but appears 
to be regulated by substrate specific receptors such as p62 (Kilonsky et al. 2011). p62 
contains multiple protein-protein interaction domains, this protein interacts with LC3-II 
allowing entry of previously ubiquitinated cargo into the autophagosome. Ubiquitin 
independent targeting of cellular components via organelle-specific autophagy receptors 
have been identified (Dodson et al. 2013).  
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Mitophagy, the targeted removal of long lived or dysfunctional mitochondria, is achieved 
via interaction of receptors such as BNIP3 that interact directly with LC3-II on the 
phagophore (Kubli et al. 2012). Additionally, two Parkinson’s disease factors have been 
implicated in exercise induced mitophagy, the E3 ligase Parkin and PINK1 (Pickrell and 
Youle. 2015). These factors interact under conditions of heightened oxidative stress and/or 
loss of membrane potential, at which point PINK1 is stabilized on the mitochondrial 
membrane recruiting Parkin to ubiquitiated targets thus signalling autophagosome 
formation (Pickrell and Youle. 2012). Once the autophagosome is complete, it transits 
along microtubule tracks to the lysosome where it fuses to form an autolysosome (Sandri, 
2013), although very little is known about this process in response to exercise. The 
autolysosome subsequently degrades the content of the prior autophagosome via 
hydrolases inside generated by the lysosome (Dodson et al. 2012). Amino acids derived 
from the degradation process can efflux from the proteolysis within the lysosomal lumen 
and subsequently be used for biosynthesis of a variety of cellular components, as well as 
acting as a retrograde signal to activate mTOR and suppress autophagosome activity.  
Of interest, two key regulators of mitochondrial biogenesis and exercise adaptation (p53 
and PGC-1α) appear to play central roles in regulation of exercise induced autophagy. p53 
has been implicated in the transcriptional regulation of autophagy-lysosome system 
following nuclear translocation. Moreover a global genomic profiling of the p53 
transcriptome revealed a large number of autophagy genes regulating various steps 
throughout the autophagic process are direct targets of p53 (Broz et al. 2013). In addition 
to the transcriptional regulation of autophagy, p53 has been documented to suppress the 
activity of mTOR (negative regulator of autophagy activity) via several upstream 
regulators (Feng et al. 2005). Specifically, p53 mediated induction of Sestrins 1 and 2 have 
been documented to regulate autophagy through the modulation of AMPK-mTOR axis 
(Maiuri et al. 2009). Naturally, the regulation of autophagy by p53 is complex and highly 
dependent on the subcellular location. For instance cytosolic p53 appears to arrest 
autophagy, in direct opposition to its nuclear status (Rosenfeldt et al. 2013). The 
transcriptional co-activator PGC-1α works to orchestrate the nuclear and mitochondrial 
genomes during mitochondrial biogenesis (see above). Recent work by Vainshtein et al. 
(2015) demonstrated that PGC-1α is required for normal autophagy and mitophagy 
kinetics, via tracking localization of key mitophagy markers during exercise as well as the 
induction of LC3 and p62 genes following endurance exercise. These authors also suggest 
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a potential mitochondrial regulatory loop where degradation signalled by Parkin may be 
balanced via targeted degradation of ZNF746 (Paris) by Parkin this releasing the Paris-
mediated repression of PGC-1α transcription (Valnshten et al. 2015). These data suggest 
the occurrence of complex regulatory systems that govern the synthesis and degradation of 
mitochondrial protein, and regulate autophagic function.   
2.6.2 Autophagy in skeletal muscle – exercise implications 
Recently it has become apparent that autophagy forms an essential part of the adaptive 
response of skeletal muscle to exercise. Although autophagy appears to have no acute 
effect on exercise performance per se (Verso et al. 2014), it appears that the cumulative 
effects of autophagy are required for adaptation to skeletal muscle. Grumati et al, (2011) 
have demonstrated that collagen-VI null (compromised autophagy) mice demonstrated an 
exacerbation of the dystrophic phenotype with acute and chronic exercise, suggesting that 
functional autophagy is required for successful adaptive response to exercise. Further 
evidence from Lira et al. (2013) demonstrated enhanced autophagic flux in parallel with 
mitochondrial biogenesis in response to chronic exercise, conversely mice lacking critical 
autophagy protein, Atg6, were unable to increase mitochondrial content or stimulate 
angiogenesis in skeletal muscle. In accordance with autophagic contribution to the 
exercised phenotype, He et al. (2012) noted that mice with BCL2 mutation presented with 
altered glucose metabolism and homeostasis, including decreased sarcolemma 
relocalization of GLUTE 4 during acute exercise. Recently, LoVerso et al. (2014) 
generated tamoxifen inducible muscle specific atg7 knockout mice, and demonstrated the 
importance of autophagy in preserving muscle function following damaging exercise 
(downhill running). The work by LoVerso et al. (2014) evidenced the inability 
mitochondria to sustain membrane potential when autophagy was knocked out in skeletal 
muscle, interestingly this effect was greater in females than males. Additionally, this group 
identified that acute autophagy induction did not affect performance or glucose 
homeostasis thus indicating that alterations in exercise capacity in autohagy-deficent 
animals is likely the result of secondary aggregates and degeneration, rather than a primary 
deficiency in autophagy capacity per se (LoVerso et al. 2014).  
Initial investigations in human skeletal muscle were conducted following an ultra-
endurance 24h treadmill run (149.8km ± 16.3 mean distance) which induced significant 
increases in LC3BII protein content and ATG12 conjugated to ATG5, in addition to 
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increase in phosphorylation of mitochondrial fission marker DRP (Jamart et al. 2012) 
indicating the removal and degradation of mitochondria under severe exercise stress. The 
same group observed significant increases in the expression of ATG4b, ATG12, Gabarapl1 
and LC3b mRNA following 200 km ultra-endurance run (28h 3min ± 2h mean time to 
completion), were observed (Jamart et al. 2012). The responses observed by this group are 
difficult to interpret given the extreme nature of the exercise protocol involved. For 
example blood glucose was reduced below 2 mmol/l at hour 24 in the initial study 
suggesting a severe reduction in muscle and liver glycogen indicative of significantly 
enhanced stress responses both within the circulation and skeletal muscle.  
To establish the signals regulating the response of autophagy to exercise, Moller et al.  
(2015) employed 1 h cycle exercise in the fed and fasted states at 50% V̇O2peak. Following 
exercise, ULK1 phosphorylation at Ser555 was increased concurrently with decreased 
lipidation of LC3b which correlated positively with AMPKα Thr127 phosphorylation. These 
signalling events appeared independently of being fed or fasted, suggesting induction of 
autophagy is related to exercise and not nutritional factors. In support, Schwalm et al.  
(2015) employed low and high intensity exercise in both fed and fasted state noting 
nutrition independent exercise-mediated phosphorylation of ULK1 although at a different 
site Ser317, as well as reduction in LC3bII protein level and LC3bII/LC3bI ratio with 
exercise. Of note, p62 protein content decreased only 1h after high intensity exercise and 
this indicator of autophagic flux again correlated with elevated AMPKα Thr172 
phosphorylation observed only following high intensity exercise. The authors conclude 
that in agreement with Moller et al.  (2015), exercise induced autophagy is independent of 
nutritional status and further suggest that exercise intensity is an underlying mediator of 
this system. The above-mentioned studies present interesting observations around the 
nature of autophagy induction, yet the nature of energy deficit induced resulting from low 
intensity exercise undertaken in the fasted state is comparatively small. The level of 
energetic stress or specific nutritional status of skeletal muscle that may tangibly increase 
the activity of autophagy has not been well characterised, as discussed below.  
2.6.3 Nutrient status and autophagy 
Early work by Kim et al.  (2011) identified glucose starvation of cultured cells induced 
AMPK mediated activation of ULK1 and that this pathway could be blocked by mTORC1 
activation subsequently preventing ULK1-AMPK interaction. Further studies observed a 
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similar response in mice, where markers of autophagy induction and transcriptional 
responses indicative of autophagic flux were elevated when low intensity exercised was 
undertaken in a fasted versus fed state and these measures coincided with reduced p70S6K 
phosphorylation (Jamart et al. 2013). In contrast to these studies, Zheng et al.  (2015) 
observed that mice fasted for 24h re-activated mTOR-dependent signalling molecules 
(Akt, p70S6K) reducing LC3 content within skeletal muscle after high intensity exercise. 
These measures contrast with results from the above-mentioned studies where autophagy 
induction is independent of fasted versus fed status (Moller et al. 2015; Schwalm et al. 
2015) and, appears to be induced by higher intensity exercise in human skeletal muscle 
(Fritzen et al. 2016). Several studies have observed attenuated or no autophagic response 
to exercise (Kim et al. 2011; Saleem et al. 2013), making concise conclusions about the 
effect of nutrition and exercise on autophagy induction difficult. In mice, it would appear 
the fibre type measured is likely to be an important consideration in experimental model. 
Further autophagic responses in human skeletal muscle need to be better characterised to 
elicit solid conclusions.   
Given that autophagic induction by AMPK-ULK1 axis can be blocked by mTOR, it is 
noteworthy that amino acid starvation has been shown to activate ULK1 and autophagy in 
an AMPK independent manner (Kim et al. 2011). Mitophagy markers BNIP3 and Parkin 
were also elevated to a greater extent following exercise in the fasted state, via a 
mechanism where mTOR appears to play a more prominent role than AMPK in autophagy 
induction (Jamart et al. 2013). Future studies are required to examine the effect of amino 
acid provision on the timing and extent of autophagy activation during exercise (Sanchez 
et al. 2014). The role of nutritional status of skeletal muscle in addition to the availability 
of exogenous substrate (CHO, protein etc.) in relation to activity of autophagy has many 
compounding factors. In addition, exercise adds further level of complexity as dependent 
on the duration and intensity will alter the response of the autophagic machinery. Clearly 
autophagy is an essential component of exercise adaptation, thus characterising this 
response in nutrition-exercise specific interactions will allow greater understanding of the 
contributions this system makes to adaptation.  
2.7 Conclusion 
The body of knowledge around low carbohydrate training has expanded significantly in 
recent years. The shift in circulatory metabolites and substrate oxidation observed during 
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exercise under conditions of low exogenous or endogenous CHO availability has 
consistently demonstrated a translational effect at a molecular level within skeletal muscle 
(Yeo et al.  2008) and more recently improvements in performance (Marquet et al.  2016). 
Nonetheless characterisation of this response has predominantly focused on putative 
signalling cascades regulating mitochondrial biogenesis during work matched exercise 
interventions (Bartlett et al. 2015). Indeed, given the emerging role autophagy plays within 
the adaptive response to exercise (He et al. 2012), and the augmented autophagic activity 
seen under energetic stress (Kim et al. 2011) this area warrents investigation in a low CHO 
context. 
Further more, application of real world nutrition practices often undertaken by elite 
athletes has not been characterised from a physiological or molecular standpoint. Indeed, 
given that athletes incorporate training sessions with low CHO availability but often ingest 
protein (Walsh, 2007); in addition to recent data pointing to the beneficial effects of 
leucine rich protein feeding during endurance exercise (Pasiakos et al. 2011) warrants 
further investigation of these practices. Nutritional interventions such as low CHO training 
have been shown to alter the molecular response to exercise, yet an unexplored component 
of the adaptive response to training is autophagy. The chapters in this thesis attempt to 
resolve some of the questions posed from reviewing the current literature, and expand the 
mechanistic and practical understanding of training with low CHO to augment adaptation 
and performance.  
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Chapter 3 - General Methodology 
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General Methodology 
3.1 Location of testing and ethical approval 
Exercise and biochemical analysis were carried out in the physiology and biochemical 
laboratories respectively at the Research Institute for Sport and Exercise Sciences 
Liverpool John Moores University. Ethical approval was granted from the local ethics 
committee at Liverpool John Moores University.  Analysis of skeletal muscle cell 
signalling activity was conducted at the University of Stirling. Analysis of plasma amino 
acid content was conducted at the University of Nottingham.  
 
3.2 Subject characteristics  
All the participants that participated in each study were young healthy and recreationally 
active males (see Table 3.1). None of the participants had a history of neurological disease 
or skeletal muscle abnormality and none were under pharmacological intervention during 
any study. Participants were asked to maintain habitual activity levels during each study, 
and refrain from additional exercise, caffeine and alcohol for at least 24 hours prior to any 
testing sessions.  
 
Table 3.1 – Subject characteristics. 
 
Study 1 Study 2 Study 3 
Age (years) 29 ± 11 24 ± 3 25 ± 3 
Height (m) 1.80 ± 0.09 1.78 ± 0.1  1.75 ± 0.1 
Body mass (kg) 79.5 ± 9.8 79.6 ± 4 74.4 ± 6.7 
V̇O2max (mL·kg-1·min-1) 53.0 ± 6.1 53.6 ± 7 56.5 ± 3.8 
 
3.3 Cardio-respiratory measures  
3.3.1 Respiratory gasses during exercise 
Participants were required to wear a neoprene face mask for measurement of respiratory 
gases during assessment of physical fitness and specific sections of exercise testing. 
64 
 
Breath-by-breath measurements were obtained throughout exercise using a CPX Ultima 
series online gas analysis system (Medgraphics, Minnesota, US). 
3.3.2 Assessment of substrate utilisation  
Carbohydrate and fat oxidation rates were estimated via indirect calorimetry (Medgraphics, 
Minnesota, US) during exercise in all studies using the equations of Jeukendrup and Wallis 
(2005) assuming negligible contribution of protein oxidation for all calculations. Oxidation 
of 1g of carbohydrate was assumed energetically equivalent to 17 KJ (80% glycogen, 20% 
glucose), while oxidation of 1g of fat was assumed energetically equivalent to 40.8 KJ. 
Oxygen and carbon dioxide are expressed in litres throughout the calculation.   
Carbohydrate oxidation (g/min) = (4.21 x CO2) – (2.962 x O2) 
Fat oxidation (g/min) = (1.695 x O2) – (1.701 x CO2) 
 
3.3.3 Assessment of peak oxygen uptake (V̇O2max) and peak aerobic power  
Peak oxygen consumption (V̇O2peak) and peak aerobic power output (PPO) were 
determined during an incremental cycle test performed on an electromagnetically braked 
cycle ergometer (SRM, Julich, Germany). The participants completed a 10 min warm up at 
100 W at a self-selected cadence, before commencing the test. The test began at 100 W and 
consisted of 2 min stages with 30 W increments in power until volitional exhaustion. 
Termination of the test occurred upon volitional exhaustion despite strong verbal 
encouragement. Breath-by-breath measurements were obtained throughout exercise using a 
CPX Ultima series online gas analysis system (Medgraphics, Minnesota, US) calibrated 
with known internal reference gases. V̇O2peak was stated as being achieved by the 
following end-point criteria: 1) heart rate within 10 beats.min-1 of age-predicted maximum, 
2) respiratory exchange ratio > 1.1, and 3) plateau of oxygen consumption despite 
increased workload. Peak aerobic power was taken as the final stage completed during the 
incremental test. 
 
 
 
65 
 
3.4 Psycho-physiological measures 
3.4.1 Ratings of perceived exertion  
Participants reported ratings of perceived exertion (see Table 3.2) during exercise 
according to a 15-point Likert scale devised by Borg (1970).   
Table 3.2 – Ratings of perceived exertion. 
Rating Description 
6 No Exertion At All 
7 Extreamly Light 
8 
 9 Very Light 
10 
 11 
 12 
 13 Somewhat Hard 
14 
 15 Hard 
16 
 17 Very Hard 
18 
 19 Extreamly Hard 
20 Maximal Exertion 
  
 
 
3.4.2 Ratings of perceived enjoyment  
Participants reported ratings of perceived enjoyment immediately after exercise in study 1 
according to the Physical Activity Enjoyment Scale (PACES) questionnaire validated by 
Kendzierski and DeCarlo (1991). According to the scale, the higher the score the more 
enjoyable the subject found the exercise session. An illustration of the PACES enjoyment 
questionnaire is presented in Table 3.3.  
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Table 3.3 – Ratings of perceived enjoyment of exercise.  
 
 
 
 
 I enjoy it 1 2 3 4 5 6 7 I hate it 
      I feel bored 1 2 3 4 5 6 7 I feel interested 
      I dislike it 1 2 3 4 5 6 7 I like it 
 I find it pleasurable 1 2 3 4 5 6 7 I find it unpleasurable 
 I am very absorbed 
in this activity 
1 2 3 4 5 6 7 I am not at all absorbed 
in this activity 
      It’s no fun at all 1 2 3 4 5 6 7 It’s a lot of fun 
 I find it energising 1 2 3 4 5 6 7 I find it tiring 
      It makes me 
depressed 
1 2 3 4 5 6 7 It makes me happy 
 It’s very pleasant 1 2 3 4 5 6 7 It’s very unpleasant 
 I feel good 
physically while 
doing it 
1 2 3 4 5 6 7 I feel bad physically 
while doing it 
 It’s very 
invigorating 
1 2 3 4 5 6 7 It’s not at all 
invigorating 
      I am very   frustrated 
by it 
1 2 3 4 5 6 7 I am not at all 
frustrated by it 
 It’s very gratifying 1 2 3 4 5 6 7 It’s not at all gratifying 
 It’s very 
exhilarating 
1 2 3 4 5 6 7 It’s not at all 
exhilarating 
      It’s not at all   
stimulating 
1 2 3 4 5 6 7 It’s very stimulating 
 It gives me a strong 
sense of 
accomplishment 
1 2 3 4 5 6 7 It doesn’t give me a 
strong sense of 
accomplishment  
 It’s very refreshing 1 2 3 4 5 6 7 It’s not at all refreshing 
     I felt as though I 
would rather be 
doing something else 
1 2 3 4 5 6 7 I felt as though there is 
nothing else I would 
rather be doing 
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3.5 Procurement, storage and analysis of muscle and blood samples 
Blood samples were drawn from a superficial vein in the anticubital crease of the forearm 
using ether standard venepuncture techniques or via an indwelling cannula (NHS supply 
chain, Alferton, UK). Samples were collected into serum separation tubes (SST), K2EDTA 
or lithium heparin vacutainers (BD Biosciences, UK). K2EDTA and lithium heparin tubes 
were stored on ice while SST vacutainers were stored at room temperature, both for 1 h 
before centrifugation at 1500 g x 15 minutes at 4̊ C. Following centrifugation, plasma or 
serum was separated into 4 aliquots and stored at -80̊ C for later analysis.      
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1 – Photograph of subject completing experimental trial with indirect calorimetry 
for assessment of substrate utilisation and blood sampling to assess serum and plasma 
metabolites. 
3.5.1 Circulating metabolite and insulin analysis  
Plasma glucose, lactate, non-esterified fatty acids, glycerol and β-hydroxybutyrate were 
analysed using a Randox Daytona spectrophotometer and commercially available kits 
(Randox Laboratories, Ireland). The coefficient of variation for plasma glucose, lactate, 
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non-esterified fatty acids and glycerol in our laboratory is ≤ 5 %. Insulin concentrations 
were analysed from serum using commercially available electrochemiluminescence 
immunoassay (Invitrogen, USA) as per the manufacturer’s instructions.  
3.5.2 Circulating amino acid analysis  
Plasma amino acids were quantified as their tert-butyldimethylsilyl (t-BDMS) derivatives 
after the addition of suitable internal standards by Gas Chromatography-Mass 
Spectrometry: briefly, 200 µl of plasma was deproteinized with 1 ml of 100% ethanol, the 
supernatant dried under nitrogen at 90oC, re-dissolved in 500 µl 0.5 M HCl, extracted with 
2ml ethyl acetate (to remove lipid fraction), and the aqueous layer was then dried and 
derivatized (with 100 µl Acetonitrile and 100 µl MTBSTFA) at 90oC for 90 min.  The t-
BDMS BCAA derivatives were separated on RTX5-ms (15m x 0.25 id, 0.25 µ film 
thickness) capillary column, initial column temp 70oC, then ramped at 12oC/min to 280oC, 
injector temperature was 240oC, Helium carrier gas was 1.2 ml/min. Selected ion 
monitoring of the (M-57) fragment was performed for each amino analysed, and the area 
under the peak determined relative to the mass isotopomer of the stable isotopically 
labelled internal standard used for each amino acid e.g. we monitored m/z 302 for Val and 
Leu and the isotopomer 303 (for 13C Valine) and 304 (for 1,2 13C2 Leucine).  
3.5.3 Muscle biopsies 
Muscle biopsies were obtained from separate incision sites (2-3 cm apart) from the lateral 
portion of the vastus lateralis muscle pre-, post- and 3 h after the exercise protocol in study 
2 and pre-, post- and 1.5 h after exercise study 3. Biopsies were obtained using a Bard 
Monopty Disposable Core Biopsy Instrument (12 gauge x 10 cm length, Bard Biopsy 
Systems, Tempe, AZ, USA).  Samples were obtained (approximately 50 mg) under local 
anaesthesia (0.5 % marcaine) and immediately frozen in liquid nitrogen and stored at –
80C for later analysis.  
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Figure 3.2 – Photograph of skeletal muscle biopsy. 
3.5.4 mRNA isolation and QRT-PCR  
RNA extraction and analysis: Muscle samples (~ 30mg) were immersed and homogenized 
in 1ml Trizol (Thermo Fisher Scientific, UK) RNA was extracted according to the 
manufacturer’s instructions. RNA concentration and purity were assessed by UV 
spectroscopy at ODs of 260 and 280 nm using a Nanodrop 3000 (Fisher, Rosklide, 
Denmark). 70 ng RNA was used for each PCR reaction. 
Primer design:  Primer sequences were identified using Gene 
(NCBI, http://www.ncbi.nlm.nih.gov.gene) and designed using Primer-BLAST 
(NCBI, http://www.ncbi.nlm.nih.gov/tools/primer-blast). Sequence homology searches 
ensured specificity, all primers had no potential unintended targets following a blast 
search. The primers were ideally designed to yield products spanning exon-exon 
boundaries to prevent any amplification of gDNA. Three or more GC bases in the last five 
bases at the 3’ end of the primer were avoided. Secondary structure interactions (hairpins, 
self-dimer and cross dimer) within the primer were avoided. All primers were between 16 
and 25 bp, and amplified a product of between 72 – 199 bp (Table 3.4). All primers were 
purchased from Sigma (Suffolk, UK). 
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Reverse transcriptase quantitative Real-Time Polymerase Chain Reaction (rt-qRT-
PCR): rt-qRT-PCR amplifications were performed using QuantiFastTM SYBR® Green RT-
PCR one step kit on a Rotogene 3000Q (Qiagen, Crawley, UK) supported by rotogene 
software (Hercules, CA, USA). rt-qTR-PCR was performed as follows: hold 50°C for 10 
min (reverse transcription/cDNA synthesis), 95°C for 5 min (transcriptase inactivation and 
initial denaturation step) and PCR steps of 40 cycles; 95°C for 10s (denaturation), 60°C for 
30s (annealing and extension). Upon completion, dissociation/melting curve analysis were 
performed to reveal and exclude non-specific amplification or primer-dimer issues (all 
melt analysis in this study presented single reproducible peaks for each target gene 
suggesting amplification of a single product). Following initial screening of suitable 
housekeeping genes, GAPDH showed the most stable Ct values across all RT-PCR runs, 
participants and regardless of experimental condition (25.5 ± 1.01); and was selected as the 
reference gene in all RT-PCR assays. The relative gene expression levels were calculated 
using the comparative Ct (
ΔΔCt) equation where the relative expression was calculated as 2
-
ΔΔct and where Ct represents the threshold cycle. mRNA expression for all target genes was 
calculated relative to the reference gene (GAPDH) within same subject and condition and 
to a calibrator of pre-exercise.     
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3.5.5 Muscle glycogen concentration 
Muscle glycogen concentration was determined according to the method described by Van 
Loon et al. (2000). Approximately 3-5 mg of freeze dried sample was powdered, dissected 
free of all visible non-muscle tissue and subsequently hydrolysed by incubation in 500 µl 
of 1 M HCl for 3-4 hours at 100◦C.  After cooling to room temperature, samples were 
neutralized by the addition of 250 µl 0.12 mol.L-1 Tris/2.1 mol.L-1 KOH saturated with 
KCl.  Following centrifugation, 200 µl of the supernatant was analysed in duplicate for 
glucose concentration according to the hexokinase method using a commercially available 
kit (GLUC-HK, Randox Laboratories, Antrim, UK). Glycogen concentration is expressed 
as mmol·kg-1 dry weight (dw) and intra-assay coefficients of variation was <5%. 
 
3.5.6 [γ-32P] ATP Kinase Assay 
Human muscle tissue was homogenized by dounce homogenisation on ice in RIPA buffer 
[(50 mM TrisHCl pH 7.5, 0.1 mM EGTA, 1 mM EDTA, 1% (v/v) TritonX-100, 50  mM 
NaF, 5  mM NaPPi, 0.27 M sucrose, 0.1% β-mecertoehtanol, 1 mM Na3(OV)4 and 1 
Complete (Roche) inhibitor tablet]. Debris was removed by centrifugation at 14,800 RPM 
for 45 minutes at 4°C. Following homogenisation protein was aliquoted for PKB/P70 S6 
(300ug) and AMPK α1/α2 (100ug) kinase activity analysis and snap frozen and stored at -
80°C.  
All kinase assays (KA) were carried out by immune precipitation (IP) ether for 2h at 4̊C or 
overnight at 4̊C in homogenisation buffer {AMPK [50 mM Tris.HCL pH 7.25, 150 mM 
NaCL, 50 mM NaF, 5 mM NaPPi, 1 mM EDTA, 1 mM EGTA, 1 mM dithiotheritol, 0.1 
mM benzamidine, 0.1 mM phenylmethylsulfonyl fluride, 5 µg/ml soybean tryppsin 
inhibitor, 1% (vol/vol) Triton X-100] and p70S6K/pan PKB [50 mM Tris-HCL pH 7.5, 0.1 
mM EGTA, 1 mM EDTA, 1% (vol/vol) Triton X-100, 50 mM NaF, 5 mM NaPPi, 0.27 M 
sucrose, 0.1% β-mercaptoethanol, 1 mM Na3(OV)4 and 1 Complete (Roshe) protease 
inhibitor tablet per 10 ml]}. Protein G sepharose (2.5 µl per IP) was used to precipitate the 
immune complexes. Immune complexes were washed twice in assay-specific high-salt 
washes (homogenization buffers as above with 0.5 M NaCL added) followed by one wash 
in assay-specific assay buffer (see below). Prior to carrying out the activity assay the 
immune-bead-complex was suspended in a total of 10 µl of assay buffer for p70S6k1 and 
pan PKB assays, and 20 µl of assay buffer for AMPK assays. All assays were carried out 
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in a 50 µl reaction. Assays were started every 20s by the addition of a hot assay mix, which 
consisted of assay buffer [PKB/p70S6K1 (50 mM Tris.HCL pH 7.4, 0.03% Brij35, and 
0.1% β-mercaptoethanol), AMPK (50 mM HEPES pH 7.4, 1 mM DTT, and 0.02% 
Brij35)], ATP-MgCL2 (100 µM ATP + 10 mM MgCL2 for p70S6K1/panPKB, and 200 
µM ATP + 50 mM MgCL2 for AMPK), 
32γ-ATP [specific activities as follows; panAMPK 
(0.25 x 106 cpm/mmol), panPKB (0.5 x 106 cpm/mol), p70S6K (1 x 106 cpm/mmol)] and 
finally synthetic peptide substrates [Crosstide for panPKB (GRPRTSSFAEG at 30 µM), 
S6tide for p70S6K (KRRRLASLR at 30 µM), and AMARA for AMPK 
(AMAEEAASAAALARRR at 200 µM)]. Assays were stopped at 20s intervals by spotting 
onto squares of p81 chromatography paper (Whatman; GE healthcare, UK) and immersing 
in 75 mM phosphoric acid and once in acetone. There were then dried and immersed in 
Gold Star LT Quanta scintillation fluid (Meridian Biotechanologies, Chesterfield, UK) and 
counted in a Packard 2200CA TriCarb scintillation counter (United Technologies). Assay 
results were quantified in nmol.min-1.min-1 (U/mg). Blanks for background subtractions 
were carried out with immunoprecipitation kinase with no peptide included in the assay 
reaction.  
3.5.7 SDS-PAGE and Western Blotting  
Approximately 20 – 30 mg of frozen muscle was round to powder and homogenised in 
120µl of ice cols lysis buffer (25 mM Tris/HCL (ph7.4), 50 mM NaF, 100 mM NaCl, 5 
mM EGTA, 1 mM EDTA, 10 mM Na-Pyrophosphatase, 1 mM Na3VO4, 0.27 M sucrose, 
1% Triton x-100, 0.1% 2-mercaptoethanol) and supplemented with a protease inhibitor 
tablet (Complete mini, Roshe Applied Sciences, West Susses, UK). Homogenates were 
centrifuged at 14000g for 10min at 4°c and the supernatant was collected. The protein 
content of the supernatant was determined using bicinchoninic assay (Signa, Dorset UK). 
Each sample was diluted with and equal volume for 2 x Laemmli buffer (National 
Diagnostics, USA) and boiled for 5 min at 100°c. For each blot a standard control was 
loaded along with 15 µg of protein from each sample and then separated in Tris-glycine 
running buffer (10 x Tris/Glycine, Bio-Rad, UK) using pre-cast, 6% stacking and 20% 
separating gels (Bio-Rad, UK). Gels were transferred semi-dry onto nitrocellulose 
membranes (Geneflow Ltd. Staffordshire, UK) for 2h at 200 V and 45 mA per get in 
transfer buffers (10% TRIS/glycine (Sigma), 20% methanol, 70% ddH2O) After transfer, 
membranes were blocked for 1h at room temperature in Tris-buffered sailine (TBST: 0.19 
M Tris pH 7.6, 1.3 M NaCL, 0.1 % Tween-20) with 5% non-fat milk. The membranes 
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were then washed for 3 x 5 min in TBST before being incubated overnight at 4°c with total 
protein content antibodies for LC3b and p62 (Cell Signalling, UK) at concentrations of 
1:1000 in 1 x TBST. The next morning, membranes were washed for a further 3 x 5 min in 
TBST and subsequently incubated with anti-species horseradish peroxidase-conjugated 
secondary antibody (Bio-Rad, UK) for 1h at room temperature. After a further 3 x 5 min 
washes in TBST, membranes were exposed in a chemiluminescence liquid (SuperSignal, 
Thermo Fisher Scientific, Rockford, IL, USA) for 5 min. Membranes were visualised using 
a Bio-Rad Chemi-doc system, and band densities were determined using ImageLab image-
analysis software. Samples from each subject for all nutritional conditions were run on the 
same gel and statistical analysis conducted on raw densitometry data. Data has been 
expressed as fold change normalised to pre-exercise values.    
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Chapter 4 
 
Leucine enriched protein feeding does not impair free fatty acid 
availability or exercise-induced lipid oxidation: beneficial 
implications for acute training in carbohydrate restricted states 
 
 
 
 
 
The aim of this chapter was to test the hypothesis that leucine-enriched protein feeding 
does not impair circulating FFA availability or whole body lipid oxidation during exercise 
This study was presented orally at the European College of Sports Science (ECSS) 
Amsterdam, Nederland 2014.The full manuscript was published in Amino Acids 
November 2014.  Additionally, the data presented in this chapter has informed the 
development of a novel commercially available whey protein based gel (SiS Whey 20). 
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 4.1 Abstract 
Given that the enhanced mitochondrial adaptations observed when training in carbohydrate 
(CHO) restricted states are potentially regulated through free fatty acid (FFA) mediated 
signalling and that leucine rich protein elevates muscle protein synthesis, the present study 
aimed to test the hypothesis that leucine enriched protein feeding enhances circulating 
leucine concentration but does not impair FFA availability nor whole body lipid oxidation 
during exercise. Nine males cycled for 2 h at 70% V̇O2peak when fasted (PLACEBO) or 
having consumed a whey protein solution (WHEY) or a leucine enriched whey protein gel 
(GEL), administered as 22g 1 hour pre-exercise, 11 g/h during and 22g thirty minutes post-
exercise.  Total leucine administration was 14.4 g and 6.3 in GEL and WHEY, 
respectively. Mean plasma leucine concentrations were elevated in GEL (P= 0.001) 
compared with WHEY and PLACEBO (375 ± 100, 272 ± 51, 146 ± 14 µmol.L-1 
respectively). No differences (P= 0.153) in plasma FFA (WHEY 0.53 ± 0.30, GEL 0.45 ± 
0.25, PLACEBO 0.65 ± 0.30, mmol.L-1) or whole body lipid oxidation during exercise 
(WHEY 0.37 ± 0.26, GEL 0.36 ± 0.24, PLACEBO 0.34 ± 0.24 g/min) were apparent 
between trials, despite elevated (P= 0.001) insulin in WHEY and GEL compared with 
PLACEBO (38 ± 16, 35 ± 16, 22 ± 11 pmol.L-1 respectively).  I conclude that leucine 
enriched protein feeding does not impair FFA availability nor whole body lipid oxidation 
during exercise, thus having practical applications for athletes who deliberately train in 
CHO restricted states to promote mitochondrial related adaptations. 
Keywords: mitochondria, endurance training, lipolysis, whey 
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4.2 Introduction  
Traditional nutritional approaches for endurance training have typically promoted high 
CHO availability before, during and after training sessions in order to ensure high daily 
training intensities and volumes as well as promoting recovery (Cermak and Van Loon, 
2013; Hawley et al. 1997). However, during the last decade, we and others have 
consistently observed a potent effect of reduced CHO availability (i.e. fasted and/or 
glycogen depleted training) in modulating training-induced adaptations in skeletal muscle 
(Hawley and Morton, 2013).   
Despite the emergence of the train-low paradigm, its practical application in athletic 
populations is not without limitations, most notably a potential reduction in absolute 
training intensities (Yeo et al. 2008) as well as increased skeletal muscle protein oxidation 
and breakdown (Lemon and Mullin, 1980; Howarth et al. 2010).  An obvious solution to 
compensate for the latter is to consume high quality protein in close proximity to the 
exercise stimulus given that protein provision before (Coffey et al. 2011), during (Hulston 
et al. 2011) and after (Breen et al. 2011; Howarth et al. 2010) endurance type exercise 
protocols reduces skeletal muscle protein breakdown and enhances post-exercise skeletal 
muscle protein synthesis. In this regard, Pasiakos et al. (2011) also observed that enhanced 
concentration of leucine (3.5 g in 10 g EAA) in an essential amino acid mixture consumed 
during two hours of endurance exercise significantly enhanced post-exercise muscle 
protein synthesis rates when compared with the same total intake of essential amino acids 
containing reduced leucine concentration (1.87 g in 10 g EAA).  I also observed that 
consuming protein before, during and after acute exercise undertaken in a glycogen 
depleted state did not impair the activation of the AMPK- PGC-1α pathway and positively 
affected molecular regulators of protein synthesis (e.g. eEF2 phosphorylation status), thus 
demonstrating that high amino acid availability still permits activation of key cell 
signalling cascades thought to regulate the training-low response (Taylor et al. 2013). 
When taken together, such data suggest that reduced CHO but high protein availability 
(especially leucine rich protein) may therefore be a strategic approach to stimulate training-
induced oxidative adaptations of skeletal muscle.  
It is noteworthy, however, that the provision of high protein availability could hinder 
additional pathways that may be involved in regulation of the training response associated 
with training-low. Indeed, our group observed that the elevated insulin induced by amino 
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acid ingestion (albeit administered as a casein hydrolysate solution) attenuated circulating 
free fatty acid (FFA) availability and whole body rates of lipid oxidation (Taylor et al. 
2013).  This effect may be problematic given that FFA may also act as signalling 
intermediates involved in regulating training adaptation in addition to providing substrate 
for oxidation (Zbinden-Foncea et al. 2013; Philp et al. 2013; Fyffe, et al. 2006). Any 
feeding strategy intended to achieve high protein availability (in an attempt to reduce 
protein breakdown and promote protein synthesis) during acute train-low sessions should 
therefore be simultaneously administered with the goal of minimising reductions in 
lipolysis such that FFA mediated cell signalling can still occur. 
Accordingly, the aim of the current chapter was to therefore test the hypothesis that leucine 
enriched protein feeding enhances circulating leucine availability but does not impair FFA 
availability and lipid oxidation during exercise. To this end, I utilised two protein feeding 
strategies consisting of a traditional whey protein solution but also a novel leucine enriched 
protein gel.  The use of the latter is considered particularly advantageous for endurance 
athletes given that gels are a highly practical approach to feeding when in locomotion 
(Pfeiffer et al. , 2010, 2012; Lee et al. 2014). When taken together, I envisage this data will 
be of immediate practical application for those athletes who deliberately train in CHO 
restricted states to promote mitochondrial related adaptations. 
4.3 Methodology   
4.3.1 Participants: Nine males (age 29 ± 10 years, height 179.7 ± 8.6 cm, body mass 79.4 
± 9.8 kg, V̇O2peak 53.0 ± 6.1 mL·kg-1·min-1 and peak power 334 ± 38 W) volunteered to 
participate in the study after providing informed written consent. Participants were 
recreational and competitive cyclists and tri-athletes who trained between 3 – 7 hours per 
week and had been cycling regularly for > 1 year. The study was approved by the Research 
Ethics Committee of Liverpool John Moores University.  
4.3.2 Experimental protocol: Participants arrived at the laboratory in the morning of the 
trial (08:00) having followed a prescribed diet (5 g·kg-1 CHO, 2 g·kg-1 Pro, 1 g·kg-1 fat) for 
two days prior and following an overnight fast. After obtaining measures of nude body 
mass, an indwelling cannula (Safety Lock 22G, BD Biosciences, West Sussex UK) was 
inserted into the anticubital vein in the anterior crease of the forearm and a resting blood 
sample drawn.  After the resting blood sample was taken, the cannula was flushed with ~ 5 
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ml of sterile saline (Kays Medical supplies. Liverpool UK) to keep the cannula patent and 
sterile, this procedure was repeated after each subsequent blood draw.  
Having obtained a resting blood sample, participants’ ingested ether a placebo gel (non-
calorific gelling agent) and 500 ml of water (PLACEBO), a leucine enriched protein gel 
that is not currently commercially available (GEL) providing 22g protein + 2.4 g leucine 
(total leucine of 4.8 g) with 500 ml of water, or 22g of commercially available whey 
protein (total leucine of 2.1 g; REGO Protein, Science in Sport, UK) mixed in 500 ml 
water (WHEY) and then rested in the laboratory for 60 min prior to the start of exercise. 
Blood samples were obtained repeatedly at 20 min intervals during the 60 min pre-exercise 
period and immediately before exercise commenced. The nutritional compositions of the 
protein supplements are shown in Table 4.1.  On the basis that caffeine can partially restore 
training intensity when in glycogen depleted states (Lane et al. 2013) and that beta-
hydroxy beta-methylbutyrate (HMB) can reduce muscle protein breakdown (Wilkinson et 
al. 2013), I also chose to fortify the GEL with additional caffeine (100 mg per 22g of 
protein) and HMB (1 g per 22g of protein). After the 60 min rest period pparticipants then 
cycled for 120 min at 60% PPO (~70% V̇O2peak) on a fully adjustable electromagnetically 
braked cycle ergometer (SRM, Julich, Germany). Each subject used their own pedals, 
cleats and shoes during each trial.   
During exercise, feeding of 5.5g protein (WHEY or GEL) or PLACEBO, with 125 ml 
water occurred at 30 min and 60 min, finally 11g protein (WHEY or GEL) or PLACEBO 
with 250 ml water was provided at 90 min. In this way subjects ingested 22g of protein 
from ether WHEY or GEL during the trials or no protein during PLACEBO condition, 
with all trials fluid matched. Blood samples were taken every 20 minutes during exercise 
and immediately at termination of exercise. Substrate oxidation (g/min) was determined 
during exercise using CPX Ultima series online gas analysis system (Medgraphics, 
Minnesota, US) using equations of Jeukendrup and Wallis (2005). Ratings of perceived 
exertion (RPE) (Borg 1970), gastrointestinal discomfort (GI) (Pfieffer et al. 2012) and 
heart rate (Polar Kempele 610i, Finland) were recorded every 15 min during exercise.  
Upon completion of exercise, participants dismounted from the ergometer, towel dried and 
nude mass was recorded. Thirty minutes after exercise, participants consumed a further 
22g of protein or placebo with 500 ml water in the form of WHEY or GEL and and two 
more blood samples were taken at 1 h and 2 h after completion of exercise. Laboratory 
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conditions remained constant across all trials (19 - 21 ̊C, 40 – 50% humidity). In this way, 
participants consumed a total of 66 g protein during the protein trials (i.e. 22g before, 22g 
during and 22g after exercise) in the form of whey protein (total leucine intake of 6.3 g) or 
a leucine enriched protein gel (total leucine intake of 14.4 g). Upon exercise completion, 
participants also rated their perceived ratings of enjoyment as quantified by the Physical 
Activity Enjoyment Scale (Kenzierski and DiCarlo, 1991). 
Table 4.1 – Protein content of gel and whey supplements  
 
GEL WHEY 
Total protein (g) 22.0 22.0 
Additional leucine (g) 2.4 0.0 
Total leucine (g) 4.8 2.1 
Total BCAA (g) 7.5 4.9 
Total EAA (g) 13.1 9.3 
Caffeine (mg) 100.0 0.0 
HMB (g) 1.0 0.0 
 
4.3.3 Blood analysis: Blood samples were collected and analysed for circulatory 
metabolites, NEFA, glycerol, glucose and lactate as well as circulatory amino acids as 
described in section 3.6.1.  
4.3.4 Statistical analysis. Statistical analysis was conducted using the Statistical Package 
for the Social Sciences software program (SPSS, version 18). Changes in physiological, 
metabolic and perceptual responses (i.e. physiological variables, amino acids, metabolites, 
substrate oxidation rates, RPE and GI) were analysed using a two-way repeated measures 
general linear where the within factors were time and condition. Descriptive statistics were 
produced for all data sets to check for normal distribution indicated by Kolmogorov-
Smirnov (accepted if P>0.05). Comparison of AUC for insulin, amino acids and 
metabolites across all time points was analysed according to a one-way repeated measures 
general linear where the within factor was condition. Where a significant main effect was, 
pairwise comparisons were analysed according to Bonferoni post-hoc tests in order to 
locate specific differences. Baseline AUC was taken at lowest X value, calculation was 
comleted using trapezoidal method. Statistical significance was set at P < 0.05 and all data 
in text, figures, and tables are presented as means ± SD.   
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4.4 Results 
4.4.1 Physiological and perceptual responses during exercise 
A comparison of participants’ physiological and perceptual responses during the exercise 
protocol is shown in Table 4.2. Heart rate (P<0.01), lipid oxidation (P<0.01) and RPE 
(P<0.01) all displayed progressive increases during exercise, whereas CHO oxidation 
exhibited a significant decline (P<0.01). In contrast, GI discomfort displayed no change 
during exercise (P=0.14). However, there was no difference in heart rate (P=0.84), oxygen 
uptake (P=0.67), CHO oxidation (P=0.97), lipid oxidation (P=0.90), RPE (P=0.11) and GI 
discomfort (P=0.19) between the PLACEBO, GEL and WHEY trials. Participants also 
reported a tendency for a higher rating of perceived enjoyment (P=0.073) in the GEL (89 ± 
5 AU) versus the WHEY (84 ± 5 AU) and PLACEBO (79 ± 5 AU) trials. 
4.4.2 Metabolic responses and substrate oxidation during exercise 
Exercise induced significant increases in plasma NEFA (P<0.01), glycerol (P<0.01) and 
lactate (P<0.01) whereas glucose displayed no significant (P=0.09) change (Figure 4.1). 
Serum insulin significantly increased in the pre-exercise period and showed significant 
declines during exercise (P<0.01) in both the WHEY and GEL trials (Figure 4.2). 
Accordingly, insulin displayed significant differences between conditions (P<0.01) where 
both WHEY (P<0.01) and GEL (P=0.01) were significantly higher than PLACEBO 
(Figure 1.2) though no differences were apparent between the WHEY and GEL trials 
(P=1.0).  Despite significant changes in insulin in the protein fed trials, plasma NEFA 
(P=0.12), glycerol (P=0.42), glucose (P=0.19) and lactate (P=0.06) were not different 
between the PLACEBO, WHEY and GEL trials at rest or during exercise.  Given that 
substrate availability was not different between conditions, the exercise-induced decrease 
in CHO oxidation (P<0.01) and increase in lipid oxidation (P<0.01) during the 2 h exercise 
protocol were not different between conditions (P=0.97 and 0.90, respectively). 
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Table 4.2 – Physiological and perceptual responses during exercise. * denotes significant 
difference from 30 min, P<0.05. 
 
30 60 90 120 
CHO Oxidation (g/min) 
    GEL 3.14 ± 0.18 2.70 ± 0.23* 2.25 ± 0.15*  1.98 ± 0.15* 
PLACEBO 3.13 ± 0.19 2.61 ± 0.18* 2.38 ± 0.15* 2.20 ± 0.13* 
WHEY 3.13 ± 0.24 2.64 ± 0.22* 2.24 ± 0.17* 1.97 ± 0.18* 
     Fat Oxidation (g/min) 
    GEL 0.12 ± 0.08 0.31 ± 0.11* 0.51 ± 0.06* 0.63 ± 0.05* 
PLACEBO 0.05 ± 0.07 0.34 ± 0.08* 0.47 ± 0.07* 0.61 ± 0.07* 
WHEY 0.11 ± 0.09 0.40 ± 0.08* 0.47 ± 0.07* 0.60 ± 0.07* 
     HR (b/min) 
    GEL 149 ± 4 154 ± 3 158 ± 4* 164 ± 4* 
PLACEBO 148 ± 3 153 ± 3 157 ± 4* 164 ± 4* 
WHEY 152 ± 5 156 ± 3 157 ± 4* 163 ± 3* 
     V̇O2 (%max) 
    GEL 67 ± 1.8 68 ± 2.1 69 ± 3.0 67 ± 4.3 
PLACEBO 63 ± 1.3 67 ± 1.5 69 ± 1.8 72 ± 2.4 
WHEY 66 ± 1.6 71 ± 1.5  67 ± 3.0 68 ± 2.8 
     RPE (AU) 
    GEL 11 ± 1.0 13 ± 0.5* 13 ± 0.6* 14 ± 0.7* 
PLACEBO 12 ± 0.5 14 ± 0.5* 15 ± 0.5* 16 ± 0.6* 
WHEY 12 ± 0.4 14 ± 0.4* 14 ± 0.7* 15 ± 1.0* 
     GI (AU) 
    GEL 10 ± 0.7 10 ± 0.7 10 ± 1.0 10 ± 1.1 
PLACEBO 9 ± 0.1 10 ± 0.8 10 ± 0.9 9 ± 0.8 
WHEY 10 ± 0.7 11 ± 0.7 11 ± 0.8 10 ± 0.7 
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Figure 4.1 - Plasma (A) NEFA, (B) glycerol, (C) glucose and (D) lactate before, during 
and after exercise in the GEL, WHEY and PLACEBO trials. Arrows represent feeding 
points. Shaded area represents exercise.  * denotes significant difference from baseline 
values, P<0.05. 
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Figure 4.2 – Serum insulin concentrations before, during and after exercise in the GEL, 
WHEY and PLACEBO trials. Arrows represent feeding points. Shaded area represents 
exercise. * denotes significant difference from baseline values, P<0.05, a denotes 
significant difference from PLACEBO, P<0.05. 
 
4.4.3 Plasma amino acid responses  
Plasma leucine, BCAAs and EAAs are displayed in Figure 4.3. Feeding-induced increases 
in plasma leucine (P<0.01) was significantly different between conditions (P<0.01) such 
that a significant interaction effect was observed (P=0.02). Specifically, plasma leucine 
was significantly greater in GEL versus both WHEY (P<0.01) and PLACEBO (P<0.01). 
Similar to leucine, feeding also induced a significant increase (P<0.01) in plasma BCAAs 
and EAAs for both WHEY and GEL where both a significant effect of condition (P<0.01) 
and interaction (P<0.01 and P=0.04, respectively) was observed. However, pairwise 
comparisons revealed there to be no differences in total BCAAs and EAAs between GEL 
and WHEY (P=1.0 and 0.6, respectively) though both were different from PLACEBO 
(P<0.01). 
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Figure 4.3 – Plasma (A) leucine, (B) BCAAs, and (C) EAAs before, during and after 
exercise in the GEL, WHEY and PLACEBO trials. Arrows represent feeding points. 
Shaded area represents exercise. * denotes significant main effect from baseline values, 
P<0.05, a denotes significant difference from PLACEBO, P<0.05, b denotes significant 
difference from WHEY, P<0.05. 
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4.5 Discussion 
The aim of the present chapter was to test the hypothesis that leucine enriched protein 
feeding enhances circulating leucine availability but does not impair FFA availability and 
lipid oxidation during exercise. To this end, I utilised two protein feeding strategies 
consisting of a traditional whey protein solution but also a novel leucine enriched protein 
gel. I provide novel data by demonstrating that provision of protein (in either of the 
aforementioned forms) before, during and after two hours of endurance exercise 
undertaken in the CHO restricted state does not impair FFA availability or lipid oxidation. 
Given that aspects of the enhanced training response observed when training in CHO 
restricted states are potentially regulated through FFA mediated signalling and also that 
leucine enriched protein elevates muscle protein synthesis, I therefore consider our data to 
have practical implications (i.e. feeding strategies) for training in CHO restricted states.   
Despite the apparent advantage to carefully scheduling periods of fasted (Van Proeyen et 
al. 2011) and/or glycogen depleted endurance training (Yeo et al. 2008; Morton et al. 
2009), such approaches may be limited in that skeletal muscle protein oxidation and 
breakdown is increased (Lemon and Mullin, 1980; Howarth et al. 2010) and hence, net 
protein balance becomes negative if amino acids are also not ingested (Hulston et al. 
2011). If performed chronically (especially in the presence of reduced daily caloric intake), 
this approach could therefore lead to a loss of skeletal muscle mass (Cabone et al. 2013; 
Mettler et al. 2010; Pasiakos et al. 2013) and potentially, a de-training effect. To this end, 
out group recently demonstrated that consuming a casein hydrolysate solution before, 
during and after glycogen depleted exercise does not impair activation of mitochondrial 
related signalling pathways (e.g. AMPK- PGC-1α) as well as positively affecting 
molecular regulators of protein synthesis (e.g. eEF2 phosphorylation status) (Taylor et al. 
2013).  As such, many elite endurance cyclists now perform prolonged morning rides in 
CHO restricted states but with protein rich breakfasts and additional protein during 
exercise (typically in the form of whey / casein drinks) in a deliberate attempt to promote 
oxidative adaptations of skeletal muscle (Walsh, 2014).   
In terms of modulating protein synthesis, however, current evidence also suggests that both 
rapidly digestible but leucine rich proteins are the optimal protein source. For example, 
Pasiakos et al. (2011) observed that enhanced concentration of leucine (3.5 g in 10 g EAA) 
in an essential amino acid mixture consumed during two hours of endurance exercise 
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significantly enhanced post-exercise muscle protein synthesis rates when compared with 
the same total intake of essential amino acids but containing reduced leucine concentration 
(1.87 g in 10 g EAA).  Furthermore, Churchward-Venne et al. (2014) demonstrated 
comparable post-exercise myofibrillar synthesis rates (albeit from a resistance exercise 
stimulus) from mixed macronutrient drinks containing 25 g whey versus a bolus of 6.25 g 
whey supplemented with 5 g leucine. Such observations therefore formed the underlying 
rationale for the present study in terms of studying whey protein (naturally high in leucine) 
but also, a novel leucine enriched protein gel. Total leucine administration during the data 
collection period (i.e. 5 hours) was 6.3 g and 14.4 g in WHEY and GEL, respectively.  
Accordingly, mean plasma leucine levels were higher in GEL versus WHEY and in both 
feeding strategies, plasma leucinemia increased to levels that would be expected to 
promote post-exercise muscle protein synthesis (Breen et al. 2011; Pasiakos et al. 2011).  
Unfortunately, direct estimates of muscle protein synthesis (and related molecular 
regulators) were not obtained in the present study nor did I quantify rates of leucine 
oxidation. Indeed, it is likely that the total leucine delivery in both trials would have 
resulted in elevated leucine oxidation given that high protein availability potentiates whole 
body leucine oxidation (Bowtell et al. 1998). However, given that exercising in CHO 
restricted states augments leucine oxidation (Lemon and Mullin, 1980; Wagenmakers et al. 
1991; Howarth et al. 2010), it was a deliberate aim to administer higher exogenous leucine 
so as to deliver both substrate to promote muscle protein synthesis (Breen et al. 2011; 
Pasiakos et al. 2011; Churchward-Venne et al. 2013) but yet, also compensate for the 
higher levels of endogenous leucine oxidation (Lemon and Mullin, 1980; Wagenmakers et 
al. 1991; Howarth et al. 2010) that have been shown to reach >50 µmol·kg-1·h-1 in trained 
males (Phillips et al. 1993).  
Importantly, I observed that neither the whey protein solution nor the leucine enriched 
protein gel attenuated circulating FFA availability or whole body rates of lipid oxidation 
during exercise, despite elevated serum insulin levels in the pre-exercise period. This 
finding is especially relevant considering that the enhanced training response observed 
when training with low CHO availability (particularly the elevated capacity for lipid 
oxidation during customary exercise) is likely regulated, in part, through FFA mediated 
signalling.  Indeed, the exercise-induced increase in p38MAPK activity is blunted by 
pharmacological reduction of circulating FFA availability (Zbinden-Foncea et al. 2013).  
Furthermore, exercise undertaken in a glycogen-depleted state increases PPARδ binding to 
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the CPT1 promoter (Philp et al. 2013), the latter considered as a rate limiting enzyme for 
long chain fatty acid oxidation.  The observation of no apparent reduction in lipolysis with 
protein feeding in the present study disagrees with previous observations from our 
laboratory where we demonstrated that a casein hydrolysate solution (administered as 20 g 
45 min pre-exercise, 10 g during exercise and 20 g post-exercise) attenuated plasma FFA 
availability and whole body rates of lipid oxidation during exercise.  Such discrepancies 
may be due in part to differences in timing of pre-exercise feeding (i.e. 60 versus 45 
minutes before exercise) as well as type of protein consumed (i.e. casein hydrolysate 
versus predominantly whey isolate proteins). The latter point is particularly relevant given 
that hydrolysate proteins induce greater insulin responses compared with isolated protein 
sources (Tang et al. 2009; Pennings et al. 2011). As such, the effects of protein ingestion 
on metabolic responses during exercise are likely dependent upon the interplay of a 
number of important factors including type and timing of protein ingestion. Such factors 
should therefore be taken into consideration when designing real world feeding strategies. 
To achieve the delivery for the leucine enriched protein trial, I chose to develop a novel 
protein based gel. Indeed, considering that leucine is often not readily soluble in water, I 
reasoned that a gel format provided a more convenient approach for which to deliver a 
leucine enriched protein source. Moreover, gels are a highly practical approach to carrying 
fuel and feeding whilst in locomotion as opposed to conventional approaches of fluid 
delivery (Pfeiffer et al. 2010; Lee et al. 2014). Accordingly, gels are a highly utilised form 
of supplement by endurance athletes (Pfeiffer et al. 2012).  On the basis that caffeine can 
partially restore training intensity when in glycogen depleted states (Lane et al. 2013) and 
also that beta-hydroxy beta-methylbutyrate (HMB) can reduce muscle protein breakdown 
(Wilkinson et al. 2013), I also chose to fortify this GEL with additional caffeine (100 mg 
per 22g of protein) and HMB (1 g per 22g of protein).  Although I did not measure 
parameters related to these products given that the exercise protocol was clamped (i.e. 2 h 
fixed intensity of 70% V̇O2peak) and no indices of protein breakdown were obtained, the 
observations of no differences in gastrointestinal discomfort between trials supports the 
notion that multiple ingredients in the gel format were well tolerated. Interestingly, 
participants’ ratings of perceived enjoyment (as quantified by the Physical Activity 
Enjoyment Scale) also tended to be higher in GEL (89 ± 5) versus both WHEY (84 ± 5) 
and PLACEBO (79 ± 5). Given that this scale takes into account subjective measurements 
of mood status related to vigor and arousal, this observation maybe related to the higher 
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plasma concentrations of leucine observed in the GEL trial and is accordance with the 
hypothesis that elevated BCAAs (especially in conditions of low CHO availability) may 
alleviate symptoms of central fatigue (Blomstrand et al. 2005; Blomstrand, 2006). 
In summary, I provide novel data by demonstrating that neither a whey protein solution nor 
a leucine enriched protein gel impairs circulating FFA availability or rates of whole body 
lipid oxidation during two hours of endurance exercise undertaken in a CHO restricted 
state.  Given that the augmented training response observed when training fasted and/or 
glycogen depleted is potentially regulated through FFA mediated signalling and also that 
leucine rich protein elevates muscle protein synthesis, I consider this data to have practical 
implications for training in CHO restricted states.  
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Chapter 5 
 
Fuel for the work required: a practical approach to 
amalgamating train-low paradigms for endurance athletes 
 
 
 
 
 
 
 
 
 
 
 
The aim of this chapter was to characterise the effects of reduced carbohydrate (CHO) but 
high leucine availability on exercise capacity and skeletal muscle cell-signalling responses 
associated with exercise-induced regulation of mitochondrial biogenesis and MPS. This 
work was presented at ECSS Malmo, Sweden 2015, with the full manuscript published in 
Physiological Reports February 2016.  
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5.1 Abstract 
Using an amalgamation of previously studied “train-low” paradigms, I characteris the 
effects of reduced carbohydrate (CHO) but high leucine availability on cell-signalling 
responses associated with exercise-induced regulation of mitochondrial biogenesis and 
muscle protein synthesis (MPS). In a repeated measures cross-over design, eleven males 
completed an exhaustive cycling protocol with high CHO availability before, during and 
after exercise (HIGH) or alternatively, low CHO but high protein (leucine enriched) 
availability (LOW+LEU). Muscle glycogen was different (P<0.05) pre-exercise (HIGH: 
583 ± 158, LOW+LEU: 271 ± 85 mmol·kg-1 dw) but decreased (P<0.05) to comparable 
levels at exhaustion (≈ 100 mmol·kg-1 dw). Despite differences (P<0.05) in exercise 
capacity (HIGH: 158 ± 29, LOW+LEU: 100 ± 17 min), exercise induced (P<0.05) 
comparable AMPKα2 (3-4-fold) activity, PGC-1α (13-fold), p53 (2-fold), Tfam (1.5-fold), 
SIRT1 (1.5-fold), Atrogin 1 (2-fold) and MuRF1 (5-fold) gene expression at 3 h post-
exercise. Exhaustive exercise suppressed p70S6K activity to comparable levels 
immediately post-exercise (≈ 20 fmol.min-1.mg-1). Despite elevated leucine availability 
post-exercise, p70S6K activity remained suppressed (P<0.05) 3 h post-exercise in 
LOW+LEU (28 ± 14 fmol.min-1.mg-1) whereas muscle glycogen re-synthesis (40 
mmol·kg-1 dw.h-1) was associated with elevated (P<0.05) p70S6K activity in HIGH (53 ± 
30 fmol.min-1.mg-1).  I conclude: 1) CHO restriction before and during exercise induces 
“work-efficient” mitochondrial related cell signalling but, 2) post-exercise CHO and 
energy restriction maintains p70S6K activity at basal levels despite feeding leucine 
enriched protein. These data support the practical concept of “fuelling for the work 
required” as a potential strategy for which to amalgamate train-low paradigms into 
periodised training programs. 
Keywords: mitochondrial biogenesis, muscle glycogen, train-low 
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5.2 Introduction  
Traditional nutritional strategies for endurance athletes have typically advised high 
carbohydrate (CHO) availability before, during and after training sessions in order to 
support high daily training volume and intensities (Burke et al. 2011).  However, in the last 
decade accumulating data demonstrate that strategic periods of reduced CHO availability 
(the so-called “train-low” paradigm) actually augments selected skeletal muscle markers of 
training adaptation (Hawley and Morton. 2014; Bartlett et al. 2015). For example, reducing 
endogenous and/or exogenous CHO availability during short-term (e.g. 3-10 week) 
endurance training increases mitochondrial enzyme activity and protein content (Morton et 
al. 2009; Yeo et al. 2008; Van Proeyen et al. 2011), increases both whole body (Yeo et al. 
2008) and intramuscular lipid oxidation (Hulston et al. 2010) and in some instances, 
improves exercise capacity and performance (Hansen et al. 2005; Cochran et al. 2015; 
Marquet et al. 2016). The augmented training responses observed when “training low” are 
thought to be mediated via the complex regulation of cell signalling pathways with potent 
roles in modulating an oxidative phenotype.  Indeed, when exercise protocols are matched 
for work done, CHO restriction augments both AMPK (Wojtaszwski et al. 2003) and 
p38MAPK activation (Cochran et al. 2010) that ultimately converge on downstream 
transcription factors and co-activators such as PGC-1α (Psilander et al. 2013), p53 (Bartlett 
et al. 2013) and PPARδ (Philp et al. 2013).  In the context of nutrient-gene interactions, it 
is therefore apparent that the acute molecular regulation of cell signalling processes 
provides a theoretical basis for understanding the molecular mechanisms underpinning 
chronic training adaptations.  
The research designs that have been used to study both acute and chronic train-low 
adaptations thus far, have largely adopted twice per day training protocols (Hansen et al. 
2005; Yeo et al. 2008; Hulston et al. 2010), fasted training (Van Proyen et al. 2011) and 
CHO restriction during (Morton et al. 2009) and/or post-exercise (Pilegaard et al. 2005). 
More recently, a “sleep-low, train-low” model has also been developed in which athletes 
perform an evening training session but sleep with reduced post-exercise CHO intake, 
followed by completion of a fasted training session on the subsequent morning. Using this 
model, we (Bartlett et al. 2013) and others (Lane et al. 2015) observed enhanced activation 
of acute cell signalling pathways and expression of genes with putative roles in regulating 
training adaptation. Furthermore, when performed chronically as part of a periodised 
nutrition strategy, this model of CHO restriction also enhanced sub-maximal cycling 
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efficiency, high-intensity cycling capacity and improved 10 km run time in already well 
trained triathletes (Marquet et al. 2016). 
Despite the emergence of the aforementioned train-low paradigms, the optimal approach 
for which to practically apply with athletic populations is not currently known. Such 
limitations are most well recognised for the potential reductions in absolute training 
intensity associated with reduced CHO availability  (Widrick et al. 1993; Yeo et al. 2008; 
Hulston et al. 2010), perturbations to immune function and associated increases in muscle 
protein degradation (Lemon and Mullin, 1980; Howarth et al. 2010), all of which could be 
detrimental to long term training and athletic performance.  Furthermore, in the real world 
training environments of elite endurance athletes, it is likely that athletes practice an 
amalgamation of the aforementioned train-low paradigms (either through default of their 
current training structure or via coach and sport scientist-led practices), as opposed to 
undertaking one potential strategy in isolation.  The complexity of practical train-low 
models is also further exacerbated by the observations that many endurance athletes 
(especially cyclists) also practice day-to-day or longer term periods of energy periodisation 
(as opposed to CHO per se) in an attempt to reduce both body mass and fat mass in 
preparation for key competitive events (Stellingwerff, 2012; Vogt et al. 2005).  Indeed, the 
performance improvements observed by Marquet et al. (2016) were also associated with a 
1 kg reduction in fat mass induced by the periodised sleep-low model.  When taken 
together, such data highlight the requirement to study train-low paradigms that may be 
more reflective of real world athletic practice (i.e. both CHO and energy restriction) and 
that are representative of an amalgamation of the train-low protocols previously studied in 
the research setting. 
With this in mind, the aim of this chapter was to examine the effects of high CHO versus 
low CHO availability on the modulation of those skeletal muscle cell-signalling pathways 
with putative roles in the regulation of both mitochondrial biogenesis and muscle protein 
synthesis (MPS). I employed a repeated measures crossover design whereby healthy active 
males performed an exhaustive cycling based protocol in conditions of high CHO 
availability (i.e. best nutritional practice of CHO loading and CHO feeding during and 
after exercise) versus a nutritional protocol representative of both low CHO and energy 
availability (as achieved via 36 h of reduced CHO intake and omission of CHO intake 
before, during and after exercise). In an attempt to compensate for the negative effects of 
energy deficit on muscle protein degradation and synthesis (Pasiakos et al. 2010, 2011, 
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2013; Breen et al. 2011; Areta et al. 2014), the low CHO protocol was also completed with 
leucine rich protein availability before, during and after exercise. I specifically hypothesise 
that reduced CHO availability would impair exercise capacity but nonetheless, would 
induce comparable or superior mitochondrial related signalling thereby inducing a work-
efficient training and nutritional train-low paradigm. I further hypothesised that high 
leucine availability would up-regulate markers of protein synthesis and reduce markers of 
muscle protein breakdown.  
 
5.3 Methodology  
5.3.1 Participants: Eleven recreationally active and amateur competitive male cyclists 
(age: 24.0 ± 3.3; height: 1.78 ± 0.1 m; body mass: 79.6 ± 4.0 kg) who trained between 3 – 
7 hours per week took part in this study. Mean V̇O2peak and peak power output (PPO) for 
the cohort was 53.6 ± 7.0 mL·kg-1·min-1 and 285 ± 20 W respectively. None of the 
participants had a history of neurological disease or skeletal muscle abnormality and none 
were under pharmacological intervention during the course of the study. All participants 
provided informed written consent and all procedures conformed to the standards set by 
the Declaration of Helsinki (2008). The study was approved by the local Research Ethics 
Committee of Liverpool John Moores University. 
5.3.2 Design: In a repeated measures cross-over design separated by 7-9 days, participants 
completed two exhaustive exercise trials in conditions of high CHO availability (HIGH) or 
reduced CHO availability but with leucine enriched protein feeding before, during and 
after exercise (LOW+LEU). At 36-40 h prior to the main experimental trials, all 
participants performed a glycogen depletion protocol followed by 36 h of high or low CHO 
intake so as to manipulate pre-exercise muscle glycogen content prior to the exhaustive 
exercise protocol. Participants in HIGH then completed the exhaustive exercise protocol in 
conditions considered as best nutritional practice i.e. pre-exercise meal consisting of both 
CHO and protein, CHO intake during exercise and both CHO and protein intake post-
exercise. In contrast, participants in LOW+LEU commenced the exhaustive exercise 
protocol with reduced pre-exercise muscle glycogen and only consumed leucine enriched 
whey protein before, during and after exercise. As such, this trial represented conditions of 
reduced CHO and absolute energy availability but high protein availability throughout. 
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Muscle biopsies were obtained from the vastus lateralis immediately before, post- and at 3 
h post-exercise. An overview of the experimental protocol is shown in Figure 5.1. 
 
Figure 5.1. Overview of study protocol. On the evening of day 1, participants completed a 
glycogen depleting protocol followed by 3h of best practice recovery nutrition (HIGH) or 
sleep-low (LOW+LEU). Throughout the entirety of day 2, participants consumed a high 
CHO diet (HIGH) or alternatively, a low CHO and low energy dietary protocol 
(LOW+LEU) that was matched for both protein and fat intake. During the main 
experimental trial on day 3, participants performed an exhaustive cycling protocol in 
conditions of best practice nutrition (HIGH) in which high CHO intakes were consumed 
before, during and after exercise. In contrast, in the LOW+LEU trial, participants 
consumed leucine-enriched protein only. In this way, the LOW+LEU trial represented 3 
days of amalgamation of train-low strategies consisting of sleep-low (day 1), low dietary 
CHO intake (day 2), and omission of CHO intake before, during and after exercise (day 3). 
Muscle biopsies were obtained immediately pre-exercise, at the point of exhaustion (Exh) 
and at 3 h post-exercise. * denotes leucine-enriched protein.   
5.3.3 Assessment of maximal oxygen uptake: At 7-10 days prior to the experimental 
trials, all participants were initially assessed for peak oxygen consumption (V̇O2peak) and 
peak aerobic power (PPO) as determined during an incremental cycle test performed on an 
electromagnetically braked cycle ergometer described in section 3.4.4 general 
methodology. 
5.3.4 Day 1 – Glycogen depletion protocol. Participants arrived at the laboratory on the 
evening (19.00) of the first experimental day having avoided alcohol and vigorous physical 
activity for the previous 24 h. Nude body mass was recorded and a heart rate (HR) monitor 
(Polar FT1, Finland) fitted. Participants then performed an intermittent glycogen-depleting 
cycling protocol lasting ~120 min, as described previously by our group (Taylor et al. 
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2013). The activity pattern and total time to exhaustion were recorded, and water was 
consumed ad libitum throughout exercise. These parameters were repeated exactly during 
the second experimental condition and all cycling protocols were conducted on a fully 
adjustable electromagnetically braked cycle ergometer (SRM, Julich, Germany). Following 
the depletion exercise protocol, participants in HIGH consumed high carbohydrate at a rate 
of 1.2 g·kg-1 body mass (BM) carbohydrate per hour for the first three hours in a mixture 
of bars and fluids (GO Bars / Go Energy, Science in Sport, Nelson, UK) and 22g of whey 
protein immediately post-exercise (REGO Protein, Science in Sport, Nelson, UK).  In 
contrast, when participants completed the LOW+LEU trial, they consumed no 
carbohydrate within the 3 h recovery period but did consume the same bolus of 22g whey 
protein (REGO Protein, Science in Sport, Nelson, UK) immediately post-exercise.   
5.3.5 Day 2 – Nutritional protocols. During day 2, participants in the HIGH trial 
consumed 8 g·kg-1 BM carbohydrate as a mixture of foods and sports supplements 
designed to maximise muscle glycogen replenishment whereas in the LOW+LEU trial, 
participants consumed 3 g·kg-1 BM carbohydrate in order to minimise muscle glycogen 
replenishment. In both trials, participants also consumed 2 g·kg-1 BM protein and 1 g·kg-1 
BM fat.  In this way, it was expected that participants would commence the main 
experimental trial on the morning of day 3 with high (HIGH) or low (LOW+LEU) muscle 
glycogen whilst also having consumed identical protein and fat intake and completed the 
same exercise loading patterns.  
5.3.6 Day 3 - Main experimental trial. On the morning of the Day 3, participants reported 
to the laboratory in a fasted state and an indwelling cannula (Safety Lock 22G, BD 
Biosciences, West Sussex UK) was inserted into the anticubital vein in the anterior crease 
of the forearm and a resting blood sample drawn.  After a resting blood sample was taken, 
the cannula was flushed with ~ 5 ml of sterile saline (Kays Medical supplies. Liverpool 
UK) to keep the cannula patent and sterile, this procedure was repeated after each 
subsequent blood draw. Following blood sampling, participants in HIGH received a 
standardised breakfast containing 2 g·kg-1 BM CHO and an absolute dose of 22g whey 
protein and 15 g fat at 2 hours prior to commencing the exhaustive exercise protocol. Two 
hours were provided post-prandial to allow sufficient time for digestion prior to 
commencing exhaustive exercise.  In contrast, participants in the LOW+LEU trial 
consumed a leucine enriched protein drink that is not commercially available (Science in 
Sport, Nelson, UK) containing a total of 22g protein of which 6.3 g was leucine at 45 min 
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prior to commencing exercise. The leucine enriched protein was given 45 min prior to 
exercise (as opposed to 2 hours prior) so as to ensure sufficient circulatory amino acid 
availability “during” the exercise protocol (Impey et al. 2015). Additionally, these timings 
and dosing strategies are in accordance with nutritional practices of professional road 
cyclists and as such, it was my aim to examine a real world nutritional protocol (Walsh, 
2013). 
Participants then completed a prescribed cycling protocol consisting of 4 x 30 seconds high 
intensity intervals (HIT) at 150% PPO interspersed with 2.5 min active recovery at 40% 
PPO followed by 45 min steady state (SS) cycling at 50% PPO to examine the effects of 
altered substrate availability on standardised exercise responses (i.e. RPE, HR, substrate 
utilisation). During the HIT and steady state component, participants in HIGH ingested a 
6% CHO solution providing 20 g of CHO (GO Electrolyte, Science in Sport, Nelson, UK) 
at 20-minute intervals to provide 60 g in the first 60 minutes of exercise, thereby in 
accordance with current nutritional recommendations for CHO intake during exercise. 
Participants in LOW+LEU ingested one third of the leucine enriched protein mix providing 
7.3 g of protein at the same 20 minute intervals as the feeding strategy in HIGH, so as to 
provide 22g protein per hour in an attempt to maintain high circulatory amino acid 
availability during exercise (Impey et al. 2015). Following the steady state cycle, 5 min of 
active recovery was provided and participants then commenced an exercise capacity test 
consisting of intermittent “1 min efforts” corresponding to 80% PPO interspersed with 1 
min recovery periods at 40% PPO. This intermittent protocol was followed until the 
participants reached volitional fatigue. Physiological and perceptual measures were 
recorded at regular intervals throughout exercise and substrate utilisation was assessed 
during the steady state component of the exercise protocol using online gas analysis (CPX 
Ultima, Medgraphics, Minnesota, US) and the equations of Jeukendrup and Wallis (2005). 
At the point of exhaustion, participants in HIGH received the same 1.2 g·kg-1 BM CHO 
feeding strategy as following the depletion ride and an absolute dose of 22g whey protein 
immediately after whereas participants in LOW+LEU consumed 22g of the leucine 
enriched protein only immediately after exercise (Fig 5.1). In this way, participants in 
HIGH undertook and recovered from exercise having ingested 6.3 g·kg-1 BM CHO across 
the duration of the experimental trial along with a total of 44 g of protein, which contained 
4.6 g of leucine. In comparison, participants in LOW+LEU consumed a total of 66 g of 
protein of which 18.9 g was leucine across the duration of the main experimental trial. 
98 
 
Laboratory conditions remained constant across all experimental trials (19 – 21oC, 40 – 
50% humidity) and an overview of the nutritional feeding protocol is shown in Figure 5.1.  
5.3.7 Blood analysis: Blood samples were collected in vacutainers containing K2 EDTA, 
lithium heparin or serum separation tubes. Serum and plasma were aliquoted and stored at 
-80 ̊C until analysis. Plasma glucose, lactate, NEFA, glycerol, β-hydroxybutyrate and 
amino acids were analysed as described in section 3.6.1.  
5.3.8 Muscle biopsies: Skeletal muscle biopsy samples were collected as described in 
section 3.6.3.  
5.3.9 mRNA extraction and analysis and Reverse transcription quantitative Real-
Time Polymerase Chain Reaction (rt-qRT-PCR):  Isolation and quantification of 
mRNA and assessment of mRNA transcription changes were completed as outlined in 
section 3.6.4.  
5.3.10 Muscle glycogen concentration: Muscle glycogen was determined via method 
outlined in section 3.6.5.  
5.3. 11 [γ-32P] ATP Kinase Assay: Thirty mg of muscle tissue was used for the 
measurement of p70S6K1 and AMPKα1 and α2 activity as previously described (McGlory 
et al. 2014); section 3.6.6. 
5.3.12 Statistics: All statistical analyses were performed using Statistical Package for the 
Social Scientist (SPSS version 21). Descriptive statistics were produced for all data sets to 
check for normal distribution indicated by Kolmogorov-Smirnov (accepted if P>0.05).. 
Changes in exercise capacity were analysed using Student t – test. Changes in 
physiological and molecular responses between conditions (i.e. muscle glycogen, 
circulatory metabolites, amino acids, mRNA transcription and activity of signalling 
molecules) were analysed using two way repeated measures general linear model, where 
the within factors were time and condition. If Mauchley’s test of sphericity indicated a 
minimum level of violation, as assessed by a Greenhouse Geisser epsilon (ε) of ≥ 0.75, 
data were corrected using the Huynh-Feldt ε. If Mauchley’s test of sphericity was violated 
data were corrected using Greenhouse Geisser ε. Where a significant main effect was 
observed, pairwise comparisons were analysed according to Bonferoni post hoc tests in 
order to locate specific differences. An alpha value of P < 0.05 was utilized for all tests and 
all data in text, figures and tables are presented as mean ± SD. 
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5.4 Results 
5.4.1 Skeletal muscle glycogen content and exercise capacity 
Muscle glycogen content was significantly higher pre-exercise (P=0.003) in the HIGH trial 
compared with the LOW+LEU trial (Figure 5.2A). Exhaustive exercise also significantly 
reduced (P<0.001) muscle glycogen stores to comparable levels (<120 mmol·kg-1 dw) with 
no difference observed between conditions (P=0.278). As expected, post-exercise CHO 
feeding significantly increased (P=0.003) muscle glycogen in the HIGH trial to 
approximately 200 mmol·kg-1 dw whereas no glycogen re-synthesis was observed in the 
LOW+LEU trial. In accordance with distinct differences in CHO availability, exercise 
capacity was significantly greater (P<0.001) in the HIGH trial (158 ± 28 min) compared 
with the LOW+LEU trial (100 ± 17 min), an effect that was apparent in ten of the eleven 
participants (range: 4 to 113 min, 95% CI differences: 38 to 79 min) (Figure 5.2B). 
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Figure 5.2 – (A) Skeletal muscle glycogen content, (B) Exercise capacity (reflective of set 
work protocol plus time to exhaustion). *P<0.05, significant main effect of condition, 
#P<0.05, significant main effect of exercise. 
 
5.4.2 Physiological and metabolic responses to exercise 
Subject’s heart rate (P=0.458) and plasma lactate (P=0.929) during exercise did not display 
any significant differences between trials (Figure 5.3A and B, respectively). However, in 
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accordance with differences in CHO availability, plasma glucose was significantly lower 
(P=0.007) in the LOW+LEU trial when compared with the HIGH trial (Figure 5.3C). In 
contrast, plasma NEFA (P<0.001), glycerol (P<0.001) and β-OHB (P<0.001) were all 
significantly elevated during exercise in the LOW+LEU trial compared with the HIGH 
trial (Figure 5.3D, E and F, respectively). As a result of such differences in substrate 
availability, the pattern of fuel use during the steady state component of the exercise 
protocol was different such that participants in LOW+LEU oxidised less CHO (P=0.004) 
and more lipid (P=0.007) when compared with the HIGH trial (Figure 5.3G and H, 
respectively).  
 
5.4.3 Regulation of mitochondrial biogenesis related cell signalling 
The exhaustive exercise protocol did not increase AMPKα1 activity in either the HIGH or 
LOW + LEU trial (data not shown). In contrast, exhaustive exercise significantly increased 
AMPKα2 activity by approximately 4-fold immediately post-exercise (P=0.001) though no 
difference was observed between conditions (Figure 5.4A). Similarly, PGC-1α mRNA 
(P=0.007) was significantly increased to comparable levels between trials at 3 h post-
exercise with no differences between conditions (Figure 5.4B). p53 (P=0.01), SIRT1 
(P=0.007) and Tfam (P=0.029) mRNA were significantly elevated pre-exercise in the 
LOW+LEU condition compared with the HIGH trial (Figure 5.4C, D and F respectively). 
Acute exercise also significantly increased p53 (P=0.013), Tfam (P=0.038) and SIRT1 
(P=0.013) mRNA to comparable levels at 3 h post-exercise such that no differences were 
apparent between conditions. In contrast, neither nutrient availability nor the exhaustive 
exercise protocol affected COXIV mRNA levels (Figure 5.4E).   
 
5.4.4 Plasma amino acid levels 
Plasma leucine (P<0.001), BCAA (P<0.001) and EAA (P<0.001) concentrations were all 
significantly elevated (Figure 5.5A, B and C, respectively) before, during and after 
exercise in the LOW+LEU trial compared with the HIGH trial.  
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Figure 5.3 – (A) Heart rate responses during exercise and plasma, (B) Lactate, (C) 
Glucose, (D) NEFA, (E) Glycerol, (F) β-hydroxybutyrate, before, during and after 
exercise. (G) Carbohydrate oxidation and (H) Lipid oxidation during exercise. *P<0.05, 
significant main effect of condition. Shaded area represents exercise duration.   
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Figure 5.4 – (A) AMPKα2 activity pre-, post- and 3h post-exercise. Shaded area 
represents exercise duration. (B) PGC-1α, (C) p53, (D) SIRT1, (E) COXIV, and (F) Tfam 
mRNA content pre- and 3 h post-exercise. Shaded area represents exercise duration. 
*P<0.05, significant main effect of condition. #P<0.05, significant main effect of exercise. 
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Figure 5.5 – (A) Leucine, (B) BCAAs, and (C) EAAs before, during and after exercise. 
Shaded area represents exercise duration. *P<0.05, significant main effect of condition.  
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5.4.5 Regulation of protein synthesis and breakdown related cell signalling 
p70S6K activity was significantly elevated (P=0.03) immediately prior to exercise in the 
LOW+LEU trial compared with the HIGH condition (Figure 5.6A). Following exhaustive 
exercise, p70S6K activity was suppressed (P<0.001) to comparable levels in both the 
LOW+LEU and HIGH conditions. In contrast to pre-exercise status, p70S6K activity at 3 h 
post-exercise was significantly higher (P=0.04) in the HIGH trial compared with the 
LOW+LEU trial. PKB activity tended to increase (P=0.056) immediately post-exercise in 
both groups (Figure 5.6B). However, at 3h after exercise, PKB activity was significantly 
greater in the HIGH trial compared with the LOW+LEU condition (P=0.021). Consistent 
with the feeding of CHO before and after exercise, plasma insulin levels were significantly 
higher immediately pre- and 3 h post-exercise (P<0.05) in the HIGH trial compared with 
the LOW+LEU trial (Figure 5.6C) whereas exhaustive exercise reduced insulin levels 
(P=0.001) to comparable levels between trials. Atrogin1 mRNA expression was higher 
immediately (P=0.009) before exercise in the LOW+LEU trial compared with the HIGH 
trial whereas pre-exercise nutrient status had no effect on MuRF1 mRNA content (Fig 
5.7A and B, respectively). Exhaustive exercise also increased (P<0.05) the expression of 
both genes at 3 h post-exercise to comparable levels in the LOW+LEU and HIGH trials. 
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Figure 5.6 – (A) p70S6K, (B) PKB, and (C) Serum insulin pre-, post-, and 3 h post-
exercise. Shaded area represents exercise duration. *P<0.05, significant main effect of 
condition, #P<0.05, significant main effect of exercise.  
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Figure 5.7 – (A) MuRF1 and (B) Atrogin1 mRNA content pre- and 3 h post-exercise. 
*P<0.05, significant main effect of condition, #P<0.05, significant main effect of exercise.  
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5.5 Discussion 
The aim of the present study was to assess the effects of high CHO versus low CHO (but 
high leucine) availability on the modulation of those skeletal muscle cell-signalling 
pathways with putative roles in the regulation of both mitochondrial biogenesis and muscle 
protein synthesis. I adopted a train-low model that represents an amalgamation of 
previously studied train-low paradigms (incorporating both CHO and energy restriction) 
and that I consider representative of the real-world practices often adopted by elite level 
endurance athletes.  Confirming the hypothesis, I provide novel data by demonstrating that 
although reduced CHO availability impaired exercise capacity, the CHO restriction 
protocol induced comparable AMPK-PGC-1α signalling, thus inducing work-efficient 
signalling responses, given that the low CHO group completed 60min less total work to 
elicit the same AMPK- PGC-1α signalling responce.  In contrast, refraining from CHO 
intake in the post-exercise period (despite the intake of leucine rich protein) maintains 
p70S6K activity at basal levels. When taken together, these data have practical 
implications by suggesting that: 1) CHO restriction before and during exercise induces 
work-efficient cell signalling related to mitochondrial biogenesis but furthermore, 2) 
complete CHO and energy restriction in the post-exercise period impairs the activation of 
key signalling proteins regulating skeletal muscle modelling processes. As such, these data 
suggest that although athletes may benefit from carefully scheduled periods of reduced 
CHO availability before and during exercise so as to enhance mitochondrial related cell 
signalling, they should consume both CHO and protein post-exercise so as to restore the 
activation of MPS-related signalling.  Furthermore, this data lend support for a potential 
fuel for the work required train-low paradigm in that athletes could strategically reduce 
CHO availability prior to completing pre-determined training workloads that can be readily 
performed with reduced CHO availability, thereby inducing a work-efficient approach to 
training. Alternatively, when the goals of the training session are to complete the highest 
workload possible over more prolonged durations, then adequate CHO should be provided 
in the 24 h period prior to and during the specific training session.  
To achieve this model of CHO restriction, I employed a protocol consisting of an 
amalgamation of previously studied train-low models. For example, having completed an 
initial glycogen depletion protocol on the evening of day 1, participants adhered to a 
dietary protocol consisting of reduced CHO and energy intake for the subsequent 36 h 
prior to arriving on the laboratory on the morning of day 3 for the main experimental trial.  
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This initial approach is thus representative of an acute sleep-low model (i.e. CHO 
restriction in the initial hours following completion of the depletion protocol on day 1) 
followed by consumption of a low CHO diet for the entirety of day 2. This approach was 
successful in inducing marked differences in pre-exercise muscle glycogen content (≈ 600 
versus 300 mmol·kg-1 dw in HIGH and LOW+LEU, respectively) on the morning of the 
main experimental trial commenced on day 3 (Figure 5.2).  Consistent with the effects of 
post-exercise CHO restriction on regulation of gene expression (Pilegaard et al. 2005; 
Bartlett et al. 2013; Lane et al. 2015), I also observed marked effects on the expression of 
genes associated with regulatory roles in mitochondrial biogenesis. Indeed, participants 
arrived in the laboratory on the morning of day 3 with higher pre-exercise mRNA content 
of p53, SIRT1 and Tfam in the LOW+LEU trial (see Figure 5.4), all of which are thought 
to be regulators of mitochondrial biogenesis (Bartlett et al. 2014, 2015; Gurd et al. 2010; 
Saleem et al. 2013). The observation of enhanced p53 mRNA following post-exercise 
CHO restriction is consistent with previous data from our group demonstrating that the 
exercise-induced phosphorylation of p53Ser15 is enhanced with CHO restriction before, 
during and after exercise (Bartlett et al. 2013). On this basis, it is possible that sustained 
p53 activation in recovery from the glycogen depletion exercise protocol in conjunction 
with no CHO intake in the LOW+LEU trial may be a common signalling axis regulating 
the aforementioned gene expression responses. Indeed, p53 is known to auto-regulate its 
own expression (Deffie et al. 1993) as well as both basal and exercise induced Tfam 
mRNA levels (Saleem et al. 2013). Furthermore, previous work in cell culture models of 
nutrient deprivation has shown transcriptional regulation of SIRT1 is mediated through 
p53 binding to the SIRT1 promoter (Nemoto et al. 2004).   
In relation to the main experimental trial on day 3, participants also refrained from CHO 
intake before, during and after the exercise protocol (but consumed leucine rich protein), 
thereby representative of an amalgamation of fasted train-low protocols (Van Proyen et al. 
2011) and protein only training sessions (Taylor et al. 2013; Impey et al. 2015).  As 
expected, I observed distinct differences in substrate availability and fuel utilisation during 
the steady-state exercise protocol, as evidenced by β-OHB levels comparable with 
nutritional ketosis (Cox & Clarke, 2014), as well as greater levels of circulating NEFA, 
glycerol and lipid oxidation in the LOW+LEU trial compared with the HIGH trial. 
Consistent with the well-documented effects of both endogenous and exogenous CHO 
availability on exercise performance (Hawley et al. 1997; Stellingwerff and Cox, 2014), I 
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also observed reduced exercise capacity in the LOW+LEU trial compared with the HIGH 
trial, an effect that was evident in ten participants. However, one subject showed no 
difference in exercise capacity between LOW+LEU and HIGH conditions. This response is 
difficult to explain but may be due to subject’s preferences towards training in a fasted 
versus fed state, or may be an artefact of motivation during HIGH condition. Such data 
therefore reiterate the obvious necessity for high CHO availability before and during those 
training sessions in which prolonged high-intensity workloads are required to be 
completed.  
From a biochemical perspective, it is well-accepted that reduced muscle glycogen stores 
induce greater skeletal muscle cell signalling when compared with “matched-work” 
exercise protocols (i.e. completion of identical duration and intensity) undertaken with 
high glycogen stores (Bartlett et al. 2015). For example, AMPKThr172 phosphorylation (Yeo 
et al. 2010; Lane et al. 2015), ACCSer79 phosphorylation (Bartlett et al. 2013), AMPK-α2 
activity (Wojtaszewski et al. 2003) and the nuclear abundance of AMPK-α2 protein 
content (Steinberg et al. 2006) are all up-regulated to a greater extent when acute exercise 
is completed with reduced pre-exercise muscle glycogen stores, an effect likely mediated 
via the presence of a glycogen binding domain on the β-subunit of the AMPK heterotrimer 
(McBride et al. 2009). Furthermore, exogenous CHO feeding during exercise attenuates 
AMPK activity only when muscle glycogen sparing has occurred (Akerstrom et al. 2006).  
The present data extend these findings as I show for the first time comparable cell 
signalling effects despite the completion of significantly less work completed. Indeed, 
although I observed no effects of exercise on AMPK-α1 activity (as reported by others, 
Fujii et al. 2000), I observed similar increases in AMPK-α2 activity and PGC-1α mRNA 
expression at comparable levels of absolute glycogen, despite mean differences of 60 
minutes less work completed in LOW+LEU vs. HIGH conditions. Such data therefore 
support the “glycogen threshold” hypotheses (Philp et al. 2012) surmising that a critical 
absolute level of glycogen must be exceeded in order for significant AMPK signalling to 
occur during prolonged endurance exercise protocols.  
Given the effects of reduced CHO and energy deficit on muscle protein degradation and 
protein synthesis (Pasiakos et al. 2010, 2013; Areta et al. 2014; Lemon and Mullin, 1980; 
Howarth et al. 2010), I also chose to feed leucine enriched whey protein before, during and 
after the main experimental trial on day 3. In accordance with the role of leucine 
availability in modulating MPS (Churchward-Venne et al. 2014; Karlsson et al. 2006), I 
111 
 
observed higher pre-exercise p70S6K activity in the LOW+LEU trial when compared with 
the HIGH trial, though I acknowledge that differences in timing of pre-exercise feeding 
between trials may also have contributed to this finding. The effects of acute endurance 
exercise on regulation of p70S6K are not well established (and are typically limited to 
measures of phosphorylation status) with some studies reporting increases (Masher et al. 
2007, 2011) and others, no change (Coffey et al. 2006; Vissing et al. 2013).  Nevertheless, 
consistent with the notion that exercise suppresses MPS during exercise (Rose & Richter, 
2009; Rennie, et al. 1980), I observed significant reductions in p70S6K activity 
immediately post-exercise to almost identical levels between trials. To my knowledge, I 
am only the second researcher to directly quantify p70S6K activity in response to 
endurance type exercise protocols and the data conflict with Apro et al. (2015) who 
observed no change in response to 5 x 4 min cycling at 85% V̇O2max. Such discrepancies 
between studies are likely most related to the exhaustive and energy restricting nature of 
the exercise protocol. Whilst it is difficult to directly compare the total energy expenditure 
between this study and the data of Apro et al. (2015), the exercise interventions used here 
elicited considerably lower muscle glycogen concentrations of ~100 mmol·kg-1dw vs 350 
mmol·kg-1dw in the study of Apro et al (2015).  The mechanism(s) behind suppressed 
p70S6K activity following exhaustive exercise likely involve a large number of signalling 
mechanisms and regulators within skeletal muscle. Indeed, AMPK mediated inhibition of 
mTOR through TSC2 (Sanchez et al. 2012) or via interaction with v-ATPase-Ragulator at 
the late endosomal/lysosme surface (Zhang et al. 2014), as well as p53-REDD1 mediated 
inhibition of mTOR (Feng & Levine, 2010; Keller et al. 2013) are all potential candidates. 
Further studies are now required to test these hypotheses in human skeletal muscle.   
In relation to post-exercise feeding, I observed that the co-ingestion of carbohydrate and 
whey protein feeding was sufficient to rescue p70S6K activity in the HIGH trial whereas 
p70S6K remained suppressed in the LOW+LEU trial despite the intake of “leucine-
enriched” whey protein feeding. Whilst it is difficult to readily ascertain the precise 
mechanism(s) underpinning these data, it is noteworthy that I did observe increased 
upstream signalling of PKB (Akt) in the HIGH condition, an effect that may be simply 
related to insulin mediated activation given the repeat 90 g intakes of CHO immediately 
post and at 1 and 2 h post-exercise. In addition, the potential reduced PKB mediated 
activation of p70S6K may be due to the presence of low muscle glycogen per se given 
previous data demonstrating that the post-exercise (albeit in resistance exercise) activation 
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of Akt phosphorylation is suppressed (independent of post-exercise feeding) when muscle 
glycogen levels are comparable to that observed in the present study i.e. <150 mmol·kg-1 
dw (Creer et al. 2005).  Alternatively, the reduced activation of p70S6K in the LOW+LEU 
trial could be due to high circulating NEFA concentrations given that high fat availability 
can impair MPS. Indeed, infusion of Intralipid and heparin to elevate circulating NEFA 
concentrations (to comparable levels seen here) attenuates MPS in human skeletal muscle 
in response to ingesting 21g amino acids under euglycemic hyperinsulemic clamp 
conditions (Stephens et al. 2015). Furthermore, Kimball et al. (2015) also reported that 
high fat feeding impairs MPS in rat liver in a manor associated with reduced p70S6K 
phosphorylation (but not PKB phosphorylation).  
The functional relevance of such divergent responses cannot be ascertained from the 
present study given that I did not directly quantify MPS.  Indeed, previous data have 
suggested that low muscle glycogen availability (during resistance exercise protocols) does 
not have any measurable effect on post-exercise MPS (Camera et al. 2012) whereas the 
recovery from endurance exercise when glycogen levels remain low results in negative 
protein balance (Howarth, et al. 2010). As noted previously, however, the experimental 
protocol adopted here was a deliberate manipulation of both CHO and energy availability. 
Indeed, consistent with the effects of acute energy deficit on skeletal muscle proteolysis 
(Carbone et al. 2013), I also observed increased resting mRNA expression of Atrogin 1 in 
the LOW+LEU trial when compared with the HIGH trial. Furthermore, given that acute 
energy deficit also impairs MPS in a manor associated with reduced PKB (Pasiakos et al. 
2010) and p70S6K phosphorylation (Pasiakos et al. 2013) the divergent signalling 
responses observed here may indeed manifest as functional reductions in MPS and 
negative protein balance. From a practical perspective, the data suggest that whilst there 
may be benefits of restricting CHO intake in the post-exercise period in terms of enhancing 
mitochondrial signalling, it is also necessary to consume sufficient CHO intake in the 
immediate post-exercise period so as to replenish muscle glycogen to sufficient levels per 
se and/or obtain upstream signalling effects associated with feeding, the result of which 
could maintain the activity of those signalling proteins with putative roles in regulating 
MPS and skeletal muscle remodelling.   
It is, of course, beyond the scope of the present paper to offer definitive guidelines on how 
best to periodise CHO restriction into an overall athletic training programme. Nevertheless, 
in accordance with the work of Lane et al. (2015), I consider the signalling responses 
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observed herein to offer further mechanistic support for the performance improvements 
observed by Marquet et al. (2016) whilst adopting the 3-week sleep low training paradigm. 
In essence, the theme that emerges appears to be the concept of both “day-to-day” and 
“meal-by-meal” CHO periodization in accordance with the upcoming training workloads 
that have been prescribed.  In practice, this approach of forward planning could represent 
an amalgamation of train-low paradigms and is perhaps best communicated by the 
principle of “fuel for the work required”.  Careful day-to-day periodization (as opposed to 
chronic periods of CHO restriction) is likely to maintain metabolic flexibility and still 
allow for the completion of high-intensity and prolonged duration workloads on heavy 
training days e.g. interval type workouts undertaken above lactate threshold. Intuitively, 
train-low sessions may be best left to those training sessions that are not CHO dependent 
and in which the intensity and duration of the session is not likely to be compromised by 
reduced CHO availability e.g. steady-state type training sessions performed at intensities 
below the lactate threshold. 
In summary, I have utilised an amalgamation of previously studied train-low paradigms 
(considered representative of real world athletic practice) to demonstrate for the first time 
that CHO restriction before and during exhaustive exercise induces work-efficient cell 
signalling related to mitochondrial biogenesis, in that the low CHO group was able to 
achieve the same level of AMPK- PGC-1α signalling response while completing 60min 
less work.  However, in the absence of CHO feeding and absolute energy intake in the 3 h 
post-exercise period, p70S6K activity remains suppressed despite consuming leucine rich 
protein immediately post-exercise.  
When taken together, these data allude to a potential muscle glycogen threshold 
hypothesis, surmising that reduced pre-exercise muscle glycogen may facilitate a greater 
portion of training being completed within an optimal window, within which enhanced 
activation of the pathways regulating mitochondrial biogenesis is seen. Importantly this 
hypothesis also suggests that keeping glycogen and energy intake at critically low levels 
post-exercise may impair the regulation muscle protein synthesis related signalling.  
Furthermore, this data lend support for a potential fuel for the work required train-low 
paradigm, in that athletes could strategically reduce CHO availability prior to completing 
pre-determined training workloads that can be readily performed with reduced CHO 
availability, thereby inducing the work-efficient approach to training detailed above. 
Alternatively, when the goals of the training session are to complete the highest workload 
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possible over more prolonged durations, then adequate CHO should be provided in the 
hours prior to and during the specific training session to provide sufficient fuel to sustain 
the required intensity and duration of that specific training session. In this way, the fuel for 
the work required paradigm suggests that in the same way training is periodised, 
carbohydrate should also be periodised to maximise the potential for training adaptations to 
occur, given the observed work efficiency seen here. Thus, the concept of fuel for the work 
required suggests that nutrition strategies before, during and after training should reflect 
the desired outcome of each specific training session, as such this requires considered 
forward planning for both training and nutrition to facilitate the desired outcome.  
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Chapter 6 
 
Co-ingestion of whey protein and carbohydrate reactivates p70S6K1 
post-exercise in recovery from an acute train-low endurance training 
session 
 
 
 
 
 
 
The aim of this chapter was to examine the role of protein composition in regulating 
skeletal muscle cell-signalling responses associated with exercise-induced regulation of 
mitochondrial biogenesis, MPS and autophagy when in recovery from a train-low 
endurance training session.  This work was presented at ISENC 2016, Newcastle, UK; 
currently under review for publication.   
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6.1 Abstract 
The purpose of this chapter is to examined the effects of whey versus collagen protein on 
regulation of post-exercise skeletal muscle remodelling processes (associated with 
mitochondrial biogenesis, protein synthesis and autophagy) when in recovery from a train-
low endurance training session.  In a repeated measures cross-over design, eight males 
completed a 75-min non-exhaustive cycling protocol. Protein provision consisted of 22g of 
collagen (COLLAGEN) or whey (WHEY) protein 45 min prior to exercise, 22g during 
exercise and 22g immediately post-exercise. Carbohydrate (CHO) was also consumed 
immediately post- and at 1 h post-exercise in both trials (1.2 g/kg body mass). Exercise 
decreased (P<0.05) muscle glycogen content by comparable levels from pre-to post-
exercise in both trials (≈ 350 to 150 mmol·kg-1 dw). Exercise induced (P<0.05) comparable 
increases in PGC-1α (8-fold), ATG12 (1.3-fold) and Parkin mRNA content (1.3-fold) at 
1.5 h post-exercise, as well as similar reductions in LC3bI, II and p62 protein content (P < 
0.05).  Exercise suppressed (P<0.05) p70S6K activity to comparable levels immediately 
post-exercise (≈ 25 fmol.min-1.mg-1). Nonetheless, post-exercise feeding increased p70S6K 
activity at 1.5 h post-exercise (P<0.05), the magnitude of which was greater (P <0.05) in 
WHEY (180 ± 105 fmol.min-1.mg-1) versus COLLAGEN (73 ± 42 fmol.min-1.mg-1, 
respectively).  When consumed with post-exercise CHO ntake, whey protein augments 
post-exercise p70S6K1 activity to a greater extent than compared with collagen. We also 
observed that protein composition does not modulate markers of mitochondrial biogenesis, 
autophagy and mitophagy when in recover from an acute train-low endurance training 
session.  
Keywords: autophagy, mitophagy, parkin, glycogen 
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6.2 Introduction 
The concept of deliberately training with reduced carbohydrate (CHO) availability to 
enhance endurance-training adaptations the train-low model is gaining increased popularity 
amongst both academic and athletic circles (Yeo et al. 2008; Marquet et al. 2016).  During 
the last decade, our group and others have consistently demonstrated that both reduced 
endogenous and exogenous CHO availability augments training-induced increases in 
whole body and intramuscular lipid metabolism (Hulston et al. 2010), oxidative enzyme 
activity and protein content (Yeo et al. 2008) and moreover, improves exercise 
performance (Cochran et al. 2015; Marquet et al. 2016). Such adaptations are likely 
mediated by increased activation of regulatory cell signalling pathways (e.g. activation of 
upstream cell signalling kinases and downstream transcriptional co-activators and 
transcription factors) to induce a co-ordinated up-regulation of both the nuclear and 
mitochondrial genomes (Wojtaszewski et al. 2003; Bartlett et al. 2013; Philp et al. 2013). 
From a practical perspective, I have previously suggested the fuel for the work required 
paradigm whereby CHO availability is periodised in both a day-to-day and meal-by-meal 
manner in accordance with the upcoming workload of the prescribed training session(s) 
(Impey et al. 2016). The fuel for the work required concept suggests that given the 
potential, from a molecular signalling perspective, to improve the efficiency with which 
training elicits adaptive responses the nutritional programming before, during and after 
each training should be specific to the duration, intensity and desired outcome of each 
training session.  
When incorporating train-low sessions into an athletic training programme, it is also 
suggested that athletes should consume increased protein before (MacLean et al. 1994; 
Coffey et al. 2011), during (Hulston et al. 2011) and/or after (Rowlands et al. 2015) each 
training session. Indeed, such a feeding strategy is facilitative of a positive net protein 
balance and activates the molecular machinery (i.e. the Akt-mTOR-p70S6K signalling 
axis) required to stimulate post-exercise remodelling processes including muscle protein 
synthesis (Breen et al. 2011). Furthermore, increased amino acid availability prior to and 
during train-low sessions does not impair circulating free fatty acid availability (Impey et 
al. 2015) nor the key signalling pathway (i.e. the AMPK-PGC-1α pathway) that is thought 
to mediate many of the beneficial adaptations associated with train-low protocols (Taylor 
et al. 2013). It is noteworthy, however, that maintaining post-exercise glycogen and energy 
availability at the critically low levels associated with exhaustion impairs the post-exercise 
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activation of p70S6K activity, despite consuming leucine enriched whey protein (Impey et 
al. 2016).  On this basis, I therefore suggested the presence of a muscle “glycogen 
threshold” i.e. a metabolic window of absolute pre- and post-exercise glycogen 
concentrations that should not be exceeded to activate the cell signalling pathways that 
mediate both mitochondrial biogenesis and muscle protein synthesis.  To this end, such 
data suggest that whilst beneficial oxidative adaptations may be achieved with reduced pre-
exercise CHO availability, the post-exercise meal should contain a combination of both 
protein and CHO to provide the necessary substrate and energy to stimulate glycogen 
synthesis and post-exercise muscle protein synthesis. 
In addition to signalling relating to mechanisms of protein synthesis, transcription of 
markers of bulk protein breakdown such as MuRF1 and Atrogin1 have been shown to be 
elevated during train low sessions (Impey et al. 2016). Indeed, while bulk degradation 
processes are important to degrade malfunctioned proteins and restore energy balance 
during energetic stress, recent data has pointed to the specific targeted degradation of 
cellular constituents, termed autophagy, as an essential part of the adaptive response to 
exercise training (He et al. 2012; Lira et al. 2013). Mitochondrial targeted degradation 
(termed mitophagy) has recently been identified to occur in response to exercise however 
little is known about this response in human skeletal muscle or if nutritional status affects 
this adaptive response (Vainshten et al. 2015; Vainshten and Hood, 2016).  
To further explore this concept, the primary aim of the present chapter was to test the role 
of post-exercise protein composition when ingested with CHO in activating post-exercise 
remodelling processes when in recovery from completion of a train-low training 
session.  To this end, I adopted an experimental design whereby recreationally active male 
cyclists completed a non-exhaustive session in which glycogen remained within the chosen 
theoretical glycogen threshold window e.g. pre-and post-exercise concentrations of <350 
and >150 mmol·kg dw-1, respectively.  Furthermore, given the emerging evidence that both 
autophagy and mitophagy are key processes involved in training adaptation (He et al. 
2012; Masiero et al. 2009; Vainshten and Hood, 2016), I also assessed the effects of 
protein composition on both gene expression and protein markers of both processes. 
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6.3 Methodology  
6.3.1 Participants:  Eight competitive and recreational male cyclists (age: 25 ± 3 years; 
height: 175 ± 0.1 cm; body mass: 74.4 ± 6.7 kg) who trained between 3 – 10 hours per 
week took part in this study. Mean V̇O2peak and peak power output (PPO) for the cohort 
was 56.5 ± 3.8 mL·kg-1·min-1 and 327 ± 26 W respectively. None of the participants had a 
history of neurological disease or skeletal muscle abnormality and none were under 
pharmacological intervention during the course of the study. Participants volunteered to 
participate in the study after providing informed written consent. All procedures 
conformed to the standards set by the Declaration of Helsinki (2008) and the study was 
approved by the local Research Ethics Committee of Liverpool John Moores University.  
6.3.2 Design: In a repeated measures, randomised and cross-over design separated by 7-9 
days, participants completed two non-exhaustive acute exercise trials in conditions of 
reduced CHO availability with whey (WHEY) or collagen (COLLAGEN) provision 
before, during and after exercise. At 36-40 h prior to the main experimental trials, all 
participants performed a glycogen depletion protocol followed by 36 h of low CHO and 
energy intake (as replicated from Impey et al. 2016) to manipulate pre-exercise muscle 
glycogen content prior to the main experimental exercise protocol undertaken on Day 3. In 
accordance with the reduced CHO availability protocol studied previously (Impey et al. 
2016), participants refrained from CHO intake on the morning of the main experimental 
trial as well as during exercise, but consumed CHO at a rate of 1.2 g/kg body mass 
immediately post-exercise and at 1 h post-exercise. This approach was designed to allow 
participants to commence and undertake the exercise protocol with reduced endogenous 
(i.e. <350 mmol/kg dw muscle glycogen) and exogenous CHO availability (i.e. no pre-
exercise meal or CHO feeding during exercise).  The provision of CHO in the post-
exercise period was in an attempt to restore muscle glycogen and energy availability to 
remain within the chosen glycogen threshold i.e. >150 mmol/kg dw.  During completion of 
the WHEY trial, participants consumed 22g of whey protein (in beverage form) at 45 
minutes prior to exercise, 22g during exercise and a further 22g immediately post-exercise.  
During completion of the COLLAGEN trial, participants consumed 22g of collagen 
protein (in the form of a gel) at identical time-points and in fluid matched conditions.  As 
such, both trials represented deliberate conditions of reduced CHO and absolute energy 
availability (to mimic an amalgamation of train-low protocols, Impey et al. 2016) but with 
high protein availability in the form of whey (WHEY) or collagen (COLLAGEN) 
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throughout. Muscle biopsies were obtained from the vastus lateralis immediately before, 
post- and at 1.5 h post-exercise. An overview of the experimental protocol is shown in 
Figure 6.1. 
6.3.3 Assessment of maximal oxygen uptake: Participants were initially assessed for peak 
oxygen consumption (V̇O2peak) and peak aerobic power (PPO) as determined during an 
incremental cycle test performed on an electromagnetically braked cycle ergometer as 
previously described (Impey et al. 2015); section 3.4.4.  
6.3.4 Experimental Protocol: 
Day 1 and 2: Participants arrived at the laboratory on the evening (17.00) of the first 
experimental day having avoided alcohol and vigorous physical activity for the previous 24 
h. Nude body mass was recorded and a heart rate (HR) monitor (Polar FT1, Finland) fitted. 
Participants then performed an intermittent glycogen-depleting cycling protocol lasting 
~120 min. This protocol and all subsequent cycling protocols were conducted on a fully 
adjustable electromagnetically braked cycle ergometer (Load Excalibur, Nederland). The 
exercise protocol used to deplete muscle glycogen has previously been used in our 
laboratory (Taylor et al. 2013; Bartlett et al. 2013; Impey et al. 2016). This protocol was 
chosen to maximally deplete muscle glycogen in both type I and type II muscle fibres. The 
activity pattern and total time to exhaustion were recorded, and water was consumed ad 
libitum throughout exercise. These parameters were repeated exactly during the second 
experimental condition. Participants then consumed a diet low in carbohydrate (3 g·kg-1 
BM) but high in protein (2 g·kg-1 bw) over the next 36 h to minimise muscle glycogen 
replenishment to ~300 – 350 mmol·kg-1 dw on the morning of the main experimental trial 
(Impey et al. 2016).  
Day 3: On the morning of the Day 3, participants reported to the laboratory in a fasted state 
and an indwelling cannula (Safety Lock 22G, BD Biosciences, West Sussex UK) was 
inserted into the anticubital vein in the anterior crease of the forearm and a resting blood 
sample drawn.  After a resting blood sample was taken, the cannula was flushed with ~ 5 
ml of sterile saline (Kays Medical supplies. Liverpool UK) to keep the cannula patent and 
sterile, this procedure was repeated after each subsequent blood draw. Participants then 
received 22g of protein from one of two supplement sources 45 minutes prior to beginning 
exercise in a randomised crossover design. Protein was provided via ether a commercially 
available collagen gel (Muscle Pharm, USA) (COLLAGEN) or whey isolate solution 
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(WHEY) (Science in Sport, Nelson, UK). Fluid intake was matched in both conditions to 
500 ml at this time-point. Participants then rested for 45 minutes prior to commencing 
exercise. Protein was given 45 min prior to exercise (as opposed to 2 hours prior) to ensure 
sufficient circulatory amino acid availability “during” the exercise protocol (Impey et al. 
2015). Additionally, these timings and dosing strategies are in accordance with nutritional 
practices of professional road cyclists and as such, it was an aim to examine a real world 
nutritional protocol (Vogt et al. 2005). Following a 5 min warm up at 150 W, participants 
then completed a prescribed cycling protocol consisting of 4 x 30 seconds high intensity 
intervals at 200% PPO interspersed with 2.5 min active recovery at 40% PPO, followed by 
45 min steady state cycling at 60% PPO and finally, 3 x 3min intervals at 90% PPO.  
During the HIT and steady state component, participants ingested 7.3g of protein every 20 
min to provide 22g of protein per hour.  Physiological and perceptual measures were 
recorded at regular intervals throughout exercise (e.g. heart rate, RPE) and substrate 
utilisation was assessed during the steady state component of the exercise protocol using 
online gas analysis (CPX Ultima, Medgraphics, Minnesota, US) and the equations of 
Jeukendrup and Wallis (2005).  Following completion of the training session, participants 
consumed 22g of COLLAGEN or WHEY protein immediately post-exercise as well as 
1.2g·kg-1 BM carbohydrate in the form of sports drinks (Science in Sport, Nelson, UK) and 
snacks (Jaffacakes, UK) immediately and 60 minutes post-exercise so as to maximise 
muscle glycogen resynthesis. Laboratory conditions remained constant across all 
experimental trials (19 – 21oC, 40 – 50% humidity) and an overview of the nutritional 
feeding protocol is shown in Figure 6.1. 
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Figure 6.1. Schematic representation of the experimental design. On the evening of day 1 
participants completed a glycogen depleting protocol followed by 22g of whey protein. 
Throughout the entirety of day 2 participants consumed a low CHO and low energy dietary 
protocol that was matched for both protein and fat intake. During the main experimental 
trial on day 3 participants ingested 22g of protein before commencing a set work protocol, 
participants consumed a further 22g during exercise and a final 22g immediately after 
exercise. Protein was provided as collagen gel (COLLAGEN) or as a protein beverage 
(WHEY). In addition to protein post-exercise, 1.2 g·kg bw CHO was provided 
immediately and 1h post-exercise to facilitate glycogen resynthesise. Muscle biopsies were 
obtained immediately pre-exercise, post-exercise and 1.5 h post-exercise.  
 
6.3.5 Muscle biopsies: Skeletal muscle biopsies were obtained from the vastus lateralis 
immediately before exercise, immediately after exercise and at 90 minutes post-completion 
of the exercise protocol. Muscle biopsies were obtained as described in section 3.6.3. 
6.3.6 Blood analysis: Blood samples were collected in vacutainers containing K2 EDTA, 
lithium heparin or serum separation tubes, and stored on ice or at room temperature until 
centrifugation at 1500 g for 15 min at 4 ̊C. Serum and plasma were aliquoted and stored at 
-80 ̊C until analysis. Plasma glucose, lactate, FFA, glycerol, β-hydroxybutyrate and amino 
acids were analysed as described in section 3.6.1.  
6.3.7 RNA extraction and analysis and Reverse transcriptase quantitative Real-Time 
Polymerase Chain Reaction (rt-qRT-PCR): Quantification of mRNA content and 
assessment of mRNA transcription were performed as described in 3.6.4. 
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6.3.8 Muscle glycogen concentration: Muscle glycogen concentration was determined 
according to section 3.6.5.  
6.3.9 [γ-32P] ATP Kinase Assay: 30 mg muscle tissue was used for the measurement of 
p70S6K1 and PKB (Akt) activity as previously described (McGlory et al. 2014); section 
3.6.6.  
6.3.10 SDS-PAGE and Western Blotting: Approximately 20 – 30 mg of frozen muscle 
was probed for LC3 I and II and p62 content. Samples from each subject for all nutritional 
conditions were run on the same gel and statistical analysis conducted on fold changes 
relative to pre-exercise values, as described in section 3.6.7. 
6.3.11 Statistics: All statistical analyses were performed using Statistical Package for the 
Social Scientist (SPSS version 21). Descriptive statistics were produced for all data sets to 
check for normal distribution indicated by Kolmogorov-Smirnov (accepted if P>0.05). 
Changes in physiological and molecular responses between conditions (i.e. muscle 
glycogen, circulatory metabolites, amino acids, mRNA, protein content and kinase 
activity) were analysed using two way repeated measures General Linear Model, where the 
within factors were time and condition. If Mauchley’s test of sphericity indicated a 
minimum level of violation, as assessed by a Greenhouse Geisser epsilon (ε) of ≥ 0.75, 
data were corrected using the Huynh-Feldt ε. If Mauchley’s test of sphericity was violated, 
data were corrected using Greenhouse Geisser ε. Where a significant main effect was 
observed, pairwise comparisons were analysed according to Bonferoni post hoc tests in 
order to locate specific differences. An alpha value of P < 0.05 was utilized for all tests and 
all data in text, figures and tables are presented as mean ± SD. 
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6.4 Results  
6.4.1 Physiological and metabolic responses to exercise 
Subject’s heart rate (P=0.614) during the steady-state component of the exercise protocol 
did not display any significant differences between trials (Figure 6.2A). Exercise 
significantly reduced (P<0.001) muscle glycogen stores to comparable levels (150 
mmol·kg-1 dw) with no difference (P=0.485) observed between conditions (Figure 6.2B).  
Plasma NEFA, glycerol and β-OHB all significantly increased during exercise (P<0.001) 
though plasma glucose did not display any change (P = 0.112) (Figure 6.2 C, D, E and F, 
respectively). Additionally, the exercise-induced increase in plasma NEFA was suppressed 
in the WHEY compared with the COLLAGEN trial (P=0.046) whereas no statistical 
differences were observed between trials for glycerol (P=0.08), β-OHB (P = 0.07) or 
glucose (P=0.963).  Despite differences in NEFA availability during exercise, no 
differences were observed in either CHO (P=0.64) or lipid oxidation (P=0.75) during the 
SS component of the exercise protocols (Figure 6.2G and H, respectively). 
6.4.2 Regulation of markers of mitochondrial turnover 
In accordance with similar glycogen utilisation and metabolic stress between trials, the 
magnitude of the exercise-induced increase (P<0.01) in PGC-1α mRNA content at 90 min 
post-exercise was not different (P = 0.370) between trials (Figure 6.3A).  In contrast, 
neither exercise (P = 0.261) nor experimental condition (P = 0.550) affected p53 mRNA 
content (Figure 6.3B).  As an acute marker of mitophagy, the mRNA content of Parkin was 
significantly increased (P = 0.037) from pre- to post-exercise though no effect of condition 
was observed (Figure 6.3C).  Nonetheless, a second mitophagy marker of Beclin1 mRNA 
content was not affected by exercise (P = 0.147) or dietary condition (P=0.348) (Figure 
6.3D). Collectively, such data suggest that acute exercise up-regulates transcriptional 
markers of both mitochondrial biogenesis and autophagy, though leucine availability does 
not affect these responses. 
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Figure 6.2. (A) Heart rate response during exercise, (B) Muscle glycogen concentrations 
across experimental trial, Plasma (C) NEFA, (D) glycerol, (E) βOHB and (F) Glucose, (G) 
CHO and (H) Fat oxidation during steady state component of exercise. *P<0.05 significant 
difference from pre-exercise, ^P<0.05 significant main effect of condition. Shaded area 
represents exercise duration.  
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Figure 6.3. Fold change of mRNA content in markers of mitochondrial biogenesis (A) 
PGC-1α, (B) p53 and mitophagy (C) Parkin, (D) BECLIN1. *P<0.05 significant difference 
from pre-exercise.  
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6.4.3 Regulation of protein synthesis related signalling 
Plasma leucine, BCAAs and EAAs all displayed significant changes (P=0.043, 0.028 and 
0.021, respectively) during the sampling period (Figure 6.4 A, C, E respectively). 
Additionally, leucine (P=0.02) and BCAA concentrations (P=0.03) were higher in WHEY 
compared with COLLAGEN whereas EAA approached statistical significance between 
trials (P=0.06). When expressed as AUC data, only plasma leucine (P=0.025) showed 
differences between trials (Figure 6.4B) whereas as AUC for BCAA (P=0.135) and EAA 
(P=0.062) did not achieve significance (Figure 6.4 D and F, respectively).   
In accordance with the provision of CHO post-exercise, plasma insulin significantly 
increased from pre- and post-exercise values (P = 0.034) though the magnitude of change 
was not different between trials (P = 0.159) (Figure 4G).  As such, no difference (P=0.187) 
was apparent between trials for insulin AUC data (Figure 6.4H) 
PKB activity was significantly elevated at 90 min post-exercise (P = 0.003) compared with 
pre-exercise values, irrespective of nutritional condition (P=0.37) (Figure 6.4I). Exercise 
suppressed (P=0.015) p70S6K activity to comparable levels immediately post-exercise (≈ 
25 fmol.min-1.mg-1).  However, post-exercise feeding increased p70S6K activity at 1.5 h 
post-exercise (P=0.004), the magnitude of which was greater (P=0.046) in WHEY (180 ± 
105 fmol.min-1.mg-1) versus COLLAGEN (73 ± 42 fmol.min-1.mg-1) (Figure 6.4J).  These 
data suggest that increased leucine availability from WHEY condition appears to regulate 
post-exercise p70S6K activity independent of insulin mediated stimulation of PKB. 
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Figure 6.4. Circulatory plasma and total AUC (A, B) Leucine, (C, D) Total BCAA, (E, F) 
Total EAA and (G, H) Insulin. Kinase activity of (I) PKB and (J) p70S6K. Shaded area 
represents exercise duration. *P<0.05 significant difference from pre-exercise, **P<0.05 
significant difference from post-exercise, ^P<0.05 significant main effect of condition.  
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6.4.4 Regulation of markers of autophagy 
Exercise significantly decreased the protein content of LC3bI, LCBII and p62 (P<0.001; 
P=0.021; P<0.001, respectively) from pre- to post- exercise (Figure 6.5 A, B, D, 
respectively) though these changes were not influenced by nutritional condition (P=0.255, 
0.754, 0.401, respectively). Additionally, the ratio of LC3bII/I displayed a trend (P = 
0.072) towards increasing at 90 min post exercise (Figure 6.5C) with no differences also 
observed between conditions (P=0.312). The mRNA content of ATG12 was significantly 
increased (P = 0.015) immediately post- and at 90 min post exercise, with no differences 
(P=0.56) between conditions (Figure 6.5E). In contrast, the additional autophagy markers 
of ATG4b (Figure 3.5F) and p62 mRNA (Figure 6.5G) were not affected by exercise 
(P=0.711; P=0.261, respectively) nor condition (P=0.76; P=0.55, respectively).  
Representative western blots are shown in Figure 6.5H.  Collectively, these data suggest 
that acute non-exhaustive exercise induces transient changes in autophagy related gene and 
protein expression, an effect that is not modulated by the composition of protein provision.  
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Figure 6.5. Protein content of bulk autophagy markers (A) LC3bI, (B) LC3BII, (D) p62 
and (C) LC3bII/I ratio. mRNA expression of (E) ATG12, (F) ATG4b and (G) p62. (H) 
representative western blots. *P<0.05 significant difference from pre-exercise.  
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6.5 Discussion  
The aim of the present study was to examine the effects of whey versus collagen protein on 
skeletal muscle adaptations associated with the acute regulation of mitochondrial 
biogenesis, muscle protein synthesis and autophagy. The rationale was motivated by 
chapter 5 in that keeping glycogen (and energy) at the critically low levels associated with 
exhaustion does not permit the re-activation of p70SK61 activity, despite feeding leucine-
enriched whey protein (Impey et al. 2016).  As such, I employed a similar train-low model 
(Impey et al. 2016) but provided CHO in the post-exercise period in accordance with 
guidelines to promote short-term muscle glycogen re-synthesis (Hulston et al. 2011).  To 
manipulate protein availability across the experimental period, I fed a matched dose of 
whey or collagen protein from commercially available sources.  When considered with my 
recent observations examining CHO (and energy) restriction (Impey et al. 2016) as well as 
post-exercise high fat feeding (Hammond et al. 2016), the data suggest that in exercise 
conditions that reduce glycogen to near depletion, the beneficial effects of whey protein on 
activation of p70S6K1 activity are especially apparent when co-ingested with sufficient 
post-exercise CHO intake. I also provide novel data by demonstrating that acute non-
exhaustive exercise up-regulates markers of both mitophagy and autophagy, an effect that 
is not modulated by protein composition.   
The rationale for train-low protocols is based on the premise that completing acute training 
sessions with reduced endogenous and exogenous CHO availability leads to activation of 
regulatory cell-signalling pathways (e.g. AMPK, p38, p53 and PGC-1) thereby co-
ordinating an up-regulation of both the nuclear and mitochondrial genomes (Hawley and 
Morton, 2014; Bartlett et al. 2013). When collectively examining the acute cell signalling 
studies conducted to date (Bartlett et al. 2013; Camera et al. 2015; Mathai et al. 2008; 
Pilegaard et al. 2002; Psilander et al. 2013), such data consistently demonstrate that the 
augmented signalling responses associated with CHO restriction are particularly evident 
when absolute pre-exercise muscle glycogen concentrations are ≤350 mmol/kg dw.  
However, restoring post-exercise glycogen levels to >500 mmol/kg dw can attenuate 
exercise-induced changes in gene expression (Pilegaard et al. 2005), whilst keeping 
glycogen (and energy) at critically low post-exercise levels (i.e. <100-150 mmol/kg dw) 
can reduce activation of signalling proteins regulating protein synthesis (Impey et al. 
2016).  Such data therefore suggest the presence of a potential muscle glycogen threshold 
that is facilitative of promoting training adaptations. To this end, the combination of the 
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non-exhaustive exercise protocol utilised here and post-exercise CHO feeding was 
successful in achieving an absolute range of muscle glycogen, remaining in our suggested 
muscle glycogen threshold (i.e. ≤350 and >150 mmol/kg dw). We acknowledge, however, 
that this range is likely specific to the training status of the populations examined.   
Confirming previous studies (Impey et al. 2016; Hammond et al. 2016), we observed that 
acute high-intensity exercise reduces p70S6K1 activity. Such studies further demonstrated 
that the presence of reduced CHO (and energy availability) and/or high post-exercise fat 
availability also suppresses the re-activation of p70S6K1, even when leucine enriched 
whey protein was consumed in the post-exercise period.  Based on these studies, I 
therefore suggested that the apparent suppression of p70S6K1 activity may be due to 1) 
reduced insulin and PKB signalling or, 2) a direct effect of increased fat availability 
(Kimball et al. 2015) and/or reduced glycogen mediating suppression of mTORC1 
complex via energetic stress related mechanisms (Bylund-Fellenius et al. 1984). The 
present data lend support for the latter mechanism for several reasons.  First, I observed 
that the superior whey-induced increase in p70S6K1 activity when compared with collagen 
feeding was independent of post-exercise insulin and PKB activity (Figure 4G, I).  Second, 
the post-exercise circulating FFA availability observed in our collagen trial was similar to 
that achieved with both CHO restriction (Impey et al. 2016) and post-exercise high fat 
feeding protocols (Hammond et al. 2016), though I acknowledge the limitations with 
making inferences on muscle FFA uptake on snapshot assessments of circulating FFA per 
se.  Nonetheless, it remains possible that subtle alterations in FFA availability (as caused 
by prior dietary manipulations) can have associated implications on mTOR related 
signalling (Stephens et al. 2015).  I would also suggest that glycogen availability per se at 
the exercise intensity used here may have a contributory and regulatory effect on 
components of the mTOR pathway. In this regard, it is possible the enhanced p53 and 
AMPK activation induced by post-exercise CHO restriction (Bartlett et al. 2013; 
Wojtaszewski et al. 2003) exerts a p53-REDD1 and/or AMPK-TSC2 mediated inhibition 
of mTOR (Feng et al. 2010; Keller et al. 2013; Rose et al. 2009), thereby reducing 
downstream activation of p70S6K1. Further studies are now required to directly test these 
hypotheses in human skeletal muscle.  When considered with our previous studies (Impey 
et al. 2016; Hammond et al. 2016), the present data therefore suggest that in those exercise 
conditions in which muscle glycogen is near depletion, the beneficial effects of whey 
protein (i.e. leucine mediated activation of mTOR: Greiwe et al. 2001; Han et al. 2012) are 
133 
 
especially apparent when co-ingested with post-exercise CHO feeding. From an applied 
practice perspective, such findings lend further support for the fuel for the work required 
concept that emphasise both a day-by-day and meal-by-meal approach to nutritional 
periodization.  Taken together, it is therefore suggested that whilst there may be benefits of 
commencing training with reduced endogenous and exogenous carbohydrate availability, 
the post-exercise meal should contain a combination of both protein and CHO, the latter to 
provide the necessary substrate and energy to stimulate both glycogen and muscle protein 
synthesis, respectively. 
The cellular recycling process of autophagy has also emerged as an integral component of 
exercise induced remodelling processes, functioning to restore energetic balance and 
preventing the accumulation of damaged organelles or aberrantly folded proteins (Lira et 
al. 2013). Nonetheless, our understanding of how exercise affects autophagic flux is 
currently limited due to between species (rodent versus humans), nutritional status (fed 
versus fasted) and differences in exercise protocols (e.g. modality, intensity and duration) 
between studies (He et al. 2012; Lira et al. 2013).  Furthermore, to the best of my 
knowledge, no investigators have yet examined the effects of endurance exercise on 
autophagy whilst also quantifying muscle glycogen availability.  On this basis, this data 
suggest that acute exercise undertaken in conditions of reduced CHO availability induces 
transient changes in markers of autophagy.  In agreement with other researchers, we also 
observed that non-exhaustive exercise reduces LC3bII (Fritzen et al. 2016) and p62 protein 
content (Schwalm et al. 2015) immediately post-exercise. Furthermore,  we provide novel 
data demonstrating exercise up-regulates changes in Parkin mRNA, an effect that may be 
mediated through upstream PGC-1α signalling (Vainshtein et al. 2015).  Whilst I 
acknowledge that we cannot currently make accurate inferences on autophagic flux based 
on measurement of these makers per se, it is noteworthy that none of the above parameters 
were influenced by protein composition or availability before, during or after exercise. 
While some studies have demonstrated a suppressive effect of mTOR signalling on 
autophagy (Kim et al. 2011) others have suggested a basal level of mTOR/p70S6K1 
activity is required to mediate maintenance level of autophagy (Datan et al. 2014). 
However considerably more work is required in this area to elaborate the precise effects of 
autophagy in human skeletal muscle under nutrient-exercise stressors.   
In summary, I demonstrate that whey protein augments post-exercise p70S6K1 activity to 
a greater extent than that compared with collagen protein when in recovery from an acute 
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non-exhaustive train-low endurance training session.  When considered in context with our 
previous train-low studies examining post-exercise CHO (and energy) restriction or high 
fat feeding, our data suggest that the beneficial effects of whey protein (i.e. leucine 
mediated activation of mTOR signalling) is especially apparent when consumed with 
sufficient post-exercise CHO intake and/or when muscle glycogen remains in a potential 
muscle glycogen threshold.  I also observe that protein composition does not modulate 
markers of mitochondrial biogenesis, autophagy and mitophagy. 
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Chapter 7 – Synthesis of Findings  
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7. Synthesis of Findings 
This chapter will present an overview of the experimental findings of this thesis in relation 
to the original aims and objectives outlined in chapter 1. A general discussion is then 
presented where specific attention is given to how the present data has advanced the 
understanding of both the mechanistic and practical application of the train-low paradigm.  
Finally, a review of limitations of the experimental chapters is presented followed by 
recommendations for future research.  
 
7.1 Achievement of aims and objectives 
The primary aim of the present thesis was to examine the effects of reduced CHO but high 
protein availability on the regulation of molecular pathways associated with modulating 
mitochondrial biogenesis, MPS and autophagy. On the basis of characterising such 
molecular responses, a secondary aim was to formulate a novel framework for which to 
practically apply train-low paradigms. 
 
Aim 1 
To test the hypothesis that leucine-enriched protein feeding does not impair 
circulating FFA availability or whole body lipid oxidation during exercise (Study 1, 
Chapter 4). 
In addition to reduced CHO availability, there is a growing rationale to consume increased 
protein before, during and after train-low sessions. Whilst such a feeding strategy is 
advantageous in terms of promoting a positive net muscle protein balance, the provision of 
amino acids (and associated rise in plasma insulin) may also be disadvantageous owing to 
the fact that some of the training adaptations arising from train-low may be mediated by 
increased FFA availability, secondary to the effects of CHO restriction per se.   
Nonetheless, the data presented in this study demonstrate that whey protein or leucine 
enriched whey protein feeding does not impair FFA availability nor whole body lipid 
oxidation during exercise, thus suggesting that protein feeding does not hinder a key 
objective of train-low sessions. Additionally, the leucine enriched protein trial in this study 
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consisted of a novel delivery of protein in the form of a “protein gel”, a delivery matrix 
that is now commercially available for oral consumption (SiS, Science in Sport, Whey 20) 
 
Aim 2 
To characterise the effects of reduced carbohydrate (CHO) but high leucine 
availability on exercise capacity and skeletal muscle cell-signalling responses 
associated with exercise-induced regulation of mitochondrial biogenesis and MPS 
(Study 2, Chapter 5). 
 
When matched for work done, numerous investigators have demonstrated that training in 
conditions of reduced CHO availability augments many of the acute cell signalling 
responses that regulate training adaptation (Table 2.1). However, using an experimental 
protocol consisting of an amalgamation of previously studied train-low protocols, the data 
presented in this chapter demonstrated that although reduced CHO availably impaired 
exercise capacity (i.e. less work was completed compared with high CHO availability), 
comparable cell-signalling responses were observed.  As such, these data lend support for 
the fuel for the work required paradigm in that CHO restriction before and during exercise 
induces work-efficient mitochondrial related cell signalling (i.e. comparable activation of 
AMPK-PGC-1α path way can be achieved under low CHO conditions from performing 
significantly less work/training than when exercise is undertaken with high CHO). 
Nonetheless, post-exercise CHO and energy restriction impairs the regulation of p70S6K1 
related pathways despite feeding leucine enriched protein.  Such data therefore suggest that 
although there are potential metabolic benefits associated with reduced pre-exercise CHO 
availability, the post-exercise meal should contain sufficient CHO to restore muscle 
glycogen to sufficient levels and/or provide the necessary energy to support post-exercise 
remodelling processes, driven from both circulatory (i.e. insulin) and intracellular 
processes (i.e. glycogen assimilation).   
 
Aim 3  
To examine the role of protein composition in regulating skeletal muscle cell-
signalling responses associated with exercise-induced regulation of mitochondrial 
138 
 
biogenesis, MPS and autophagy when in recovery from a train-low endurance 
training session (Study 3, Chapter 6).  
 
Having identified the potential importance of post-exercise CHO intake in Chapter 5, the 
aim of Chapter 6 was to examine the role of protein composition in regulating post-
exercise skeletal muscle remodelling processes when in recovery from a train-low training 
session.  Using the train-low paradigm developed in Chapter 5, the data presented in this 
study suggest that whey protein intake is indeed facilitative of reactivating p70S6K1 
related signalling pathways but only when consumed with sufficient post-exercise CHO 
intake and/or when muscle glycogen remains in a potential muscle glycogen threshold (e.g. 
<300 but >150 mmol·kg-1 dw).  These data also demonstrate that acute exercise induces 
transient changes in markers of mitophagy and autophagy, an effect independent of leucine 
availability.   
7.2 General discussion of findings  
 
7.2.1. Overview of molecular mechanisms regulating mitochondrial turnover  
 
Mitochondrial biogenesis underpins skeletal muscle oxidative capacity and is therefore 
considered a hallmark of intracellular adaptation to endurance exercise (Holloszy, 1967). 
In addition to increased number and size of mitochondria per gram of muscle tissue, recent 
data also highlight the importance of regulating mitochondrial quality via targeted 
autophagy to support adaptive oxidative responses to endurance training (He et al. 2012). 
From a functional perspective, the study of the regulation of mitochondrial turnover 
(biogenesis and degradation) has important implications for health and performance. In 
relation to exercise performance, training induced increase in metabolic enzyme activity 
and mitochondrial density/function result in enhanced respiratory control, thus the same 
cellular rate of oxidative metabolism can be achieved with less agitation of adenine 
nucleotides and lower rate of oxidative phosphorylation per mitochondrion, cumulatively 
observed as enhanced efficiency of energy production (Holloszy and Coyle, 1984). These 
adaptations result in preservation of ATP and PCr during exercise, attenuating the 
formation of allosteric regulators for glycogenolysis, glycolysis and lactate production, 
ultimately reducing muscle glycogen oxidation (Gollinck and Saltin, 1982). 
Physiologically, this manifests as the classic rightward shift in the lactate threshold curve 
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(Holloszy and Coyle, 1984) thereby increasing the absolute work that can be undertaken 
before onset of acidosis and fatigue.   
 
The molecular mechanisms underpinning mitochondrial turnover are increasingly being 
understood.  It is now generally recognised that acute muscle contraction induces 
homeostatic perturbations to cellular energy status to activate several cell signalling 
kinases such as CaMKII, p38MAPK and AMPK. These kinases converge on nuclear and 
mitochondrial transcription factors (e.g. p53, Tfam, NRF1/2) and transcriptional co-
activators (e.g. PGC-1α), all of which are collectively responsible for synthesis of 
mitochondrial proteins, lipid and DNA constructs required for mitochondrial biogenesis.  
In this way, a controlled expression of those proteins involved in the regulation of substrate 
oxidation, substrate transport and mitochondrial fusion and fission collectively occur in the 
hours and days following each successive exercise training bout, providing the exercise 
stimulus is sufficient to perturb homeostasis (Perry et al. 2010).  In addition to regulating 
mitochondrial biogenesis, several of these signalling kinases converge in coordination with 
others to regulate the targeted degradation of cellular constituents termed autophagy (Ding 
and Yin, 2012).  Of particular interest, p53 and PGC-1α appear to play central roles in the 
regulation of exercise induced mitophagy. Indeed, nuclear translocation of p53 (seen 
during exercise) appears to regulate bulk auophagic processes (Broz et al. 2013) in 
addition to PGC-1α regulating mitophay through a regulatory feedback loop (Valnshten et 
al. 2015). The ability of exercise to regulate mitochondrial turnover would appear, from a 
molecular perspective, to represent a balance in the coordination of signalling cascades 
dependent on a wide variety of factors such as, energy status of the cell, intensity and 
duration of exercise. An overview of how acute exercise affects key cell signalling 
processes is shown in Figure 6.1 where specific attention is given to areas informed by the 
experimental data collected in the present thesis. 
 
  
140 
 
 
  
F
ig
u
re 7
.1
 –
 S
u
m
m
ary
 o
f th
e alteratio
n
s in
 sk
eletal m
u
sc
le sig
n
allin
g
 resu
ltin
g
 fro
m
 em
p
lo
y
in
g
 C
H
O
 p
erio
d
isatio
n
 fo
llo
w
in
g
 a fu
el fo
r 
th
e w
o
rk
 req
u
ired
 p
arad
ig
m
. P
re-ex
ercise lo
w
 ex
o
g
en
o
u
s an
d
 en
d
o
g
en
o
u
s C
H
O
 av
ailab
ility
 w
ith
 h
ig
h
 p
ro
tein
 av
ailab
ility
, facilitates 
au
g
m
en
ted
 
m
ito
ch
o
n
d
rial 
reg
u
lated
 
sig
n
allin
g
. 
D
esp
ite 
h
ig
h
 
p
ro
tein
 
av
ailab
ility
, 
w
h
en
 
C
H
O
 
an
d
 
en
erg
y
 
av
ailab
ility
 
rem
ain
s 
lo
w
, 
p
7
0
S
6
K
1
 activ
ity
 is su
p
p
ressed
 d
u
rin
g
 p
o
st-ex
ercise reco
v
ery
 p
erio
d
. p
7
0
S
6
K
1
 su
p
p
ressio
n
 is lik
ely
 a resu
lt o
f elev
ated
 A
M
P
K
α
2
 activ
ity
 
in
 ad
d
itio
n
 to
 elev
ated
 F
F
A
. P
o
st-ex
ercise p
ro
v
isio
n
 o
f h
ig
h
 C
H
O
 an
d
 leu
cin
e rich
 p
ro
tein
 in
creases circu
lato
ry
 in
su
lin
 facilitatin
g
 
in
creases in
 P
K
B
-m
T
O
R
-p
7
0
S
6
K
1
 sig
n
allin
g
. In
 ad
d
itio
n
 th
e p
ro
v
isio
n
 o
f leu
cin
e rich
 p
ro
tein
 fu
rth
er au
g
m
en
t p
7
0
S
6
K
1
 activ
ity
. S
o
lid
 
lin
es w
ith
 arro
w
 h
ead
s rep
resen
t activ
e effecto
rs o
f th
e o
rig
in
; so
lid
 lin
es w
ith
 b
lu
n
ted
 h
ead
s rep
resen
t rep
ressio
n
 effecto
rs o
f th
e o
rig
in
; 
d
ash
ed
 lin
es rep
resen
t tran
slo
catio
n
.   
 
141 
 
7.2.2. Effects of CHO availability on mitochondrial biogenesis  
 
The ability for nutritional manipulation, particularly of carbohydrates, to augment the 
activation of signalling process regulating mitochondrial turnover has been an intense area 
of investigation in the last decade. Early studies initially aimed to understand the shift in 
metabolism when exercise is undertaken with reduced muscle skeletal muscle glycogen 
(Lemon and Mullen, 1976). However, at the turn of the millennium, researchers realised 
the potential to augment the signalling mechanisms regulating mitochondrial biogenesis by 
undertaking exercise with reduced skeletal muscle glycogen (Pileggard et al. 2002).  
 
For example, Wojtaszewski et al.  (2003) observed significantly elevated AMPKα2 
activity and ACCSer221 phosphorylation during 1h cycling exercise undertaken with low 
muscle glycogen. Previous research in rodents demonstrated that the allosteric regulators 
of AMPK activity, adenine nucleotide and creatine phosphate content were similar 
between muscles with low and normal muscle glycogen (Derave et al. 2000; Wojtaszewski 
et al. 2002), therefore implicating a role for glycogen content per se on AMPK activity. 
Indeed, a glycogen binding domain regulating activity was subsequently discovered in the 
β subunit (McBride et al. 2009). These seminal studies identified augmented AMPK 
activity when work-matched exercise was undertaken with reduced muscle glycogen and 
later studies also demonstrated the role of exogenous CHO feeding during exercise on 
regulating training adaptation (Akerstrom et al. 2006; Morton et al. 2009). Additionally, 
the work presented in this thesis presents the first evidence that a comparable level of 
AMPK activity can be induced in a work efficient manner when exercise is undertaken 
with low endogenous and exogenous CHO availability (Impey et al. 2016). This 
observation in line with research from other groups (Table 2.1) points to the potential for a 
specific range of glycogen concentrations within which intracellular signalling relating to 
mitochondrial biogenesis is augmented (Figures 7.1, 7.2).  Such data lend support for the 
fuel for the work required model in that beneficial cell signalling responses can be 
achieved with strategic periods of reduced CHO availability (Chapter 5).  
 
Consistent with augmented kinase activity, several investigations have identified increases 
in mRNA production from genes known to be regulated by transcription factors and 
transcriptional co-activators regulating mitochondrial biogenesis. Increased mRNA 
transcription has been seen using contralateral leg models (Hansen et al. 2005; Pilegaard et 
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al. 2002), exercising in the fasted state (Cluberton et al. 2005; Russel et al. 2005; van 
Proeyen et al. 2011), training twice per day (Pislander et al. 2013; Yeo et al. 2008) and 
sleep low models (Bartlett et al. 2013; Lane et al. 2015). In accordance, here I demonstrate 
comparable mRNA transcription of PGC-1α when exhaustive exercise was completed 
having started with high or low CHO despite total exercise duration being ~60 min less in 
the low CHO condition (Impey et al. 2016).  Furthermore, using an amalgamation of low 
CHO methodologies (sleep low, low CHO diet and restriction of exogenous CHO during 
exercise) I demonstrated a significant increase in mRNA transcription of SIRT1, Tfam and 
p53 with post-exercise CHO restriction and subsequent low CHO diet following a 
glycogen depletion exercise protocol.  When taken together, it appears therefore 
manipulation of CHO availability before, during and after exercise can significantly alter 
the molecular mechanisms underpinning mitochondrial biogenesis, in a time ans work 
efficient manner.  
 
The incorporation of nutritional periodisation into a structured training program based on 
the data I present here in addition to previous research, suggests that when high intensity 
(lactate threshold or above) is the goal of the specific training session then high CHO 
should be provided to meet the glycolytic nature of that training, yet not over fuelling in a 
way that may dampen the beneficial adaptive responses, hence remaining within the 
proposed critical glycogen threshold/window. However, when oxidative adaptations, such 
as increasing lipid utilisation during exercise are the focus of training, low CHO nutritional 
strategies can be implemented to facilitate this outcome while also activating 
mitochondrial related signalling cascades in a work efficient manner by completing as 
much of the training as possible within the ranges of the critical glycogen threshold. 
 
7.2.3. Effects of CHO availability on protein turnover  
 
While the beneficial effects of training with low CHO availability on signalling regulating 
mitochondrial biogenesis are increasingly being understood, the energetic stress of this 
approach is not without potential limitations. Indeed, early studies noted increase in serum 
urea and amino acid efflux from skeletal muscle (Blomstrand and Saltin. 1999; Lemon and 
Mullin. 1980). These studies were followed by direct assessment of whole body protein 
balance and skeletal muscle protein turnover during 2 h of knee extensor exercise in 
conditions of high or low CHO availability (Howarth et al. 2010).  Exercise with reduced 
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muscle glycogen availability produced a negative protein balance during exercise and 
recovery, an effect that was predominantly due to an increase in protein breakdown 
(Howarth et al. 2010).  
 
To resolve these issues from a practical perspective, I examined the effect of leucine rich 
protein ingestion before during and after exercise as a potential method to compensate for 
the negative effects of low CHO training on protein balance.  Indeed, I first confirmed that 
provision of leucine rich protein did not impair metabolic responses to exercise (i.e. 
circulating FFA availability and lipid oxidation) versus fasted conditions (Impey et al. 
2015). Subsequently, I conducted a novel assessment of p70S6K1 activity following 
exhaustive endurance exercise in conditions of high or low CHO availability (Impey et al. 
2016). To compensate for the negative effects of energy deficit on muscle protein turnover, 
the low CHO protocol was completed with leucine-rich protein provided before, during 
and after exercise. Despite the high leucine availability, I was unable to rescue p70S6K1 
activity during recovery in the low CHO condition, thus demonstrating the negative effects 
of post-exercise CHO and energy restriction on MPS related signalling pathways (Impey et 
al. 2016). These findings indicated that whilst a level of glycogen depletion is required to 
augment mitochondrial related signalling (i.e. the potential glycogen threshold), keeping 
glycogen and energy at critically low levels may impair the regulation of post-exercise 
remodelling processes (Figure 7.1). Such data therefore suggested the requirement to 
consume post-exercise CHO in order to restore muscle glycogen to sufficient levels and/or 
provide the necessary energy required to facilitate remodelling processes.  
 
I next tested the hypothesis that CHO and protein provision after a low CHO training 
session could restor p70S6K1 acitivty. The data in chapter 6 demonstrated that collagen 
and whey protein is indeed facilitative of reactivating post-exercise p70S6K activity when 
muscle glycogen remains in the suggested glycogen threshold (i.e. 150-350 mmol/kg dw) 
and CHO is consumed in the post-exercise period. However, an augmented activity of 
p70S6K1 was seen with whey protein. Given that this response was observed with 
comparable insulin and PKB activity, it suggests an effect of elevated leucine content 
within whey protein modulating the mTOR-p70S6K signalling axis. When taken together, 
such data suggest that recovery from train-low endurance training sessions should be 
supported with both carbohydrate and leucine rich protein to provide the necessary energy 
and substrate to support post-exercise remodelling processes. Indeed, while mitochondrial 
144 
 
adaptations and significant increases in lipid oxidation are beneficial components of a well-
structured training program the ability to re-activate p70S6K1 (i.e. translation initiation) 
represents a vital component of the systems that remodel cellular structure as an adaptive 
response to training. While I acknowledge that the level of activity does not necessarily 
correlate with the rate of protein synthesis (myofibrillar or mitochondrial) the activity of 
p70S6K1 remains an essential component of the process (Figure 2.1) and thus ensuring the 
re-activation following exercise remains a pertinent goal for well-structured nutritional 
periodisation.   
 
7.2.4. Effects of CHO availability on autophagy and mitophagy  
 
Although a considerable bulk of research exists examining the signalling mechanisms that 
regulating mitochondrial biogenesis and MPS, a relative lack of data exists concerning the 
essential degradation and removal of malfunctioned cellular components, a process vital to 
sustain cellular functionality. The degradation of proteins by autophagy in response to 
exercise was initially characterised in the 1980’s (Salminen and Virchows. 1984).  Recent 
work elaborated on the contribution autophagy makes to adaptation from endurance 
exercise (He et al. 2012; Lira et al. 2013). While bulk autophagy clearly presents itself as 
an essential component of the adaptive response, in the context of low CHO training where 
a primary goal is mitochondrial biogenesis, mitochondrial specific autophagy (i.e. 
mitophagy), should also be considered. Recently, mitophagy has been shown to be 
upregulated by endurance exercise, an effect regulated in part by PGC-1α (Vainshtein et al. 
2015; Vainshtein and Hood. 2016).  Given these data, I chose to examine how exercise 
undertaken with reduced CHO availability would affect markers of bulk autophagy, and 
for the first time in humans, examine components of mitophagic signalling (Chapter 6). I 
demonstrate that training in a low CHO state appears to increase atuphagic flux 
independent of leucine availability, and observed significant transcriptional response of 
mitochondrial specific E3 ligase Parkin, therefore indicating that training with reduced 
CHO availability up-regulates markers of mitophagy.  Nonetheless, I acknowledge that 
further research is required using a combination of methodological technique to fully 
characterise the effects of acute train-low paradigms on mitophagy. For example the 
incorporation of electron microscopy to directly observe number and structure of 
atuophagosomes as well as potentially identify the predominant cargo selected for 
degradation during low CHO training.   
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7.2.5. Practical application of the train-low paradigm 
 
Experimental models of train-low thus far have typically studied twice per day models, 
fasted training, post-exercise  CHO restriction and sleep-low (Table 2.1). Such models 
have consistently demonstrated that acute manipulation of CHO availability augments 
skeletal muscle cell signalling whilst short-term chronic CHO manipulation, can also 
improve exercise capacity and performance (Cochran et al. 2015; Marquet et al. 2016, 
2016).  Nonetheless, it is noteworthy that elite athletes rarely practice such models in 
isolation and indeed, CHO manipulation often presents itself as energy manipulation. As 
such, I deliberately studied an experimental model that represents an amalgamation of 
train-low paradigms. When examining the last decade of research in combination with the 
present experimental data, the picture that emerges therefore is that although high CHO 
availability unequivocally improves exercise performance, strategic periods of reduced 
CHO availability augments cell signalling related to mitochondrial biogenesis.  From a 
practical perspective, it is becoming clear that CHO availability should be manipulated in a 
day-by-day and meal-by-meal manner depending on the upcoming workloads. A practical 
model for CHO and/or energy periodisation according to the principle of fuel for the work 
required within an endurance sport context is displayed in Table 7.1.  In this model, high 
CHO availability is ingested before, during and after training sessions where the intensity 
is likely to be intermittent in nature and would be greater than lactate threshold and over a 
sustained duration (>60 min). In contrast, CHO availability is reduced for those sessions 
undertaken below lactate threshold and where intensity is not likely to be compromised. As 
with any training tool, each sport must develop a unique method of applying nutritional 
periodisation that elicits the required adaptation when considered in addition to the other 
components of a training program (i.e. sport specific skills, strength and conditioning etc.) 
in a manner that suits the specific nuances of the sport.  
 
Essentially, I propose a critical glycogen threshold in which beneficial effects may arise if 
training sessions are commenced with reduced CHO availability yet, post-exercise 
glycogen and energy should not be restricted to a level that may impair the regulation of 
post-exercise remodelling processes. For this reason, post-training meals should contain 
appropriate CHO to facilitate recovery based on the training session just completed and 
considering the time available for recovery, intensity and duration of the next training 
session. Additionally, CHO may be restricted in the evening meal (to achieve potential 
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sleep low effects) depending on, the intensity and duration of the training session on the 
subsequent morning (Table 7.1). In relation to the level of glycogen required to facilitate 
beneficial cell signalling responses, a suggested glycogen threshold is shown in Figure 7.2. 
Here I describe a range of glycogen that provides a metabolic milieu that is conducive to 
augmented mitochondrial related signalling (also see Figure 7.1). From a performance 
perspective, it is not currently known whether a block of train-low or a periodised model is 
superior to facilitate performance improvements.  Clearly, future studies are now required 
to test the efficacy of the periodised model outlined in Table 7.1. In conclusion, there is 
now a considerable body of molecular and physiological evidence of the beneficial 
potential for undertaking some parts of training with low CHO availability, the focus and 
goal of sports scientists and nutritionists alike is to refine and develop the specific contexts 
and program methodologies (amount and timing of CHO intake around training) that is 
both practical for athletes and underpinned by robust scientific framework, to elicit 
beneficial performance outcomes.  
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7.3 Limitations  
 
Chapter 4: While this chapter holds methodological rigor in standardising total work done, 
exercise duration, exercise intensity and energy availability, the use of indirect calorimetry 
per se (as opposed to tracer methodology) does not allow for measurement of protein 
oxidation. Additionally, the use of indirect calorimetry does not permit the assessment of 
lipid substrate from peripheral versus intramuscular stores, as has been examined 
previously (Hulston et al. 2010). However, I believe the methodologys employed 
facilitated a true representation of the physiological responses and thus present valid and 
reliable data from which to base conclusions.   
 
Chapter 5: The different exercise capacity between the two conditions in this chapter 
resulted in different time points for post-exercise biopsy sampling, potentially limiting 
direct comparison of molecular responses. Had the low CHO trial been performed first in 
every subject thereby identifying the point of fatigue, then collecting a biopsy at the time 
point corresponding to low CHO fatigue in the high CHO trial would have allowed a more 
direct comparison of low vs high CHO training. However, this prevents the use of a 
randomised crossover counterbalanced design potentially influencing physiological and 
molecular responses as well as increasing the chances of statistically observing an order 
effect (Prescott, 1981). Additionally, a major limitation of this chapter was the inability to 
directly quantify muscle protein synthesis or breakdown owing to the lack of tracer 
methodology. Indeed, as it stands, I have provided a snapshot assessments of the regulation 
of relevant signalling pathways based on cell signalling assays conducted at set time-
points. As such, I readily be acknowledge the requirement to provide dynamic assessments 
of both mitochondrial and muscle protein turnover. Of note, the use of a quantative 
measure of AMPK and p70S6K1 activity represent an attempt to present a more detailed 
understanding of the nature of intracellular signalling in response to nutrition-exercise 
interactions, rather than observing post-translational modifications which only act as proxy 
for activity.  
 
Chapter 6: Here I present a study design that allows the distinction between collagen and 
whey protein on their ability to re-activate p70S6K activity following an acute train low 
endurance session. Additionally, I also examined how an acute train-low session may 
affect surrogate markers of autophagy and mitophagy. However, given the lack of a basal 
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or high CHO control I can identify that low CHO exercise induces activity of auto- and 
mitophagy markers but if this is different from exercise with high CHO can not be 
identified. Interpretation of autophagy activity from protein content and ratio of LC3bI and 
II in isolation can be problematic given the tissue specific expression and differences in 
basal rates of protein expression and lipidation (Kilonsky et al. 2011). By measuring p62 
protein content and mRNA content in addition to LC3b, I can be more confident of the 
induction of autophagy given p62 acts as an autophagosome substrate (Kilonsky et al 
2011). Despite the inclusion of additional measures to better quantify the activity of 
autophagy activity via western blotting and qRT-PCR, a potentially better method would 
be to use electron microscopy given its capacity to directly quantify changes in 
autophagosome formation and number as well as examining the constituents of the newly 
formed vacuoles to characterise the nature of specific vs bulk autophagy (Eskelinen et al. 
2011).  Like chapter 5, I wss also unable to directly quantify muscle protein synthesis or 
breakdown owing to the lack of tracer methodology. 
 
  
7.4 Future studies 
 
Recommendation 1: Following the formulation of the “fuel for the work required” strategy, 
the use of CHO periodisation in a well-structured real world representative training plan 
should be examined chronically. The work of Marquet et al. (2016) successfully 
demonstrated the potential for CHO manipulation to improve performance, however the 
use of a ‘block’ of low CHO training (as based on findings from this thesis) may not 
represent an optimal strategy to maximise the adaptive potential of low CHO training. 
Thus, incorporation of pre-determined selected train low sessions along with training 
sessions requiring considerable CHO availability should be utilised in a training study 
across several weeks. Furthermore, the effect of acute and chornic train-low interventions 
have yet to be tested in females and this also represents a considerable body of work still to 
be conducted.  
 
Recommendation 2: This thesis presents the hypothesis of a critical glycogen threshold that 
must be achieved to induce the signalling required to elicit the augmented adaptive 
response. The use of step-wise reduction in muscle glycogen levels prior to exercise with 
muscle biopsy analysis, would allow better definition of the upper and lower limits of this 
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threshold. This data would considerably improve the understanding and ability to prescribe 
exercise-nutrition protocols to elicit the desired glycogen level appropriate to complete the 
pre-determined intensity and duration of training while still achieving the required 
threshold for augmented adaptive responses.  
 
Recommendation 3: Glycogen depletion via exercise has a considerable effect on the 
transcription of several regulators of mitochondrial biogenesis and function (Cluberton et 
al. 2005; Pilegaard et al. 2002; Impey et al. 2016; Hammond et al. 2016), yet the full 
extent of low CHO training on transcriptional activity has not been well quantified. 
Screening all transcriptional responses and targeted analysis of the greatest responder 
genes holds significant potential to identify previously unreported regulators of low CHO 
training (Timmons et al. 2011). Indeed, use of ‘omic’ approaches to globally quantify 
protein, phosphorylation and metabolite (both intracellular and circulatory) changes holds 
considerable potential to better define the adaptive responses induced by low CHO training 
(Padro et al. 2009).    
 
Recommendation 4: Much of the molecular targets measured here only provide a snapshot 
estimation of the regulation of key processes such as mitochondrial biogenesis, MPS and 
protein breakdown. The use of stable isotope methodology would therefore permit a more 
definitive assessment on the effects of reduced CHO availability on regulation of the above 
processes.    
 
In summary, the novel data presented in this thesis allude to a potential muscle glycogen 
threshold (e.g. <350 but >150 mmol·kg-1 dw) hypothesis surmising that reduced pre-
exercise muscle glycogen may enhance the activation of those pathways regulating 
mitochondrial biogenesis but also suggest that keeping glycogen (and energy intake) at 
critically low levels (i.e. <100 mmol·kg-1 dw) may impair the regulation of post-exercise 
remodelling processes.  From a practical perspective, data lend support for a potential “fuel 
for the work required” train-low paradigm in that athletes could strategically reduce CHO 
availability prior to completing pre-determined training workloads that can be readily 
performed with reduced CHO availability, thereby inducing a “work-efficient” approach to 
training.  Alternatively, when the goals of the training session are to complete the highest 
workload possible over more prolonged durations, then adequate CHO should be provided 
in the 24 h period prior to and during the specific training session.  Future studies should 
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now examine the functional relevance of the signalling responses observed here, not only 
in terms of acute muscle protein synthesis but also the chronic skeletal muscle and 
performance adaptations induced by long-term use of this feeding strategy. 
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Leucine enriched protein feeding does not impair exercise-induced lipid oxidation: 
implications for training in carbohydrate restricted states 
 
Samuel G Impey1, Daniel J Owens1, Jon D Bartlett1, Ken Smith2, Graeme L Close1 and 
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Introduction 
Training with reduced carbohydrate (CHO) availability augments skeletal muscle oxidative 
adaptations, an effect that may be mediated via free fatty acid (FFA) signalling (Hawley 
and Morton, 2014). However, a negative effect of CHO restriction during training is 
increased skeletal muscle protein breakdown (Howarth et al. 2010). A potential solution to 
overcome the latter is increased protein provision (especially leucine rich protein) so as to 
promote protein synthesis (Churchwood-Venne et al. 2013) though this strategy may be 
limited in that elevated insulin associated with protein feeding may actually attenuate 
lipolysis thereby negating FFA mediated signalling. The aim of the present study was 
therefore to test the hypothesis that leucine enriched protein feeding enhances circulating 
amino acid availability but does not impair lipid oxidation during exercise despite elevated 
insulin levels. 
 Method 
Nine male cyclists performed 2 hours of cycling at 70% V̇O2peak in fasted conditions 
(PLACEBO) or having consumed a whey protein isolate solution (WHEY) or a leucine 
enriched protein gel (GEL), administered as 20g 1 hour before, 10 g/h during and 20 g 
thirty minutes after exercise.  Total leucine administration was 11.4 g and 4.6 in GEL and 
WHEY, respectively. Primary and secondary outcome variables were plasma FFA 
availability and rates of lipid oxidation during exercise, respectively. 
Results 
Mean plasma leucine concentrations during the 5 h collection period were elevated in GEL 
(P= 0.001) compared with WHEY and PLACEBO (375 ± 100, 272 ± 51, 146 ± 14 µmol.L-
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1 respectively). No differences (P= 0.153) in plasma FFA (WHEY 0.53 ± 0.30, GEL 0.45 ± 
0.25, PLACEBO 0.65 ± 0.30, mmol.L-1) were apparent between trials during exercise, 
despite elevated (P= 0.001) insulin in WHEY and GEL compared with PLACEBO (38 ± 
16, 35 ± 16, 22 ± 11 pmol.L-1 respectively).  Accordingly, whole body rates of lipid 
(WHEY 0.37 ± 0.26, GEL 0.36 ± 0.24, PLACEBO 0.34 ± 0.24 g/min) oxidation were not 
different (P= 0.955) between conditions.  
Discussion 
Leucine enriched protein feeding does not impair FFA availability or whole body rates of 
lipid oxidation during exercise. Data have practical applications for those athletes who 
deliberately train in CHO restricted states given that high leucine availability promotes 
protein synthesis and that high rates of lipid oxidation is one of the main aims of CHO 
restriction. 
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availability: the critical glycogen hypothesis 
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2 Stirling University, UK 
Introduction  
Reduced carbohydrate (CHO) availability during training augments mitochondrial 
biogenesis (Bartlett, et al. 2014) and ingestion of leucine rich protein elevates (Pasiakos et 
al. 2011) muscle protein synthesis (MPS). We tested the hypothesis that reduced CHO but 
simultaneous high leucine availability enhances cell signalling responses associated with 
regulation of mitochondrial biogenesis and MPS. 
Method  
In a repeated measures crossover design, eleven males completed an exercise-nutrition 
protocol to modulate muscle glycogen prior to completing 45 min cycling at 50% peak 
power output (PPO) followed by an exercise capacity test (1-min bouts at 80% PPO 
interspersed with 1-min bouts at 40% PPO) in conditions of high CHO and protein 
availability (HIGH) or low CHO but high protein (leucine enriched) availability (LOW). 
Vastus lateralis biopsies were obtained pre-, post- and 3 h post-exercise to assess muscle 
glycogen content and activity of p70S6K, AMPK and PKB using kinase assays. Two way 
RM ANOVA was used to compare differences between conditions and across time. 
Results 
Muscle glycogen was different (P<0.05) pre-exercise (HIGH: 583 ± 158, LOW: 271 ± 84 
mmol/kg), similar post-exercise (HIGH: 114 ± 72, LOW: 85 ± 59 mmol/kg) and different 
(P<0.05) 3 h post-exercise (HIGH: 216 ± 132; LOW: 116 ± 60 mmol/kg). Despite 
differences (P<0.05) in exercise capacity (HIGH: 98 ± 29, LOW: 40 ± 17 min), exercise 
increased AMPK (P<0.05) at exhaustion in both groups (HIGH: 6 ± 4, LOW: 9 ± 5 
mU/mg). In accordance with elevated leucine availability in LOW, p70S6K activity was 
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different (P<0.05) pre-exercise (HIGH: 45 ± 23, LOW: 65 ± 24 µU/mg) whilst exercise 
suppressed activity at exhaustion (HIGH: 22 ± 16, LOW: 22 ± 13 µU/mg). However, 
despite elevated leucine availability post-exercise in LOW, PKB activity was reduced 
(P<0.05) at 3h in LOW (HIGH 49 ± 24, LOW 29 ± 6 µU/mg) accordingly p70S6K activity 
was not restored at 3 h post-exercise (HIGH: 53 ± 38, LOW: 28 ± 14 µU/mg).  
Discussion 
We show for the first time that the post-exercise recovery of p70S6K activity is impaired 
when muscle glycogen remains low despite high leucine availability. Although reduced 
CHO availability augments mitochondrial adaptations, we also suggest that post-exercise 
glycogen stores should not remain depleted (< 150 mmol·kg) to restore activity of 
p70S6K; we suggest there is a ‘critical glycogen threshold’ below which remodelling is 
impaired following exercise. Athletes should minimise time spent below this threshold 
during periods of low CHO training to augment the adaptive response to training.  
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We assessed the ability of protein with augmented leucine content to reactivate p70S6K 
following low CHO training. In a repeated measures cross-over design eight males 
completed 75 minutes of cycling exercise comprised of HIT and steady state intensity in a 
low carbohydrate but high protein state. Protein was provided before, during and after (20g 
per hour) in the form of collagen gel (GEL) or conventional whey protein (WHEY). 
Following exercise carbohydrate was provided in addition to protein so as to facilitate 
muscle glycogen synthesis. Muscle glycogen was comparable before (GEL: 354 ± 44; 
WHEY: 339 ± 66 mmol·kg dw) exercise and decreased post exercise (GEL: 141 ± 25; 
WHEY: 158 ± 80 mmol·kg dw) (P < 0.05). Exercise induced comparable PGC-1α (8-fold), 
ATG12 (1.3-fold) and Parkin (1.3-fold) increases in gene expression at 90 minutes’ post-
exercise. Suppression of p70S6K activity was comparable between conditions post-
exercise (~ 25 fmol.min-1.mg-1) (P < 0.05), while provision of carbohydrates and collagen 
protein was sufficient to re-activate p70S6K activity (GEL: 73 ± 42 fmol.min-1.mg-1), 
provision of leucine rich whey protein further augmented activity at 90 min post exercise 
(WHEY: 180 ± 105 fmol.min-1.mg-1) (P < 0.05). This augmented response occurred 
independent of insulin (WHEY AUC: 5296 ± 1478; GEL AUC: 3925 ± 602 AU) (P > 
0.05) and PKB (WHEY: 47.7 ± 21.9; GEL: 40.4 ± 19.8 fmol.min-1.mg-1) (P > 0.05). These 
data support the notion of a critical glycogen threshold for augmented oxidative 
adaptations in addition to identifying optimal nutritional recommendations to augment 
signalling to facilitate recovery processes.  
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